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Abstract 
Background. Severe illness, like that caused by the infectious disease tuberculosis (TB), is 
associated with direct expenses accessing healthcare, and indirect costs from time away 
from work. Cash transfers, which provide regular income transfers to eligible vulnerable 
households, might improve the coping capacity of poor households. This PhD aimed to 
investigate whether cash transfers prevent household financial hardship from severe illness. 
Objectives. 
1. Evaluate the effect of cash transfers on changes in household income and consumption 
in response to severe illness. 
2. Assess uptake of social protection and financial hardship amongst drug resistant TB 
affected households.  
3. Evaluate the most effective and affordable approach for delivering cash transfers to 
prevent household financial hardship related to TB. 
Methods. Systematic review of conditional cash transfers, income shocks, and household 
coping; historical cohort study of self-reported severe illness and changes in household 
labour income and food consumption; cross-sectional survey of notified drug resistant TB 
costs; economic modelling of cash transfers and catastrophic TB-related costs in seven 
countries.  
Results. Systematic review identified 5 studies, which together indicate that conditional 
cash transfers improve households’ capacity to safeguard consumption in response to 
shocks. Panel data analysis found no effect of self-reported severe illness on household 
labour income or food consumption. Cross-sectional analysis indicated that uptake of social 
protection, including cash transfers, reduces the likelihood of experiencing financial 
hardship because of drug resistant TB. In economic modelling, providing cash transfers to 
defray TB-related costs was more effective and affordable for preventing catastrophic costs 
than providing cash transfers to reduce poverty amongst households vulnerable to TB. 
Conclusion. Cash transfers appear to enhance the capacity of poor households to cope with 
severe illness. However, it remains unclear if cash transfers as currently implemented are 
sufficient to ensure that every household is able to meet their basic needs. 
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Chapter 1. Background, aims, and objectives 
1.1 Background 
1.1.1 Severe illness and household financial hardship 
Worldwide, illness is associated with direct medical expenses purchasing healthcare services 
(e.g. consultations), direct non-medical expenses accessing health services (e.g. 
transportation and food), and indirect costs from time off work related to disability; or 
discrimination for diseases that are stigmatized (1–5). Together, these costs are a frequent 
cause of household financial hardship, and can hinder patients’ access to healthcare services 
and ultimately their recovery from illness (4,6). Enshrined it its founding principle of health 
being a fundamental human right, the World Health Organization continues to push for 
international Universal Health Coverage of essential healthcare services at a price that 
prevents poor and rich households alike from suffering undue financial hardship (7). In 
response to this drive, concerted efforts have been made to minimize direct medical 
expenses associated with paying for healthcare services (2,3,8). However, paying for 
healthcare services is only a part of the financial burden of severe illness. Acknowledging 
this, some areas of public health, and in particular tuberculosis (TB) control, have also begun 
to focus on addressing direct non-medical expenses, and indirect costs associated with 
illness, which can be especially high for longer lasting illnesses (9–12). This approach goes 
beyond the conventional concept of Universal Health Coverage, and spans both the health 
and social development sectors (10). 
1.1.2 Estimating household financial hardship from severe illness 
In order to quantify the financial impact of illness for affected households, two principle 
approaches are used (5). The first empirical approach evaluates the impact of illness on 
households’ non-medical consumption growth over time, with consumption referring to the 
sum of the monetary values of all items consumed by a household (including home-grown 
products) (13). The strengths of this approach are that studies are often able to use a 
control group, and that consumption is a reliable measure of household welfare (14). 
Limitations are that illness is often self-reported, and therefore, affected by the subjective 
perception and cultural background of respondents (15–17). The second empirical approach 
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used to study the financial impact of illness, is to evaluate whether households’ health costs 
exceed a threshold of affordability considered to be catastrophic (18,19). Thresholds of 
affordability are usually measured using household income or non-medical consumption 
(18). The strength of this alternative approach is that it can provide a full breakdown of 
incurred costs for a particular illness. Limitations are that studies usually take a cross-
sectional design, often with small sample sizes and no control group, and thresholds of 
affordability are often set arbitrarily with little scientific grounding (e.g. 10%, 20%, or 40% of 
household pre-illness income) (20). 
In addition to evaluating changes in household non-medical consumption, or 
comparing the value of costs relative to a threshold of affordability, studies have also 
emphasised the importance of assessing households’ use of financial coping strategies in 
response to severe illness (21,22). Defined as strategies to relieve the impact of shocks after 
they occur, households may use financial coping strategies to defray direct expenses and 
indirect costs associated with illness, and thus protect their current non-medical 
consumption, Figure 1 (23). Common coping strategies include seeking favours and gifts 
from family and friends, drawing on savings, and selling non-productive assets (24). In 
extreme circumstances, households may resort to more costly coping strategies like 
borrowing high interest credit, selling productive assets, and withdrawing children from 
school for work (21,25,26). Whilst helping households to maintain a constant level of 
current consumption, this second category of coping strategy can compromise households’ 
future livelihood, and lead to long-term intergenerational consequences (22). 
Understanding households’ use of such coping strategies provides crucial detail about the 
price at which they may maintain a constant level of consumption, Figure 1. 
 
 
Figure 1. Conceptual framework illustrating the consumption effect of illness. 
Illness 
Lost 
income 
Consumption 
effect 
Coping 
Direct 
expenses 
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1.1.3 Preventing household financial hardship from illness 
The relationship between poverty, illness, and financial hardship is multi-faceted. It is widely 
acknowledged that poverty leads to increased risk of illness and worse health outcomes 
(27). Evidence also suggests that poverty is a key determinant of financial hardship related 
to illness, as poorer households have limited access to formal insurance initiatives, spare 
income, savings, or assets that may defray or reimburse either direct expenses or indirect 
costs associated with illness (12,28). A combination of the known effects of poverty on 
health, and health on poverty suggests that these factors may be related in a positive 
feedback loop that households find hard to break out of. Economic models highlight the 
possible influence of this system, known popularly as the poverty-disease trap, on persistent 
poverty and economic development (29). Initiatives to reduce poverty and/or enhance poor 
households’ ability to cope with economic shocks may have the potential to break the 
poverty-disease trap and impact across both Sustainable Development Goal 1: “End poverty 
in all its forms everywhere”, and Sustainable Development Goal 3: “Ensure healthy lives and 
promote wellbeing for all at all ages” (30). 
Designed to protect populations against poverty, livelihood risks, and social 
exclusion, social protection has a key role to play in both preventing illness, and helping 
poor households that are affected by illness to cope with the associated financial impact 
(31,32). There are two dominant forms of delivering social protection: social insurance, and 
social assistance, Table 1 (33). Social insurance protects beneficiaries against financial 
hardship related to unexpected sickness, unemployment, disability, and death in exchange 
for regular payments of premiums known as contributions, Table 1. Coverage of this type of 
initiative is usually low amongst poor households who find it hard to make regular 
contributions because of high levels of informal work and irregular income (34–36). In 
comparison, coverage of social assistance, which is designed to provide regular and 
predictable support to populations deemed eligible because of deprivation, and thus does 
not require regular contributions, is much higher (34). Principle social assistance initiatives 
include: cash transfers, non-contributory social pensions, food and in-kind transfers, school 
feeding programs, public works, and fee waivers, Table 1 (33). 
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Table 1. Summary of key social protection initiatives. 
Social protection: A set of initiatives that secure protection aimed at preventing or 
alleviating poverty, livelihood risks and social exclusion (33). 
Social insurance: An initiative to provide transfers to households in the event of adverse 
economic events, conditional on prior contributions and participation in the labour 
market (33). 
Examples: Sickness benefits, unemployment benefits, disability benefits and survivor’s 
benefits. 
Social assistance: An initiative to provide transfers to deprived households unconditional 
on previous payments or contributions (33). 
Examples: Cash transfers, in-kind transfers, non-contributory social pensions, and fee 
waivers. 
 
Households in poverty, and on the margins of poverty have heightened risk of illness, 
and associated financial hardship, and are therefore, a priority population for protection 
from direct expenses and indirect costs related to illness (27,28). Healthcare services funded 
or subsidized by government budgets are the most effective way of reducing the burden of 
direct medical health expenses for poor households, and many countries are making steady 
progress towards this goal (2,3). Alternatively, conclusive recommendations for protecting 
poor households against direct non-medical expenses and indirect costs related to illness 
are currently lacking. Cash transfers, which are based on regular and predictable income 
transfers to populations living below a poverty threshold, are one form of social protection 
that might help in this regard. Cash transfers may be given to beneficiaries with or without 
conditions. Unconditional cash transfer (UCT) initiatives provide regular income transfers to 
eligible households with no strings attached; whereas conditional cash transfer (CCT) 
initiatives make receipt of transfers contingent on utilization of public services (e.g. 
education and healthcare) as further encouragement for recipients to invest in child 
education, health, and nutrition (37). 
Since the 1990s, cash transfers have been adopted by an increasing number of 
governments in low- and middle-income countries as central elements of their poverty-
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reduction strategies (33). The value of monthly transfers is usually around 20% of pre-
transfer monthly household consumption, which for an average household living on the 
international poverty line is approximately US$ 46 (37,38). Synthesised evidence indicates 
that cash transfers have the potential to reduce monetary poverty, stimulate health service 
use, increase school attendance, improve dietary diversity, and foster economic autonomy 
via accumulation of savings (39). There is also evidence supporting the potential of cash 
transfers to contribute to disease prevention, and improve health outcomes for affected 
populations (40–45). The simple design of cash transfer initiatives lends itself to high 
numbers of beneficiaries like in Brazil and Mexico, where in 2016, anti-poverty cash 
transfers were distributed to 55 million households, and 26 million households, respectively 
(46).  
The primary objective of governmental anti-poverty cash transfer initiatives is to 
reduce current poverty by providing immediate income, and reduce future poverty by 
enabling investments in child education, health, and nutrition (37). Based on evidence 
demonstrating the potential of cash transfers to achieve these objectives, there are several 
ways that cash transfers may act on the poverty-disease trap, and ultimately protect 
households from experiencing financial hardship from severe illness (39). Firstly, by reducing 
current poverty and associated disease risk factors like undernutrition, they may altogether 
prevent some households from experiencing poverty-related illnesses and any associated 
financial hardship, Figure 2 (39,47,48). Secondly, for poor households who continue to 
experience severe illness, cash transfer initiatives may increase their capacity to cope with 
this adversity; however, the potential of cash transfers achieving this may vary according to 
when households begin to receive them (49–51). Specifically, if households receive cash 
transfers prior to experiencing severe illness, they may benefit from both additional 
savings/assets which cash transfers have helped them accumulate, as well as the ongoing 
monthly income effect (49–51), Figure 2. On the other hand, if households uptake cash 
transfers at the onset of severe illness they may only benefit from their monthly income 
effect, Figure 2.
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Figure 2. Conceptual framework illustrating the impoverishing effect of illness, and the protective effects of prior or subsequent receipt of cash 
transfers.  
Green arrows indicate a strengthening effect of cash transfers. Red arrows indicate an attenuating effect of cash transfers.
Illness with 
serious economic 
consequences 
Social Protection 
Cash Transfers 
Regular and predictable income & 
increased access to health services 
Uptake of cash 
transfers after illness 
Receipt of cash transfers 
before illness 
Direct expenses 
& lost income 
Financial 
hardship and 
deeper poverty 
Capacity to cope 
Regular and predictable income 
Regular and predictable income & 
accumulated savings and assets 
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1.1.4 Tuberculosis as a severe illness known to cause household financial hardship 
Severe illness that results in patients having to take time off work is known to cause 
excessive financial hardship. TB is one such illness (4). It is an infectious disease caused by 
Mycobacterium tuberculosis, which can be contracted by breathing in the air that someone 
suffering from the disease has contaminated (52). In 2017, an estimated 10 million people 
fell ill with TB, and it was the leading cause of death from a single infectious agent (52). TB 
generally affects the lungs but can also affect other parts of the body (52). Without prompt 
diagnosis and treatment, TB is severely debilitating, causing exhaustion, weight loss, and 
inability to work (52). The recommended treatment duration for drug sensitive (DS) TB is six 
months, and for drug resistant (DR) TB is up to 24 months (52). Because the early symptoms 
of TB - cough and loss of appetite - lack distinctive characteristics, evidence also shows that, 
on average, patients spend 2 months seeking a TB diagnosis (53). 
Most prevalent in low- and middle-income countries, TB disproportionately affects 
poor households that are least able to afford the burden that TB-related costs represent 
relative to their income (12,54,55). Even when diagnosis and treatment is available free of 
direct charges, households affected by TB are known to incur extreme health costs (12). 
Systematic review of TB-related costs across low- and middle-income countries found that 
whilst direct expenses are a major component, indirect costs contribute most to the 
economic impact of TB illness (direct medical expenses: 20%; direct non-medical expenses: 
20%; indirect costs: 60%) (12). Addressing households’ TB-related costs is essential for 
ensuring that people with active TB disease are able to complete their treatment 
successfully without falling into poverty (56). Acknowledging this, the World Health 
Organization’s End TB Strategy includes a high-level financial risk protection milestone for 
2020: “zero TB-affected households facing catastrophic costs due to TB” (9). 
Social protection initiatives have been endorsed as a key instrument for preventing 
TB-affected households from experiencing catastrophic costs (9). Appreciating that TB 
disproportionately affects poor households, pro-poor social assistance initiatives, including 
cash transfers, are considered a particularly effective form of social protection for TB-
affected households. Estimates for coverage of social insurance or social assistance in TB-
affected households remain scarce. In Brazil, 13% of notified TB patients have been found to 
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receive anti-poverty cash transfers, and in South Africa, close to 45% of households affected 
by multidrug resistant TB access non-contributory disability transfers during treatment 
(57,58). Evidence for the potential of cash transfers to protect households from 
experiencing financial hardship in response to TB is also limited. In 2015, a Cochrane review 
of the use of cash transfers in TB control identified no studies with financial hardship as an 
outcome (59). Since then, evidence from a randomised control trial in Lima, Peru has 
demonstrated the effectiveness of cash transfers to defray TB-related catastrophic costs and 
improve treatment outcomes (45,56). 
Table 2. Summary of key background messages for the thesis. 
1. Illness is associated with direct medical expenses purchasing healthcare, direct 
non-medical expenses accessing care, as well as indirect costs from time off work 
related to disability. 
2. Costs associated with illness are a frequent cause of household financial hardship, 
especially for households in poverty. 
3. Social protection has a key role to play in helping households to cope with the 
financial impact of illness, and social assistance initiatives, including cash transfers, 
may be most appropriate for households in poverty. 
4. TB is an illness known to cause excessive financial hardship for affected 
households. Indirect costs are a key driver of TB-related financial hardship. 
5. Social protection initiatives have been endorsed as a key instrument for 
preventing TB affected households from experiencing catastrophic costs. 
TB, tuberculosis.  
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1.2 Research gaps and rationale for this work 
Ensuring healthy lives, ending poverty, and promoting inclusive and sustainable economic 
growth are each goals in the 2030 Agenda for Sustainable Development adopted by the 193 
United Nations Member States (30). Illness is a common cause of household financial 
hardship especially for those in poverty. Preventing household financial hardship from 
illness might improve treatment outcomes, reduce poverty, and support economic growth 
(56,60). 
Previous efforts to prevent household financial hardship from illness have focused 
primarily on minimising direct medical expenses related to purchasing healthcare services. 
However, in addition to direct medical expenses, direct non-medical expenses accessing 
healthcare services, and indirect costs related to time away from work are also important 
drivers of financial hardship, especially for longer lasting illness (12). Limited research has 
evaluated the potential of interventions to protect households from these additional cost 
components (56,61). Cash transfers, are one social protection initiative from beyond the 
health sector that may help poor households to cope with the economic consequences of 
severe illness. Three specific research gaps that remain for informing the potential of cash 
transfers to protect households from financial hardship related to severe illness include: 
1. Uncertainty if governmental anti-poverty cash transfers protect poor households 
from financial hardship related to severe illness. 
2. Lack of knowledge as to which governmental social protection initiatives are 
accessed by TB-affected households during care, and whether they are sufficient to 
protect against household financial hardship. 
3. Doubt whether providing cash transfers to make poor households at risk of TB more 
resilient to TB-related costs, or to defray poor households’ costs after a family 
member develops TB is more effective and affordable for preventing financial 
hardship. 
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1.3 Aim, research objectives, and methodological approach of this thesis 
To address the three research gaps outlined above, the overall aim of this thesis was to 
establish whether cash transfers can prevent poor households from experiencing financial 
hardship from severe illness, like that caused by the infectious disease TB. In line with this 
aim, the thesis pursued five research objectives: 
1. Summarise existing evidence for the potential of governmental anti-poverty 
conditional cash transfers to help poor households cope with household-level shocks 
especially severe illness. 
2. Quantify the protective effect of governmental anti-poverty conditional cash 
transfers on household labour income and food consumption growth in response to 
self-reported severe illness with serious economic consequences in Brazil. 
3. Describe the proportion of households affected by DR TB that uptake social 
protection during treatment in Rio de Janeiro, Brazil. 
4. Evaluate whether uptake of social protection during DR TB treatment protects 
household from experiencing financial hardship in Rio de Janeiro, Brazil. 
5. Assess the most effective and affordable way of providing cash transfers to 
households affected by TB to prevent them experiencing financial hardship. 
The thesis took a predominantly quantitative approach to achieve its aim and 
objectives. For objective (1), it conducted a systematic literature review of evidence 
published before December 2016 relating to the impact of conditional cash transfers on 
both poor households’ ability to maintain a constant level of consumption, and their use of 
coping strategies in response to household-level shocks. For objective (2), it undertook a 
historical cohort study of 9457 poor Brazilian households using publically available 
secondary data that was collected in the early years of the Brazilian government’s rollout of 
its renowned Programa Bolsa Família conditional cash transfer program. For objective (3) 
and (4), it used a cross-sectional survey of 119 DR TB patients in Rio de Janeiro, Brazil. For 
objective (5), it conducted a country-level economic modelling study in seven countries 
using secondary data collected from a literature review.
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Chapter 2. Review of conditional cash transfers and financial 
hardship 
 
2.1 Research gaps addressed by reviewing the literature 
In line with objective (1) of this thesis, this chapter aimed to summarise existing evidence of 
the impact of governmental anti-poverty cash transfers on poor households’ consumption 
growth, and use of coping strategies in response to idiosyncratic shocks, such as death, 
injury, or unemployment. In doing so, this chapter addresses the first research gap 
identified by the thesis for informing the potential of cash transfers to protect households 
from financial hardship related to severe illness: Uncertainty if cash transfers protect poor 
households from financial hardship related to severe illness. 
2.2 Key findings from reviewing the literature 
The reviewed evidence indicates that cash transfers may protect household consumption 
growth, as well as reduce household informal borrowing and withdrawal of children from 
school, all in response to household-level shocks. 
2.3 Background to review 
Shocks are classified into two broad categories: covariate and idiosyncratic (62,63). 
Covariate shocks affect communities, regions, or whole countries, and include events like: 
natural disasters, disease epidemics, and financial crises (63). Idiosyncratic shocks affect 
particular individuals or households, and include events like: unemployment, illness, death, 
and loss of crops or livestock (63). In low- and middle-income countries, when faced with 
shocks, unable or reluctant to access formal insurance, poor households rely on other 
strategies to maintain a basic level of consumption (21). 
How households react to idiosyncratic shocks has been widely studied. Much of this 
research has focussed on poor households’ ability to maintain a constant level of 
consumption in response to shocks, and in most cases shows that households are unable to 
do this (13,62,64–66). Furthermore, evidence shows that that when faced with an 
idiosyncratic shock, households have to use coping strategies to fund their consumption 
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such as drawing on informal networks or savings, mobilising assets; and even turning to 
more costly strategies like borrowing high-interest credit, or withdrawing children from 
school (21,22,24,67,68). The inability of households to cope with idiosyncratic shocks and 
their reliance on harmful coping strategies is a key driver of poverty worldwide. Formulating 
policies that build the resilience of poor households is critical. This is formally recognised in 
target 1.5 of Sustainable Development Goal 1: “End poverty in all its forms everywhere”, 
which calls for the need to build the resilience of households in poverty to economic, social, 
and environmental shocks (30). 
As a form of social protection, social assistance initiatives are an effective way of 
supporting poor and vulnerable households. Originating in Brazil and Mexico in the 1990s, 
and now operated in over 60 countries, conditional cash transfers (CCTs) are a particularly 
popular social assistance initiative (33,37). They provide regular and predictable income to 
eligible poor households; and by making receipt of cash transfers contingent on utilization 
of public services, they incentivise investments in education, health, and nutrition (33,37). 
Studies consistently show that CCTs increase household income, consumption, and savings 
(39,61). The last attempt to review the literature for evidence of the effect of CCTs on 
households’ ability to cope with income shocks was conducted in 2010 (61). The review, 
which was part of a broader review of the economic impacts of CCTs, concluded that CCTs 
"protect household consumption and educational patterns during times of crisis" (61). 
However, the study did not provide an indication of the degree of protection that CCTs 
might provide, and results were not disaggregated by different types of shock. 
There are two mechanisms by which CCTs might help households cope with shocks. 
They might help households prepare for shocks before they occur by alleviating credit 
constraints and supporting accumulation of wealth either as formal bank savings, or, in 
settings where financial institutions such as banks are not readily available, informal savings 
or assets (49–51). CCTs might also help households respond to shocks after they occur by 
guaranteeing a continued regular and predictable source of income. Households’ increased 
ability to mobilise savings and assets together with a guaranteed regular source of income 
might enable them to avoid using costly coping strategies like borrowing high-interest 
credit, or withdrawing children from school for work, to finance their consumption, Figure 3. 
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Figure 3. Conceptual framework illustrating the negative consumption effect of idiosyncratic 
shocks, and the protective effect of prior receipt of conditional cash transfers. 
This review aimed to update evidence, and provide a quantitative summary of the 
impact of CCTs on poor households’ capacity to cope with shocks. For transparency, the 
review was reported according to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) checklist (69). 
2.4 Review methodology 
2.4.1 Electronic searches 
According to the PICO framework for developing literature search strategies, in this review, 
the population of interest was poor and vulnerable households, the intervention was receipt 
of CCTs, the comparator no receipt of CCTS, and outcomes of interest were the effect of 
CCTs on a) household consumption growth, and b) use of coping strategies in response to 
idiosyncratic shocks (70). This framework was used to develop a search strategy relating to 
CCTs, idiosyncratic shocks, consumption, and coping strategies. A systematic search strategy 
was employed using three electronic bibliographic databases: Econlit, Social Policy & 
Practice, and Global Health. Search terms were entered in English. The full search strategy is 
included in Table S1. 
Regular and predictable income 
Consumption effect 
Household-level shock 
Lost income 
Coping 
Receipt of conditional cash 
transfers before illness 
Accumulated savings and assets 
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2.4.2 Types of studies included in the review 
The review searched studies published from inception of database to December 2016 
reporting original analyses. Randomised and observational studies comparing households by 
receipt of CCTs, or by situation in a community targeted by CCTs were eligible for inclusion. 
CCTs were defined as programs transferring cash to poor households on the condition that 
they make pre-specified investments in the human capital of their children (37). Both peer-
reviewed and grey literature studies (e.g. working papers) were eligible for inclusion. 
For inclusion, studies had to evaluate a) the change in household consumption in response 
to a shock; and/or b) household use of coping strategies in response to a shock. Shocks were 
defined as an idiosyncratic health, economic, or social incident that reduces household 
wellbeing (71). The impact of CCTs on households’ ability to cope with covariate shocks was 
not studied as unlike for idiosyncratic shocks, this kind of shock has widespread effects on 
local markets (labour, food, credit etc.), which alters the coping strategies that are available 
to households (72). Household consumption was defined as the sum of the monetary values 
of all items (final goods and services) consumed by the household (including home-grown 
products) during the reference period (73), and coping strategies were defined as strategies 
to relieve the impact of shocks after their occurrence (23). Studies also had to use a 
research design corresponding to a score of two or above on the five-point Maryland 
Scientific Methods Scale (SMS), Table S2 (74). The Maryland SMS ranks policy evaluations 
from one (least robust) to five (most robust) according to the method used, with robustness 
referring to the extent to which a study’s design attempts to deal with selection and 
confounding biases inherent to policy evaluations. The Maryland SMS was used to decide on 
inclusion of studies in a previous review on the economic impact of CCTs (75). Included 
studies had to be in a low- or middle-income country as defined by the World Bank (76). 
2.4.3 Data extraction and management 
Information extracted from included studies included: First author, year of publication, peer 
reviewed publication (Yes/No), study country, study data source, year data source was 
collected, study design, study sample size, CCT name, CCT target population, shock, and 
effect of CCTs on household consumption and/or use of coping strategies in response to a 
shock. As recommended by Cochrane Methods, risk of bias in included studies was assessed 
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using the Risk Of Bias In Non-randomised Studies - of Interventions (ROBINS-I) assessment 
tool (77,78). The tool assesses study designs against a hypothetical pragmatic ‘target 
randomised control trial’ and focuses on seven domains of potential bias: confounding, 
selection bias, misclassification, time-varying confounding, missing data, measurement of 
outcomes, outcome reporting. For this review, the target trial that study designs were 
compared to was assignment to CCTs versus control. All evaluations were assessed for their 
dealing of potential confounding by household demographic factors (e.g. household size, 
household location, and sex, ethnicity, education of household head), and household 
poverty and labour (e.g. household labour and total income, number of economically active 
household members, employment of household head, and household access to credit). 
Evaluations were also assessed for whether they investigated if there was differential 
receipt of anti-poverty benefits from other social protection policies or initiatives by 
treatment status. Because the lowest risk of bias judgement in ROBINS-I corresponds to the 
risk of bias in a high quality randomised control trial, and for comparability across studies, in 
addition to non-randomised studies, ROBINS-I was also used to assess risk of bias in 
randomised studies included in the review.  
2.4.4 Data synthesis 
Extracted effect estimates were summarised using forest plots. A meta-analysis was not 
conducted as the review returned too few studies, and it was not appropriate to synthesise 
results across distinct shocks. 
2.5 Characteristics of identified studies 
The main literature search resulted in 68 citations, Figure 4. After screening of abstracts, 14 
full text articles were retrieved (24,79–91), 5 of which were included in the review 
(79,80,84,85,91), Figure 4. 
32 
 
Figure 4. Flow chart of the review process. 
CCT, Conditional Cash Transfer.  
68 articles identified through database 
searching (EconLit = 45; Global Health = 
23; Social Policy and Practice = 0) 
65 Full text articles after duplicates 
removed. 
65 Titles and abstracts screened for 
eligibility. 
14 Full text articles screened for 
eligibility. 
5 Full text articles included in the review 
51 articles excluded. Studies evaluated, 
reviewed or commented on the effects 
of CCTs on consumption but not in 
response to shocks. 
9 Full text articles excluded: 
4 Did not evaluate impact of shock. 
1 Evaluated impact of CCTs on 
household consumption in response to 
drought 2 years after the end of a 1-
year pilot program. 
1 Evaluated coping strategies of 
households receiving CCTs with no 
control group. 
1 Used the same data as Skoufias 2007 
but with fewer eligible exposures and 
outcomes. 
1 Used the same data as de Janvry et al. 
2006 but with fewer eligible exposures 
and outcomes. 
1 Previous version of updated working 
paper. 
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2.6 Findings from reviewed studies 
2.6.1 Conditional cash transfer programmes 
Evaluated CCT programmes were: Familias En Acción in Colombia (84), and Programa de 
Educación, Salud, y Alimentación (PROGRESA)/Oportunidades in Mexico (79,80,85,91). One 
study focused specifically on the urban component of PROGRESA/Oportunidades (85). The 
objectives of Familias En Acción and PROGRESA/Oportunidades were both to advance child 
health and education (37). Both programmes were made up of cash transfers conditional on 
regular visits to the health clinic for mothers and young children, and cash transfers 
conditional on child school attendance (37). Eligibility for PROGRESA/Oportunidades was 
determined using geographical, proxy-means and community targeting, and for Familias en 
Acción using geographical and proxy-means targeting (37,92). For both programmes, the 
average value of monthly CCTs received by treatment households was approximately 20% of 
monthly household total income (37). Included studies measured household exposure to 
CCTs as either household receipt of CCTs (84,85), or household situation in a community 
targeted by CCTs (79,80,91). In studies where analyses were conducted at both the 
household- and community-level, we extracted results from the primary analysis, which in 
both cases were at the household-level (80,84). 
2.6.2 Study designs 
Details of included studies are summarised in Table 3. Two studies involved explicit 
randomisation of treatment and control groups and had a Maryland SMS score of 5 (79,80), 
two involved comparing outcomes between matched treatment and control groups and had 
a Maryland SMS score of 3 (84,91), and one was a cross-sectional comparison of treated and 
control groups and had a Maryland SMS score of 2 (85), Table 3. Both randomised studies 
evaluated PROGRESA/ Oportunidades and involved the same random and sequential 
crossover of villages to treatment in 1998 and 2000 (79,80). One restricted the study 
population to only households eligible to receive CCTs (79). Across the three non-
randomised studies, one evaluated PROGRESA/ Oportunidades and used matching to select 
a group of control villages in 2003 (91). In this study, control villages were crossed-over to 
treatment between baseline and follow-up. As a result, this study evaluated the effect that 
duration of receipt of cash transfers had on household consumption growth, rather than the 
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overall treatment effect of CCTs. Another study evaluated urban PROGRESA/Oportunidades, 
and using matching to select a control group of eligible/quasi-eligible households (85). The 
last study evaluated Familias en Acción and used matching to select a group of control 
municipalities according to region, population size, area, quality of life index, and an index 
of educational and health infrastructure (84). 
2.6.3 Risk of bias assessment 
Risk of bias judgements based on ROBINS-I for each evaluation of the effect of CCTs on 
households’ consumption growth, or their use of coping strategies in response to 
household-level shocks are summarised in Table 4. With regards to evaluations of the effect 
of CCTs on households’ consumption growth in response to an idiosyncratic shock, two of 
the three studies evaluating this outcome were assessed to have low risk of bias (80,84). 
The third study was assessed to have moderate risk of bias, as control communities were 
matched to treatment communities several years after treatment was initiated (91). For 
evaluations of the effect of CCTs on households’ use of coping strategies in response to an 
idiosyncratic shock, three of the four studies evaluating this outcome were assessed to have 
low risk of bias (79,80,84). One study was assessed to have serious risk of bias, as 
participants’ treatment status was not recorded at the start of the intervention and could 
have been influenced by whether they experienced a household-level shock and used a 
coping strategy (85). Across studies included in the review, there was either poor, or no 
reporting of information on missing data, which meant that few studies’ risk of bias 
judgements could be informed by this domain.
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Table 3. Summary of studies included in the review. 
Study 
Peer 
reviewed 
Study 
location 
Data  
source 
CCT programme 
Measure  
of shock 
Study  
population 
Consumption effect           
Skoufias, 
2007 
Yes Mexico 
ENCEL  
(1998, 
1999) 
PROGRESA/ 
Oportunidades 
(i) 10% household income drop. 
(ii) Indicators for lost crops, lost 
livestock, lost land, or lost home 
related to natural disaster. 
506 communities randomly allocated 
to treatment (n=320) and control 
(n=186) in May 1998 with sequential 
cross-over of control communities to 
treatment in Dec 1999. 
Ospina, 
2010 
No Colombia 
SISBEN 
(2002, 
2003, 
2005/06) 
Familias en Acción 
(i) 10% household income drop. 
(ii) Indicators for 
unemployment of household 
head, illness of household head, 
death of a household member 
and crop loss. 
Representative stratified sample of 
treatment municipalities (n=57), and 
matched sample of control 
municipalities (n=65). 
Uchiyama
, 2106 
No Mexico 
ENCEL  
(2003, 
2007) 
PROGRESA/ 
Oportunidades 
(i) 10% household income drop. 
506 communities randomly allocated 
to treatment (n=320) and control 
(n=186) in May 1998 with sequential 
cross-over of control communities to 
treatment in Dec 1999. An additional 
group of 151 control communities was 
matched to treatment communities in 
2003, and crossed-over to treatment 
through 2004. 
Coping strategies           
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de Janvry, 
2006 
Yes Mexico 
ENCEL 
(1998,1999
, 2000) 
PROGRESA/ 
Oportunidades 
Indicators for unemployment of 
household head, illness of 
household head, illness of 
younger siblings, natural 
disaster, and lost crops, 
livestock or land related to 
natural disaster. 
10,855 households eligible to receive 
CCTs amongst 506 communities 
randomly allocated to treatment 
(n=320) and control (n=186) in May 
1998 with sequential cross-over of 
control communities to treatment in 
Dec 1999. 
Skoufias, 
2007 
Yes Mexico 
ENCEL 
(1999) 
PROGRESA/ 
Oportunidades 
Indicators for lost crops, lost 
livestock, lost land, or lost home 
related to natural disaster. 
506 communities randomly allocated 
to treatment (n=320) and control 
(n=186) in May 1998 with sequential 
cross-over of control communities to 
treatment in Dec 1999. 
Ospina, 
2010 
No Colombia 
SISBEN 
(2002, 
2003, 
2005/06) 
Familias en Acción 
Indicators for unemployment of 
household head, illness of 
household head, death of family 
member, and crop loss.  
Representative stratified sample of 
treatment municipalities (n=57), and 
matched sample of control 
municipalities (n=65). 
Vinay, 
2010 
Yes Mexico 
ENCELURB 
(2004) 
PROGRESA/ 
Oportunidades 
(urban component) 
Indicator for death, 
unemployment, property-
damaging fire, loss of a 
business, accident, illness, 
marital separation or problems 
with the law. 
3541 households that experienced a 
shock amongst a representative 
stratified sample of beneficiary 
households in treatment areas 
(n=11,563), and matched sample of 
eligible/quasi-eligible control 
households in treatment areas 
(n=5638). 
Abbreviations: CCT, Conditional Cash Transfer; ENCEL, Encuesta de Evaluación de los Hogares; ENCELURB, Encuesta de los Hogares Urbanos; SMS, Scientific 
Methods Scale; PROGRESA, Programa de Educación, Salud y Alimentación; SISBEN, Sistema de Selección de Beneficiarios Para Programas Sociales. 
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Table 4. Summary of risk of bias judgements of studies included in the review. 
Study 
Risk of bias domain 
Overall risk of 
bias Confounding Selection bias Classification Deviations Missing data Outcome Reporting 
Consumption effect               
Skoufias, 2007 Low risk Low risk Low risk Low risk No information Low risk Low risk Low risk 
Ospina, 2010 Low risk Low risk Low risk Low risk 
Insufficient 
information 
Low risk Low risk Low risk 
Uchiyama, 2016 Low risk Moderate risk Low risk Low risk 
Insufficient 
information 
Low risk Low risk Moderate risk 
Coping strategies               
de Janvry, 2006 Low risk Low risk Low risk Low risk Low risk Low risk Low risk Low risk 
Skoufias, 2007 Low risk Low risk Low risk Low risk No information Low risk Low risk Low risk 
Ospina, 2010 Low risk Low risk Low risk Low risk 
Insufficient 
information 
Low risk Low risk Low risk 
Vinay, 2010 Low risk Moderate risk Serious risk Low risk 
Insufficient 
information 
Low risk Low risk Serious risk 
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2.6.4 Evaluated shocks and coping strategies 
Evaluated idiosyncratic shocks included a 10% household income drop controlling for 
average change in community income (80,84,91), an indicator of “any” self-reported shock 
(85), and indicators of eight specific self-reported shocks: death of a household member 
(79,84), illness of household head (79,84), illness of household child (79), unemployment of 
household head (79,84), loss of harvest (79,80), loss of livestock (79,80), loss of land (79,80), 
and loss of home (80). Evaluated coping strategies included: reducing household 
expenditures (84,85), using savings (80,84), using assets (80,84), borrowing informal credit 
from family or friends (80,84,85), using social support from family and friends (80), getting 
government help (80), borrowing formal credit (84), increasing household work (80,84), 
increasing child work (79,84), maintaining child school attendance (79,84). 
2.6.5 Conditional cash transfers and consumption in response to shocks 
Three studies evaluated the effect of CCTs on family food, non-food and/or total 
consumption in response to idiosyncratic shocks (80,84,91), Figure 5, Figure 6, and Figure 7. 
In response to shocks that had a negative effect on family consumption, CCTs had a 
consistently protective effect (Range of CCT treatment effect: 0.04 % point difference to 
14.1 % point difference) (80,84,91). This effect was significant in response to loss of harvest 
in Colombia (p<0.1), and loss of livestock in Mexico (p<0.1) (80,84). The largest reduction in 
family consumption was in response to unemployment of household head (Effect of shock 
across food, non-food, and total consumption: -15.5%, -28.5%, and -23.6%, respectively), 
and for this shock, the treatment effect of CCTs was noticeably small (Treatment effect of 
CCTs across food, non-food, and total consumption: 0.5 % point difference, 7.7 % point 
difference, and 6.3 % point difference respectively) (84). In response to death of a 
household member, which had a positive effect on family non-food and total consumption, 
CCTs also had a significant protective effect (CCT treatment effect: -18.2 % point difference, 
p<0.01; and -19.8 % point difference, p<0.05, respectively) (84). Across studies, the 
treatment effect of CCTs on family consumption was reduced by education and 
employment-status of household head, and increased by household eligibility for CCTs, and 
duration of receipt of CCTs (80,91).
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Figure 5. Forest plot summarising the effect of conditional cash transfers on food consumption in response to a shock.  
Abbreviations: CCT, Conditional Cash Transfer; HH, Household; CI, Confidence Intervals. Estimates are from ordinary least square model. Box size is based on precision. 
*p<0.1, **p<0.05, ***p<0.01. 
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Figure 6. Forest plot summarising the effect of conditional cash transfers on non-food consumption in response to a shock. 
Abbreviations: CCT, Conditional Cash Transfer; HH, Household; CI, Confidence Intervals. Estimates are from ordinary least square model. Box size is based on precision. 
*p<0.1, **p<0.05, ***p<0.01.  
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Figure 7. Forest plot summarising the effect of conditional cash transfers on total consumption in response to a shock. 
Abbreviations: CCT, Conditional Cash Transfer; HH, Household; CI, Confidence Intervals. Estimates are from ordinary least square model. Box size is based on precision. 
*p<0.1, **p<0.05, ***p<0.01. 
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2.6.6 Conditional cash transfers and use of coping strategies in response to shocks 
Four studies evaluated the association between CCTs and household use of coping 
strategies in response to idiosyncratic shocks (79,80,84,85), Figure 8. Shocks were 
consistently associated with increased informal borrowing from family and friends (Range of 
effect of shock: 0.003 to 0.265), but to a lesser extent amongst CCT treatment households in 
response to summary measures of any shock, loss of harvest, or loss of livestock (Range of 
negative CCT treatment effect: -0.002 to -0.25) (80,84,85). Evidence consistently showed 
that CCTs were associated with increased probability of child school attendance in response 
to shocks (Range of positive CCT treatment effect: 0.01 to 0.05) (79,84). Apart from this, 
there was no obvious trend for an association between CCTs and household use of coping 
strategies. In response to specific shocks, there was weak evidence for an association 
between CCTs and increased probability of households reducing spending, using assets, 
seeking social support from friends and family, getting help from the government, and 
increasing household work, as well as decreased probability of households using assets, and 
increasing household work (79,80,84,85). There was stronger evidence for an association 
between CCTs and child work in response to loss of land, harvest, or livestock, whereby 
overall this shock was associated with decreased probability of using child work in all groups 
(Effect of shock: -0.019), but to a lesser extent amongst CCT treatment households (CCT 
treatment effect: 0.02) (79). Illness of household head, and illness of household child were 
both associated with increased child work overall, and to no lesser extent amongst CCTs 
treatment households (79). Studies were underpowered to detect associations between 
CCTs and use of coping strategies in response to rare shocks like death of a household 
member (84).
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Figure 8. Forest plot summarising the association between conditional cash transfers and household coping 
strategies in response to a shock. 
Abbreviations: CCT, Conditional Cash Transfer; Dif., Difference; HH, Household; Gov, Government. Unless stated, 
estimates are average marginal effects from probit model. Box size is based on precision. *p<0.1, **p<0.05, 
***p<0.01. †Estimates refer to linear probability model; ‡Refers to proportion of children aged 0-5 ill; ~Estimate was 
not available. 
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2.7 Discussion of findings 
This review identified five studies evaluating the impact of CCTs on the capacity of poor 
households to cope with idiosyncratic shocks. It suggests that CCTs consistently provide 
some protection from the negative effects of idiosyncratic shocks on household 
consumption, especially in response to loss of harvest or livestock. The review indicates that 
CCTs increase the likelihood of children staying in school when households face idiosyncratic 
shocks, but in response to illness, they may not protect against children simultaneously 
working. There was consistent evidence suggesting that CCTs reduce the probability of 
households borrowing informally from family and friends, and mixed evidence for whether 
or not CCTs increase the likelihood of households using assets or working more in response 
to shocks. 
The finding that CCTs may increase poor households’ capacity to smooth their 
consumption and respond to some idiosyncratic shocks using assets supports the study 
conceptual framework, and previous work showing that CCTs help households accumulate 
wealth (49,51). Evidence for a protective effect of CCTs on child school attendance in 
response to idiosyncratic shocks also demonstrates that CCTs may be an effective way of 
ensuring that short-term shocks do not have long-term consequences for child human 
capital accumulation (79,84). Together these findings add to the growing evidence for the 
positive effects of CCTs across a wide variety of social, economic, and health outcomes (39). 
Whilst there was consistent evidence for a protective effect of CCTs on household 
consumption in response to idiosyncratic shocks, one study found that CCTs did not fully 
protect household consumption from unemployment of the household head (84). This 
shock would be expected to result in at least a 50% drop in household income, which might 
be too much for the income effect of CCTs to fully compensate (37). Furthermore, when 
faced with this shock, beneficiary households might prioritise part of the value of CCTs to 
fund consumption that non-beneficiary households save on. For example, as was found in 
this review, CCTs are associated with increased likelihood of children staying in school in 
response to idiosyncratic shocks (79,84). The need to further support poor households in 
response to more severe shocks was further highlighted by evidence that CCTs might not 
prevent increased child work in response to illness of the household head (79). 
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Across various types of idiosyncratic shocks, there was inconclusive evidence for the 
association between CCTs and households’ use of assets as a coping strategy (80,84). Whilst 
CCTs increase use of assets in response to some idiosyncratic shocks, they also reduce their 
use in response to others including illness of household head. It is possible that either, CCTs 
do not support households sufficiently to gather assets that provide adequate return to help 
them cope with certain shocks; or, households might have difficulty mobilising assets that 
CCTs help them accumulate, especially if they are difficult to sell quickly (e.g. land), or 
complex to divide (e.g. assets of microenterprise) (49,51,93,94). Alternatively, if the assets 
that CCTs help households accumulate are productive and are used to generate income (e.g. 
livestock), there may be some reluctance to sell them to fund current consumption if that 
would risk permanently lowering consumption in the future (94). The inconsistent evidence 
for the effect of CCTs on household use of assets in response to idiosyncratic shocks 
highlights the need for further research on this issue. 
Although informal borrowing from family and friends was found to be a common 
coping strategy overall, its use was slightly lower amongst CCT treatment households 
(80,84). Consistent with previous evidence, the wealth effect of CCTs amongst beneficiary 
households might increase the availability of informal credit for non-beneficiary households, 
and thus increase their use of this coping strategy in response to idiosyncratic shocks (95). 
Additionally, CCTs might help beneficiary households to partially replace informal borrowing 
with other strategies like selling assets (84,96). Reduced reliance on informal loans as a 
coping strategy is likely to minimize beneficiary households’ accumulation of debt, and 
speed up recovery. 
The quality of studies included in this review was medium to high, and only one was 
assessed to have serious risk of bias (85). Two studies were randomised (79,80), and three 
matched treatment and control groups on socioeconomic characteristics (84,85,91). 
Although included studies did not report power calculations, they all had high sample sizes 
at community- and household-levels. Household-level analyses within community 
randomised studies may have suffered residual bias from restriction of study samples to 
only eligible households (79,80). Most studies suffered from some degree of loss to follow 
up (Range: 16% to 24%), and only one checked for associations between exposure to CCTs 
and loss to follow up (79). Loss to follow up could have led to bias if poor households were 
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both more likely to be lost to follow-up, and more likely to experience shocks. Future 
studies should report characteristics of households lost to follow up, and employ statistical 
methods to minimise this bias (97). 
This review had several limitations. First, the internal validity of findings might be 
limited from inclusion of only English language studies, as, related to the spread of CCTs 
across Latin America, an increasing number of studies are published in Spanish and 
Portuguese (33). Identification of only a few eligible articles meant it was not possible to use 
a meta-analysis to synthesize a common effect of CCTs on households’ capacity to cope with 
distinct shocks. Whilst valuable, the qualitative approach that was used to synthesise CCT 
treatment effects did not account for sample size or magnitude of effect. Finally, the 
external validity of the review’s findings is limited by identification and inclusion of studies 
in only two low- and middle-income countries. 
2.8 Further research gaps emerging from the review 
The limited evidence identified in this review highlights the need for further research into 
whether CCTs help poor households cope with idiosyncratic shocks, Table 5. Exploring both 
of these issues in settings beyond Mexico and Colombia is a priority. Besides PROGRESA/ 
Oportunidades and Familias En Acción, CCT programmes are ongoing in at least 59 other 
countries around the world (33). In addition to evaluating whether CCTs help households 
maintain a constant level of consumption, studies should also estimate whether they help 
households maintain a level of consumption that guarantees all of their basic needs. This is 
important, as whilst CCTs might not protect consumption fully, they may provide sufficient 
protection to prevent households from falling below the poverty line. Studies should also be 
more specific about the coping strategies that households use, as this will help gauge how 
severe these strategies are for households. For example, does informal credit received from 
family or friends need to repaid, and are assets that are sold productive (i.e. have the 
potential to generate income)? To inform future interventions aimed at helping households 
cope with idiosyncratic shocks, work should both characterise which households are most 
vulnerable to these shocks, and estimate how much CCTs would need to be topped up in 
order to prevent households from having to reduce their consumption, or use costly coping 
strategies. Studies should also evaluate other modifiers of the treatment effect of CCTs on 
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households’ coping capacity for example, the duration, intensity, and predictability of 
shocks. Finally, attempts to synthesise evidence on the potential of other forms of social 
assistance would serve to inform how effective other initiatives might be at helping poor 
households cope with idiosyncratic shocks (33). 
 
Table 5. Summary of further research gaps emerging from review. 
1. Is the level of protection that CCTs provide in response to idiosyncratic shocks 
sufficient to guarantee all of affected households’ basic needs? 
2. In addition to preventing less severe borrowing and sale of assets, are CCTs able to 
prevent households from using harmful forms of borrowing, or sale of assets? 
3. How much would CCTs need to be topped up in order to fully protect household 
consumption from the negative effects of an idiosyncratic shock? 
4. Does the duration of time a household has received CCTs modify their potential to 
help households cope with idiosyncratic shocks? 
5. Do other social assistance initiatives provide a similar level of protection against 
idiosyncratic shocks as CCTs? 
 
2.9 Concluding remarks 
Limited evidence indicates that CCTs enhance poor households’ capacity to cope with 
idiosyncratic shocks, and that a policy promoting CCTs is likely to have beneficial effects for 
households that experience such shocks. However, whether CCTs as currently implemented 
are sufficient to ensure that all households are able to meet their basic needs in response to 
such shocks remains uncertain. There is also little knowledge as to how CCTs affect 
households’ use of coping strategies in response to shocks. Such knowledge could usefully 
inform CCT implementation.
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Chapter 3. Conditional cash transfers and the consumption effect of 
self-reported severe illness in Brazil 
 
3.1 Research gaps addressed with the AIBF historical cohort in Brazil 
In line with objective (2) of this thesis, this chapter aimed to evaluate whether poor 
households are able to safeguard their labour income and food consumption in response to 
self-reported severe illness with serious economic consequences, and whether receipt of 
governmental anti-poverty cash transfers helps them do this. In doing so, this chapter 
addresses the first research gap identified by the thesis for informing the potential of cash 
transfers to protect households from financial hardship related to severe illness: Uncertainty 
if cash transfers protect poor households from financial hardship related to severe illness. 
3.2 Key findings from historical cohort study in Brazil 
Self-reported severe illness with serious economic consequences had surprisingly little 
effect on poor households’ labour income, or food consumption. This finding, which is 
considered to be largely driven by measurement error, meant that there was limited scope 
to assess any protective effect of cash transfers, and the observed effects were modest. 
3.3 Background to historical cohort study in Brazil 
Illness is associated with direct expenses accessing healthcare, and lost income related to 
incapacity to work or reduced productivity (5). Together, these costs are a frequent cause of 
welfare loss and financial hardship for affected households (5,4,12,98). The most vulnerable 
households are those in poverty without access to risk-management strategies like formal 
insurance, savings, or assets. Consumption is a common measure of household welfare, and 
vulnerability has often been evaluated as households’ ability to maintain a constant level of 
consumption in response to illness (28). Studies taking this empirical approach have mixed 
results. Whilst many find that households experience decreased consumption in response to 
illness, some find that households are able to safeguard consumption in response to this 
shock (5). When households are found to safeguard their consumption, this is sometimes at 
the cost of using harmful coping strategies like borrowing high-interest credit, or 
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withdrawing children from school, which have long-term consequences for household 
welfare (21,99). 
Illnesses affecting the ability of household heads to carry out activities of daily living 
have the largest impact on household welfare (13,15). Strengthening the ability of poor 
households to manage and cope with such severe illness is key in trying to break the trap of 
ill health and poverty (100). Acknowledging this, the International Labour Organization and 
World Health Organization promote the concept of a social protection floor that provides 
universal access to essential health care and income security at a nationally defined 
minimum level (11). Social protection consists of initiatives designed to protect vulnerable 
populations against poverty, livelihood risks and social exclusion, and can be divided into 
social assistance, social insurance, and labour market measures (31). High-levels of informal 
work and irregular income has meant that traditionally, coverage of social insurance has 
been low amongst poor households (34–36). Designed to provide regular and predictable 
support to poor populations, and not requiring regular contributions, coverage of social 
assistance is much higher (34). 
Originating in Brazil and Mexico in the 1990s, conditional cash transfers (CCTs) are a 
particularly popular social assistance initiative (33,37). CCT programs provide monthly 
income transfers to millions of poor households with two principle objectives: provide 
beneficiaries with a minimum level of income (reduce present poverty); and by making cash 
transfers conditional on utilization of public services, incentivise their investment in child 
education, health, and nutrition (reduce future poverty for next generations) (37). 
Synthesised evidence shows that CCTs increase child school attendance and use of health 
services, and reduce household monetary poverty (39). Providing transfers close to 20% of 
households’ pre-program income, CCTs might also help households prepare for shocks ex 
ante by supporting accumulation of wealth either as savings or assets, and help households 
cope with shocks ex post by guaranteeing a continued regular and predictable source of 
income (37,49–51). A systematic review in 2010 found some evidence that CCTs protect 
household consumption and educational patterns during times of crisis (61). More recent 
evidence also supports this (84,85,91). 
Better understanding of poor households’ vulnerability to the financial impact of 
mid- to long-term severe illness is needed to guide the formulation of future policies. We 
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aimed to evaluate whether poor households in Brazil are able to cope with severe illness, 
and whether receipt of CCTs helps them with this. We used households’ ability to maintain a 
constant level of consumption as our measure of vulnerability. 
3.4 Methodology 
3.4.1 Study design 
The study was a historical prospective cohort study of Brazilian households, and was reported 
according to the Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) checklist for cohort studies (101). The study population was households across 
Brazil registered in the national social registry Cadastro Único at study baseline in 2005 (102). 
Living on the margin of poverty, this population are highly vulnerable to shocks like disabling 
illness. 
3.4.2 Study setting 
The setting for this study was Brazil, an upper-middle income country in South America with 
a population of approximately 200 million (103). Brazil is divided into five great political-
administrative regions: Central West, North, Northeast, South, and Southeast. Across Brazil, 
a historic regional variation in living standards persists today. States in the South and 
Southeast regions, which include the major cities of São Paulo and Rio de Janeiro, remain 
generally more urban and industrialised, compared to states in the North and Northeast 
regions which remain generally more rural and agrarian.  
Between 2000 and 2012, Brazil was one of the fastest growing world economies 
(104). This was accompanied by strengthening of the formal labour market, increases in the 
minimum wage, and the expansion of social policies; which all contributed to substantial 
reductions in poverty (Poverty headcount: 25% in 2001; 9% in 2012), and income inequality 
(Gini index: 58.4 in 2001; 52.6 in 2012) (105,106). In 2013, economic growth decelerated, 
and in 2014, the country entered a recession, leading to increased unemployment, mainly in 
low-income populations, and a reversal in previous gains in poverty and inequality reduction 
(107). Economic growth picked up again in 2017 with an annual GDP growth of 1% (104). 
At the beginning of the 2000s, major social protection policies in Brazil included the 
national Unified Health System, which provides healthcare free at the point of care for all 
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citizens (108). There was also the non-contributory social assistance programme Benefício 
de Prestação Continuada, which provides monthly unconditional cash transfers to people 
with a monthly household income per capita less than US$67, and are either older than 65 
years of age, or have a medically approved disability that lasts at least 24 months (109). 
National social insurance was also available for workers who contributed independently or 
via their employer (approximately 50% of workers) (110). During the 2000s, Brazil 
consolidated its existing social protection system by rolling out the national CCT programme 
Programa Bolsa Família. Designed to reduce levels of poverty, in 2005, Programa Bolsa 
Família provided monthly CCTs to 8.7 million households (39 million individuals) in extreme 
poverty (household income per capita < US$ 21), and poverty (household income per capita 
between US$ 21 and US$ 41) with children or a pregnant/lactating mother registered in the 
national social registry Cadastro Único (108,109,111,112). 
3.4.3 Description of the data source 
The Brazilian Ministry of Social Development’s Secretary of Evaluation and Information 
Management (SAGI) publishes microdata from publically funded evaluations (113). The data 
for this study came from a panel survey of households, known as Avaliação do Impacto do 
Bolsa Família (AIBF), designed to evaluate the impact of Program Bolsa Família on household 
labour participation, women’s bargaining power, and child education, anthropometry, and 
health (97). The sampling frame was designed to obtain a ratio of 30%:60%:10% across 
households receiving Programa Bolsa Família in 2005 vs. households not receiving Programa 
Bolsa Família but registered in the national social registry Cadastro Único vs. households not 
receiving Programa Bolsa Família and not registered in Cadastro Único. Households were 
first surveyed in August 2005 and followed up in October 2009. In each wave, data were 
collected in the same month for all households. Data were collected in 24 out of the 27 
Brazilian states, and included detailed information on household income and consumption, 
household members’ contribution to social insurance, household receipt of social 
assistance, and exposure to multiple types of income shock. The AIBF panel data was 
downloaded on the 1st August 2017. 
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3.4.4 Severe illness with serious economic consequences 
The study exposure was a self-reported binary indicator (Yes/No) of severe illness in the family 
that led to a serious reduction in family patrimony, income, or consumption between 2005 
and 2009. The exact phrasing of the question was: “Now, we would like to know more about 
adverse events (shocks) in the last 4 years. Was the family affected by a severe event – an 
occurrence that led to a serious reduction in your patrimony, caused substantial reduction in 
your family income, or resulted in a significant reduction in consumption?” (Agora, nós 
gostaríamos de saber mais acerca de eventos adversos (choques) nos últimos 4 anos. Será que 
a família foi afetada por eventos graves – um acontecimento que levou a uma séria reducao 
do seu patrimônio, causou um redução substancial da renda familiar, ou resultou emu ma 
redução significativo no consumo?). Respondents could then choose from a list of 30 severe 
events including: illness of the husband, illness of the wife, illness of another person. 
Responses to these three questions were combined into a single indicator of severe illness in 
the family with serious economic consequences between 2005 and 2009.  
3.4.5 Food consumption, labour hours, and labour income 
The primary study outcome was household per capita monthly food consumption between 
2005 and 2009. Monthly food consumption was calculated as the summed value of self-
reported consumption of 65 food items purchased in the 7 or 30 days prior to interview. 
Secondary study outcomes were, household per capita weekly labour hours, and household 
per capita monthly labour income. Weekly labour hours were measured as the summed 
value of hours worked by all household members, and monthly labour income was 
measured as the summed value of individual salaries of all household members. Food 
consumption and labour income were both measured in Brazilian reais (R$). Household per 
capita monthly non-food consumption was not included as a study outcome as previous 
analysis shows that reporting of some non-food expenditure items in 2009 was unreliable. 
3.4.6 Receipt of conditional cash transfers 
Receipt of CCTs was measured as self-reported receipt of Programa Bolsa Família, or one of 
Programa Bolsa Família’s predecessor programmes: Bolsa Alimentação, Bolsa Escola, Cartao 
Alimentação, or Programa de Erradicação do Trabalho Infantil in 2005. The characteristics of 
Programa Bolsa Família and its predecessors were very similar, and were therefore expected 
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to have a similar effect on study outcomes, Table 6. Households that began to receive CCTs 
between baseline and follow up were not included in the receivers group as the data was not 
detailed enough to tell if households experiencing severe illness received their first income 
transfer before or after illness. Furthermore, if households did begin receiving CCTs before 
illness it is unlikely that they would have received them for long enough to accrue savings. 
3.4.7 Covariates 
Covariates summarised, and included in all multivariate regression models were self-reported 
household exposure to drought or flooding, loss of crops or livestock, and death with serious 
economic consequences between 2005 and 2009; as well as household baseline region of 
residence, location of residence, type of residence, number of household members aged 0 to 
6 years, number of household members aged 7 to 15 years, self-reported number of 
household members working and contributing to social insurance, and self-reported total 
income per capita; as well as household responsible baseline sex, age, ethnicity, literacy, work 
branch, and self-rated health. Household exposure to unemployment with serious economic 
consequences between 2005 and 2009 was summarised, but was not adjusted for in 
multivariate regression models as it lies on the causal pathway between severe illness and 
financial hardship. 
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Table 6. Summary of conditional cash transfer programmes received by poor households in Brazil in 2005. 
Programme Household eligibility criteria 
Transfer 
frequency 
Transfer value Conditionality 
Programa Bolsa 
Família 
Monthly household income per capita < US$ 21 
Monthly household income per capita between 
US$ 21 and US$ 41 and pregnant/lactating 
mother, or child aged between 0 and 15 years 
(Up to a maximum of 3). 
Monthly 
US$ 6 to US$ 39 
(US$ 21 base 
transfer for 
extreme poor, and 
US$ 6 per 
pregnant/lactating 
mother, or child) 
Pregnant mothers must complete ante-
natal checks. Children aged 0 to 6 years 
must be breastfed, and receive all 
vaccinations. Children aged 0 to 15 must 
not work and keep an annual school 
attendance of 85%. 
Bolsa Escola 
Monthly household income per capita < US$ 37, 
and child aged between 7 and 15 years (Up to a 
maximum of 3). 
Monthly 
US$ 6 to US$ 18 
(US$ 6 per child) 
Children aged 7 to 15 must not work and 
keep an annual school attendance of 
85%. 
Bolsa Alimentação 
Monthly household income per capita < US$ 37, 
and pregnant/lactating mother, or child aged 
between 0 and 6 years (Up to a maximum of 3). 
Monthly 
US$ 6 to US$ 18 
(US$ 6 per 
pregnant/lactating 
mother, or child) 
Pregnant mothers must complete ante-
natal checks. Children aged 0 to 6 must 
be breastfed, and receive all 
vaccinations. 
Programa do 
Cartão 
Alimentação 
Monthly household income per capita < US$ 59 
Monthly 
for 6 
months  
(possible to 
renew 
twice) 
US$ 39 Benefits must only be spent on food. 
Programa de 
Erradicação do 
Trabalho Infantil 
Child aged 0 to 15 years in or at risk of falling 
into dangerous, unhealthy or degrading work. 
Monthly 
US$ 10 in rural 
areas, and US$ 16 
in urban areas. 
Children aged 0 to 15 must not work and 
keep an annual school attendance of 
75%. 
Abbreviations: US$, United States Dollar. 
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3.4.8 Bias 
Loss to follow up (LTFU) is a concern for any longitudinal study. In 2009, 26% of the original 
sample surveyed in 2005 could not be located. Predictors of LTFU were investigated using 
logistic regression. Attrition weights generated in the original Programa Bolsa Família impact 
evaluation were used to account for LTFU in the analysis. Details of how these attrition 
weights were estimated are described in the original evaluation’s summary report (97). 
Missing data is another potential source of bias (115). The extent of missing data was 
tabulated, and missing patterns were investigated using logistic regression. A combination of 
methods was used to account for missing data. For food consumption, because food prices 
are fixed, missing values were imputed using mean local-, regional- or sample-prices. Aside 
from food consumption, to account for the multi-level structure of the data, missing values 
were imputed using Markov Chain Monte Carlo hierarchical multiple imputation clustered at 
the household level (116). Separate interaction terms were included between individuals’ 
type of work and work salary, and their type of work and work hours. Five imputed datasets 
were created using a total run length of 25 iterations with imputations after every 5th iteration 
using the ‘jomoimpute’ command of the ‘mitml’ package in R (117). Imputation assumed that 
missing data were missing at random conditional on observed individual and household 
characteristics. 
3.4.9 Study sample size 
A basic sample size calculation was used to check if the AIBF data included sufficient 
participants to investigate the impact of severe illness on this study’s primary outcome, 
change in household per capita monthly food consumption. Based on a mean change in 
household food consumption per capita of US$ 16 (SD: US$ 37), and 14% prevalence of 
severe illness, as observed in the AIBF data, to detect a conservative effect of severe illness 
of US$ 3, with a two-tailed 5% type I error rate, 80% power, a minimum overall sample size 
of 9,918 was required. This indicates that the AIBF data (N=12,792) was sufficiently powered 
to investigate the effect of severe illness on change in household per capita food 
consumption. Given the minimum four-fold increase in sample size required to investigate 
2x2 interactions (114), the AIBF data had low power to evaluate whether receipt of CCTs 
modifies the effect of severe illness on change in household per capita food consumption. 
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3.4.10 Statistical analysis 
Data management. All monetary values were deflated and converted to 2005 United States 
dollars (US$). In 2005 R$ 1 = US$ 0.41 (118). 
Data analysis. Baseline and time-varying characteristics of study participants were 
summarised overall and by exposure to severe illness. The data analysis was then divided into 
two parts. First, the overall effect of severe illness on household per capita labour hours, 
labour income, and food consumption was estimated. The hypothesis was that severe illness 
reduces affected household members’ capacity to work and generate income, and that less 
disposable labour income reduces household food consumption. For each study outcome, 
estimates for the effect of severe illness were quantified using a difference in difference 
estimator, which compared the estimated growth in study outcome between baseline and 
follow up for households that did and did not experience severe illness.  
Second, an evaluation of the effect of severe illness on household per capita labour hours, 
labour income and food consumption by receipt of CCTs at baseline in 2005 was carried out. 
The hypothesis was that CCTs help households prepare for shocks ex ante by supporting 
accumulation of wealth, and help them respond to shocks ex post by guaranteeing a 
continued regular and predictable source of income. These effects should result in a lower 
reduction in food consumption amongst households that experience severe illness. 
Determinants of receipt of CCTs were summarised using logistic regression. For each study 
outcome, estimates for the effect of severe illness by receipt of CCTs were quantified using a 
difference in difference estimator, which contrasted the difference in estimated growth in 
study outcome between baseline and follow up for households that did and did not 
experience severe illness across households that did and did not receive CCTs. 
Estimates for the effect of severe illness on study outcomes were adjusted for household 
characteristics that might have confounded the association between the study exposure and 
outcome. Fitted regression models were used to obtain predictive margins for mean 
outcomes on their original scale at each time and in each group. Difference in difference 
estimates were then calculated by linear combination of coefficients.  
A natural log transformation was used to obtain an approximately normal distribution for 
household per capita food consumption. For household per capita labour hours and labour 
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income, an excess of zero values was encountered. A cube root transformation was used to 
obtain an approximately normal distribution for non-zero values of household per capita 
labour hours and labour income. To account for the excess of zeros, estimates for the effect 
of severe illness on household per capita labour hours and labour income were quantified 
using a hurdle function as proposed by Cragg (119). In a hurdle model, a binary 0/1 decision 
model for having household per capita labour hours or labour income equal to 0 is combined 
with a truncated-at-zero linear model for having household per capita labour hours or labour 
income above 0. 
Throughout the analysis, estimates for the effect of severe illness were pooled across the 5 
imputed datasets using Rubin’s rule (120). All analyses were done in STATA 15. 
Sensitivity analysis. The sensitivity of effect estimates was tested to imputation of missing 
data by repeating the analysis using only complete cases, and by repeating the analysis 
using self-reported severe illness with serious economic consequences between 2005 and 
2009 that was reported to be worst in 2009 as the study exposure. 
3.5 Results 
Out of a target 15,418 households interviewed in 2005, 4052 (26%) were LTFU, and of those 
that were traced, 231 (1%) had no information recorded in 2009 and so were also 
considered LTFU. The two most common reasons for LTFU were “could not locate address” 
(64%) and “address located but household moved” (32%). LTFU was more common in urban 
informal settlements in the Central West, South, and Southeast regions of Brazil, Table S3. 
Of households that were traced, 1594 (10%) were not registered in the national social 
registry in 2005 and so were excluded. As a result, 9547 households were included in the 
study, Figure 9. After reweighting included households using attrition weights, the study 
sample size was 12,792. 
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Figure 9. Flow chart for inclusion of AIBF respondents in the historical cohort study.  
AIBF 2005 households = 15,426. 
4285 households lost to 
follow up between 2005 
and 2009. 
Households included in analysis = 9547 
Final sample size accounting for attrition weights = 12,792 
AIBF 2009 households = 11,141. 
Households = 11,141. 
Hierarchical imputation used to 
impute missing values for 17,582 
individuals from 6514 households. 
Households = 15,426. 
Hierarchical imputation used to 
impute missing values for 5894 
individuals from 2774 households. 
1594 households not 
registered in the national 
social registry in 2005. 
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3.5.1 Missing data 
In 2005, 7207 (10%) individuals were missing values, and in 2009, 21,965 (47%) individuals 
were missing values, Table S3 and Table S4. In 2005, 0.3% of individuals were missing values 
for more than 3 variables (range: 1 to 12), whilst in 2009, 12.1% of individuals were missing 
values for more than 3 variables (range: 1 to 36). The two variables with the most missing 
values in 2005 were individual work salary (5%) and household location (2%); while in 2009, 
it was individual work salary (14%) and household food consumption (13%), Table S3 and 
Table S4. In both 2005 and 2009, missing data was most common in male agricultural 
workers in rural areas, Table S3 and Table S4. In 2005, missing data was more common in 
the Northeast region of Brazil, and in 2009, it was more common in the Central West and 
South regions of Brazil, Table S3 and Table S4. In 2005, missing data was more common 
amongst non-recipients of Programa Bolsa Família; while in 2009, it was more common 
amongst recipients of Programa Bolsa Família, Table S3 and Table S4. 
3.5.2 Characteristics of study participants 
Most households were in the Northeast, and Southeast regions of Brazil (Central West: 13%, 
North: 16%, Northeast: 33%, South: 7%, Southeast: 31%), in detached buildings 
(Condominium: 19%, informal settlement: 6%, tenement: 11%, detached: 64%), with piped 
water (81%), in urban areas (79%), Table 6. The mean number of people in a household was 
4.6 (SD: 1.8), Table 6. The majority of households had one member working (0: 13%, 1: 47%, 
2: 27%, 3+: 13%), and amongst working members nobody contributing to social insurance (0% 
of workers contributing: 67%, 1% to 50% of workers contributing: 11%, 51% to 100% of 
workers contributing: 22%), Table 6. The greater part of household responsibles were male 
(63%), aged 35 to 54 (16 to 34: 27%, 35 to 54: 52%, 55+: 19%), mixed race (Mixed: 54%, 
white/oriental: 34%, black/indigenous: 12%), literate (77%), worked in a non-agricultural job 
(Agricultural: 20%, non-agricultural: 50%, unemployed: 31%), and had very good or good self-
reported health (Very good/good: 55%, regular: 34%, very bad/bad: 10%, don’t know: 1%), 
Table 6. Overall, median household per capita weekly labour hours were 11.7 hours (IQR: 6.7 
hours to 18 hours), monthly labour income was US$ 30.8 (IQR: US$ 15.4 to US$ 51.3), and 
monthly food consumption was US$ 22.3 (IQR: US$ 14.8 to US$ 32.4), Table 6. 
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Between 2005 and 2009, 1752 (14%) households experienced severe illness, Table 7. 
Households exposed to severe illness were more likely to reside in rural areas (p=0.001) of 
the Central West, South, and Southeast regions of Brazil (p<0.001), Table 7. They were no 
more likely to receive CCTs at baseline (p=0.71), Table 7. The household responsible was more 
likely to be male, older than 55 years of age, illiterate, work in agriculture, and have regular, 
or bad to very bad self-reported health (p<0.001), Table 7. Household per capita monthly total 
income, weekly labour hours, monthly labour income, and monthly food consumption were 
approximately equal (p=0.33, p=0.53, p=0.3, and p=0.96, respectively), Table 7. Households 
exposed to severe illness, were more likely to experience drought or flood, loss of crops or 
livestock, unemployment, and death between 2005 and 2009 (p<0.001), Table 8. Before 
adjustment, exposed and unexposed households experienced similar growth in household 
per capita labour hours, labour income, and food consumption (p=0.56, p=0.49, and p=0.17, 
respectively), Table 8.
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Table 7. Baseline characteristics of the historical cohort. 
  
Overall 
n (%) 
n = 12,792 
No severe illness  
n (%) 
n = 11,040 
Severe illness 
n (%) 
n = 1752 
p-value 
Household characteristics       
Region       <0.001 
  Central Western 1628 (13) 1361 (12) 267 (15)   
  North 2101 (16) 1958 (18) 143 (8)   
  Northeast 4203 (33) 3629 (33) 573 (33)   
  South 855 (7) 701 (6) 154 (9)   
  Southeast 4005 (31) 3390 (31) 615 (35)   
Location       <0.001 
  Rural 2724 (21) 2281 (21) 443 (25)   
  Urban 10,068 (79) 8759 (79) 1309 (75)   
Type       0.2 
  Condominium 2450 (19) 2100 (19) 351 (20)   
  Informal settlement 771 (6) 688 (6) 83 (5)   
  Tenement 1371 (11) 1179 (11) 193 (11)   
  Detached 8199 (64) 7074 (64) 1125 (64)   
Piped water       0.006 
  Yes 10,375 (81) 8906 (81) 1469 (84)   
  No 2416 (19) 2133 (19) 283 (16)   
Members       0.7 
  Mean (SD) 4.6 (1.8) 4.6 (1.8) 4.6 (1.8)   
Members aged 0 to 6 years       0.06 
  None 6949 (54) 5946 (54) 1003 (57)   
  1 3736 (29) 3244 (29) 492 (28)   
  2 1575 (12) 1373 (12) 202 (12)   
  3+ 532 (4) 477 (4) 55 (3)   
Members aged 7 to 15 years       0.008 
  None 3627 (28) 3063 (28) 564 (32)   
  1 4534 (35) 3964 (36) 570 (33)   
  2 3046 (24) 2647 (24) 400 (23)   
  3+ 1585 (12) 1366 (12) 219 (12)   
Members working       0.12 
  0 1715 (13) 1451 (13) 265 (15)   
  1 5962 (47) 5189 (47) 773 (44)   
  2 3476 (27) 3002 (27) 474 (27)   
  3+ 1638 (13) 1398 (13) 239 (14)   
Members working contributing to 
social insurance, % 
      0.42 
  0 8607 (67) 7456 (68) 1151 (66)   
  1 to 50 1418 (11) 1211 (11) 207 (12)   
  51 to 100 2767 (22) 2373 (21) 394 (22)   
Monthly total income PC, US$*       0.33 
  < 21 2597 (20) 2264 (21) 333 (19)   
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  21 to 41 4063 (32) 3514 (32) 550 (31)   
  42 to 118 5162 (40) 4438 (40) 724 (41)   
  > 118 969 (8) 824 (7) 145 (8)   
Weekly labour hours PC; hours       0.53‡ 
  Median (IQR) 12 (6.7 to 18) 12 (6.7 to 18) 11 (5.8 to 18)   
Monthly labour income PC; US$       0.30‡ 
  Median (IQR) 31 (15 to 51) 31 (15 to 51) 31 (14 to 51)   
Monthly food consumption PC; US$    0.96‡ 
  Median (IQR) 22 (15 to 32) 22 (15 to 32) 22 (15 to 33)  
Receipt of CCTs†       0.71 
  No 5607 (44) 4848 (44) 759 (43)   
  Yes 7185 (56) 6192 (56) 993 (57)   
Household responsible characteristics       
Sex       <0.001 
  Male 8052 (63) 6847 (62) 1205 (69)   
  Female 4740 (37) 4192 (38) 547 (31)   
Age, years       <0.001 
  16 to 34 3484 (27) 3085 (28) 400 (23)   
  35 to 54 6820 (53) 5863 (53) 957 (55)   
  55+ 2487 (19) 2092 (19) 395 (23)   
Ethnicity       0.24 
  Mixed 6888 (54) 5974 (54) 915 (52)   
  White/Oriental 4324 (34) 3695 (33) 629 (36)   
  Black/Indigenous 1579 (12) 1371 (12) 208 (12)   
Literate       0.001 
  Yes 9805 (77) 8525 (77) 1280 (73)   
  No 2986 (23) 2515 (23) 472 (27)   
Work branch       <0.001 
  Agricultural 2493 (19) 2092 (19) 400 (23)   
  Non-agricultural 6358 (50) 5604 (51) 754 (43)   
  Unemployed 3941 (31) 3343 (30) 598 (34)   
Self-rated health       <0.001 
  Very good/good 7082 (55) 6220 (56) 862 (49)   
  Regular 4396 (34) 3752 (34) 644 (37)   
  Very bad/bad 1227 (10) 991 (9) 236 (13)   
  Don't know 87 (1) 77 (1) 10 (1)   
Abbreviations: PC, Per Capita; US$, United States Dollar; SD, Standard Deviation; IQR, Interquartile 
Range; CCT, Conditional Cash Transfer. Data is weighted using attrition weights. Values refer to the 
first of the five imputed datasets. All monetary values are deflated to 2005 constant values. In 2005 
R$ 1 = US$ 0.41. *In 2005, extreme poverty: monthly household income per capita < US$ 21, 
poverty: monthly household income per capita between US$ 21 and US$41, 1 minimum wage: US$ 
118. †Refers to receipt of Programa Bolsa Família or one of its predecessors: Bolsa Escola, Bolsa 
Alimentação, Cartao Alimentação, or Programa de Erradicação do Trabalho Infantil. ‡P-value for 
Kruskal-Wallis test.
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Table 8. Time-varying characteristics of the historical cohort.  
  
Overall 
n (%) 
n = 12,792 
No severe 
illness 
n (%) 
n = 11,040 
Severe 
illness 
n (%) 
n = 1752 
p-value 
Household characteristics         
Δ weekly labour hours PC, Hours       0.56 
  Mean (SD) 1.6 (13.1) 1.6 (13.1) 1.8 (13.2)   
Δ monthly labour income PC, US$       0.49 
  Mean (SD) 11.2 (52.9) 11.3 (53.2) 10.2 (50.8)   
Δ monthly food consumption PC, US$       0.17 
  Mean (SD) 15.7 (37.1) 15.5 (37) 17 (37.2)   
Drought or flood       <0.001 
  No 10,935 (85) 9585 (87) 1351 (77)   
  Yes 1856 (15) 1455 (13) 401 (23)   
Loss of crops or livestock       <0.001 
  No 12,440 (97) 10,790 (98) 1649 (94)   
  Yes 352 (3) 249 (2) 103 (6)   
Death       <0.001 
  No 9334 (73) 8257 (75) 1077 (61)   
  Yes 3457 (27) 2782 (25) 675 (39)   
Unemployment       <0.001 
  No 11,745 (92) 10,267 (93) 1477 (84)   
  Yes 1047 (8) 772 (7) 275 (16)   
Abbreviations: Δ, Change in; PC, Per Capita; US$, United States Dollar; SD, Standard Deviation. Data 
is weighted using attrition weights. Values refer to the first of the five imputed datasets. All 
monetary values are deflated to 2005 constant values. In 2005 R$ 1 = US$ 0.4.  
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3.5.3 Overall effect of severe illness 
In multivariate analysis, there was no significant difference in the growth of household per 
capita weekly labour hours, monthly labour income, or monthly food consumption according 
to whether the household experienced severe illness (0.1 hours, 95% CIs: -0.6 hours to 0.9 
hours; US$ 1, 95% CIs: US$ -1.8 to US$ 3.7; US$ 2.1, 95% CIs: US$ -0.4 to US$ 4.5, respectively), 
Table 9. 
3.5.4 Determinants of receipt of conditional cash transfers 
Receipt of CCTs at baseline was most common amongst households residing in the North and 
Northeast regions of Brazil (p=0.008), Table 10. In line with the eligibility criteria of Programa 
Bolsa Família and its predecessor CCT programmes, receipt of CCTs at baseline was more 
common amongst households in extreme poverty (p<0.001), and with children aged 7 to 15 
years (p<0.001), Table 10. Households with 0% of working household members contributing 
to social insurance were more likely to receive CCTs at baseline (p<0.001), as were households 
with a responsible who was younger, who was illiterate, or who worked in agriculture 
(p<0.001), Table 10. 
3.5.5 Effect of severe illness by receipt of conditional cash transfers 
In multivariate analysis, there was no significant difference in the growth in household per 
capita weekly labour hours, monthly labour income, or monthly food consumption according 
to whether the household experienced severe illness and received CCTs or did not receive 
CCTs (0 hours, 95% CIs: -1.7 hours to 1.8 hours; US$ 1.9, 95% CIs: US$ -3.9 to US$ 7.8; US$ -
0.9, 95% CIs: US$ -5.8 to US$ 3.9, respectively), Table 111.  
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Table 9. Impact of severe illness on household per capita weekly labour hours, monthly labour income, and monthly food consumption.  
  
No severe illness 
n (%) 
n = 11,040 
Severe illness 
n (%) 
n = 1752 
Difference in Difference 
(95% CIs) 
Weekly labour hours PC, Hours       
  2005 9.5 (9.3 to 9.7) 9.4 (8.8 to 9.9) 0.1 (-0.6 to 0.9) 
  2009 9.7 (9.5 to 10) 9.7 (9.1 to 10.4)   
Monthly labour income PC, US$       
  2005 28 (27.3 to 28.7) 27.4 (25.8 to 29) 1 (-1.8 to 3.7) 
  2009 33.5 (32.4 to 34.6) 33.8 (31.4 to 36.2)   
Monthly food consumption PC, US$       
  2005 26.1 (25.6 to 26.5) 26.1 (25 to 27.2) 2.1 (-0.4 to 4.5) 
  2009 42.2 (41.3 to 43) 44.3 (41.9 to 46.6)   
Abbreviations: CIs, Confidence Intervals; PC, Per Capita; US$, United States Dollar. Selected marginal effects are reported. Data is weighted using attrition 
weights. Values are pooled across the five imputed datasets using Rubin’s rule. All values are mutually adjusted for household region of residence, location 
of residence, number of household members aged 0 to 6 years, number of household members aged 7 to 15, % of family members working and 
contributing to social insurance, total income per capita (net of social assistance), and receipt of Programa Bolsa Família or one of its predecessors: Bolsa 
Escola, Bolsa Alimentação, Cartao Alimentação, or Programa de Erradicação do Trabalho Infantil all at baseline; household responsible sex, age category, 
age squared, ethnicity, literacy, and self-rated health all at baseline; and, household exposure to drought or flooding, loss of crops or livestock, or death 
between 2005 and 2009. All monetary values are deflated to 2005 constant values. In 2005 R$ 1 = US$ 0.4. 
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Table 10. Predictors of household receipt of conditional cash transfers at study baseline.  
  Baseline receipt of CCTs† 
  
No 
n (%) 
n = 5607 
Yes 
n (%) 
n = 7185 
OR (95% CI) p-value 
Household characteristics       
Region       0.008 
  Central Western 737 (13) 892 (12) 1.0   
  North 891 (16) 1210 (17) 1.1 (1 to 1.3)   
  Northeast 1750 (31) 2453 (34) 1.2 (1 to 1.3)   
  South 382 (7) 473 (7) 1 (0.8 to 1.3)   
  Southeast 1847 (33) 2157 (30) 1 (0.8 to 1.1)   
Location       0.3 
  Rural 1248 (22) 1476 (21) 1.0   
  Urban 4359 (78) 5709 (79) 1.1 (1 to 1.2)   
Type       0.07 
  Condominium 1105 (20) 1346 (19) 1.0   
  Informal settlement 325 (6) 446 (6) 1.1 (0.9 to 1.4)   
  Tenement 552 (10) 819 (11) 1.2 (1 to 1.4)   
  Detached home 3625 (65) 4574 (64) 1 (0.9 to 1.2)   
Piped water       <0.001 
  Yes 4642 (83) 5733 (80) 1.0   
  No 965 (17) 1452 (20) 1.2 (1.1 to 1.4)   
Members       <0.001 
  1 608 (11) 326 (5) 1.0   
  2-4 2949 (53) 3114 (43) 2 (1.7 to 2.3)   
  5+ 2050 (37) 3745 (52) 3.4 (2.9 to 4.1)   
Members aged 0 to 6 years       0.14 
  None 3093 (55) 3856 (54) 1.0   
  1 1638 (29) 2098 (29) 1 (0.9 to 1.1)   
  2 668 (12) 907 (13) 1.1 (1 to 1.2)   
  3+ 208 (4) 324 (5) 1.3 (1 to 1.5)   
Members aged 7 to 15 years       <0.001 
  None 2312 (41) 1315 (18) 1.0   
  1 1939 (35) 2594 (36) 2.4 (2.1 to 2.6)   
  2 967 (17) 2080 (29) 3.8 (3.4 to 4.3)   
  3+ 389 (7) 1195 (17) 5.4 (4.6 to 6.3)   
Members in work       0.47 
  0 761 (14) 954 (13) 1.0   
  1 2637 (47) 3325 (46) 1 (0.9 to 1.1)   
  2 1527 (27) 1949 (27) 1 (0.9 to 1.2)   
  3+ 682 (12) 956 (13) 1.1 (1 to 1.3)   
Members in work contributing to 
social insurance, % 
      <0.001 
  0 3610 (64) 4997 (70) 1.0   
  1 to 50 638 (11) 780 (11) 0.9 (0.8 to 1)   
  51 to 100 1359 (24) 1408 (20) 0.8 (0.7 to 0.8)   
Monthly total income PC, US$*       <0.001 
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  < 21 880 (16) 1717 (24) 1.0   
  21 to 41 1571 (28) 2492 (35) 0.8 (0.7 to 0.9)   
  42 to 118 2530 (45) 2633 (37) 0.5 (0.5 to 0.6)   
  > 118 626 (11) 343 (5) 0.3 (0.2 to 0.3)   
Drought or flood during follow up       0.34 
  No 4813 (86) 6122 (85) 1.0   
  Yes 794 (14) 1062 (15) 1.1 (0.9 to 1.2)   
Loss of crops or livestock during 
follow up 
      0.13 
  No 5468 (98) 6972 (97) 1.0   
  Yes 139 (2) 213 (3) 1.2 (0.9 to 1.5)   
Death during follow up         
  No 4072 (73) 5263 (73) 1.0 0.49 
  Yes 1535 (27) 1922 (27) 1 (0.9 to 1.1)   
Household responsible characteristics       
Sex       0.31 
  Male 3560 (63) 4493 (63) 1.0   
  Female 2048 (37) 2692 (37) 1 (1 to 1.1)   
Age, years       <0.001 
  16 to 34 1657 (30) 1828 (25) 1.0   
  35 to 54 2691 (48) 4129 (57) 1.4 (1.3 to 1.5)   
  55+ 1259 (22) 1228 (17) 0.9 (0.8 to 1)   
Ethnicity       0.08 
  Mixed 2974 (53) 3915 (54) 1.0   
  White/Oriental 1963 (35) 2361 (33) 0.9 (0.8 to 1)   
  Black/Indigenous 670 (12) 909 (13) 1 (0.9 to 1.2)   
Literate       <0.001 
  Yes 4397 (78) 5408 (75) 1.0   
  No 1210 (22) 1776 (25) 1.2 (1.1 to 1.3)   
Work branch       <0.001 
  Agricultural 992 (18) 1501 (21) 1.0   
  Non-agricultural 2831 (50) 3527 (49) 0.8 (0.7 to 0.9)   
  Unemployed 1784 (32) 2156 (30) 0.8 (0.7 to 0.9)   
Self-rated health       0.53 
  Very good/good 3129 (56) 3953 (55) 1.0   
  Regular 1892 (34) 2504 (35) 1.1 (1 to 1.2)   
  Very bad/bad 552 (10) 674 (9) 1 (0.8 to 1.1)   
  Don't know 34 (1) 53 (1) 1.2 (0.8 to 2)   
Abbreviations: CCT, Conditional Cash Transfer; OR, Odds Ratio; CI, Confidence Interval; PC, Per 
Capita; US$, United States Dollar. Data is weighted using attrition weights. Values refer to the first of 
the five imputed datasets. All monetary values are deflated to 2005 constant values. *In 2005, 
extreme poverty: monthly household income per capita < US$ 21, poverty: monthly household 
income per capita between US$ 21 and US$41, 1 minimum wage: US$ 118. †Programa Bolsa Família 
or one of its predecessors: Bolsa Escola, Bolsa Alimentação, Cartao Alimentação, or Programa de 
Erradicação do Trabalho Infantil. 
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Table 11. Impact of severe illness on household per capita weekly labour hours, monthly labour income, and monthly food consumption, by receipt of 
conditional cash transfers at study baseline. 
  
No severe illness 
n (%) 
n = 11,040 
Severe illness 
n (%) 
n = 1752 
Difference in difference 
(95% CIs) 
Difference in effect of severe 
illness by receipt of CCTs 
(95% CIs) 
Weekly labour hours PC, Hours         
 No receipt of CCTs         
   2005 10.3 (10 to 10.6) 9.3 (8.5 to 10.1) 0.7 (-0.6 to 2) 0 (-1.7 to 1.8) 
   2009 10.4 (10 to 10.8) 10.1 (9 to 11.2)     
 Receipt of CCTs         
   2005 9.1 (8.9 to 9.4) 8.5 (7.9 to 9.2) 0.7 (-0.4 to 1.9)   
   2009 9.9 (9.5 to 10.2) 10 (9.1 to 10.9)     
Monthly labour income PC, US$         
 No receipt of CCTs         
   2005 32.2 (31.3 to 33.2) 29.5 (27.2 to 31.8) 0 (-4.5 to 4.5) 1.9 (-3.9 to 7.8) 
   2009 37.2 (35.6 to 38.9) 34.5 (30.5 to 38.5)     
 Receipt of CCTs         
   2005 25.5 (24.8 to 26.2) 24 (22.3 to 25.6) 1.9 (-1.7 to 5.6)   
   2009 32.8 (31.5 to 34.1) 33.2 (30.2 to 36.2)     
Monthly food consumption PC, US$         
 No receipt of CCTs         
   2005 28.1 (27.4 to 28.7) 27.4 (25.6 to 29.3) 2.6 (-1.1 to 6.4) -0.9 (-5.8 to 3.9) 
   2009 45.3 (43.9 to 46.7) 47.3 (43.3 to 51.3)     
 Receipt of CCTs         
   2005 24.8 (24.2 to 25.4) 24.3 (23 to 25.6) 1.7 (-1.6 to 4.9)   
   2009 39.7 (38.6 to 40.7) 40.9 (37.9 to 43.8)     
Abbreviations: CCT, Conditional Cash Transfer; CI, Confidence Interval; PC, Per Capita; US$, United States Dollar. Selected marginal effects are reported. Data is weighted 
using attrition weights. Values are pooled across the five imputed datasets using Rubin’s rule. All values are mutually adjusted for household region of residence, location of 
residence, number of household members aged 0 to 6 years, number of household members aged 7 to 15, % of family members working and contributing to social 
insurance, and total income per capita (net of social assistance) all at baseline; household responsible sex, age category, age squared, ethnicity, literacy, and self-rated 
health all at baseline; and, household exposure to drought or flooding, loss of crops or livestock, or death between 2005 and 2009. All monetary values are deflated to 2005 
constant values. In 2005 R$ 1 = US$ 0.4.
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3.5.6 Sensitivity analysis 
Repeating the analysis with only complete cases resulted in the same results as our main 
analysis: absence of any difference in the growth of household per capita weekly labour 
hours, monthly labour income, and monthly food consumption according to whether the 
household experienced severe illness, and absence of any modifying effect of prior receipt 
of CCTs, Table S5 and Table S6. Use of self-reported severe illness with serious economic 
consequences that was reported to be worst in 2009 as the study exposure also resulted in 
the same results as the main analysis, Table S7 and Table S8. 
3.6 Discussion 
3.6.1 Summary of main findings 
In Brazil, in 2005, two thirds of households registered in the national social registry did not 
contribute to formal social insurance, putting them at risk of income loss in the event of 
severe illness. Between 2005 and 2009, 15% of households reported experiencing severe 
illness that seriously reduced their patrimony, income, or consumption. Households reporting 
such severe illness were more likely to be located in rural areas of the Central West, South, 
and Southeast regions of the country, and were more likely to report experiencing other 
income shocks: drought or flooding, loss of crops or livestock, unemployment, and death. 
Overall, self-reported severe illness was not associated with reduced growth in household 
labour hours, labour income, or food consumption. It was found that approximately half of 
households registered in the national social registry received CCTs, with receipt higher 
amongst households with children, in extreme poverty, and residing in the North and 
Northeast regions of Brazil. Contrary to the study hypothesis, the effect of CCTs on household 
labour hours, labour income, and food consumption in response to severe illness was 
negligible. However, a basic sample size calculation estimated that the study had low 
statistical power to investigate this relationship.  
3.6.2 Study strengths 
A strength of this study was its use of longitudinal data over two time points. Unless 
participants experienced severe illness with serious economic consequences in the month 
before follow-up, it is likely that they experienced this exposure before study outcomes. The 
study minimised potential selection bias by using a representative sample of households 
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registered in the national social registry, Cadastro Único, in 2005. The large sample size of 
the AIBF dataset provided a valuable opportunity for evaluating a rare exposure like chronic 
and disabling illness. Of other known datasets that have been used to evaluate the effect of 
CCTs in Latin America, AIBF is second only in size to the ENCEL dataset used to evaluate the 
impact of the PROGRESA/ Oportunidades CCT initiative in Mexico (80,121,122). The study 
also took steps to account for selection bias from LTFU using attrition weights, and missing 
data using hierarchical multiple imputation. 
3.6.3 Study limitations 
The study hypothesised that self-reported severe illness with serious economic consequences 
would reduce household labour productivity, and that less disposable labour income would 
lead to reduced growth in household food consumption. In contrast, the measure of severe 
illness used in this study had no impact on household labour income, or household food 
consumption. Previous studies highlight two central issues for accurately estimating the 
welfare impact of illness: how illness is measured, and focus on both households’ ability to 
maintain a constant level of income and consumption, as well as their use of coping strategies 
in response to this shock (13,15,22,25).  
In this study, illness was self-reported as severe, and leading to a serious reduction in 
family patrimony, income, or consumption. A general concern with self-reported measures of 
illness, is that they are likely to suffer from measurement error related to the subjective 
perception and cultural background of respondents (13,15–17). Previous studies show that 
more objective measures of severe illness like change in the ability to carry out activities of 
daily living, or long spells of hospitalisation are more reliable for capturing the financial impact 
of illness compared to self-reported measures of illness, which generally detect minor effects 
on labour income and food consumption (13,22,64,65,68,84,123,124). In the case of this 
study, any severe illness may be expected to have a subjectively serious economic impact for 
households living on the margins of poverty, but not necessarily a sustained one, which is 
what this study aimed to measure in order to evaluate the protective effect of CCTs. Common 
self-reported severe illnesses have been found to be: hypertension, typhoid fever, 
tuberculosis and other lung and respiratory diseases, physical injury, and heart disease (125). 
With the exception of tuberculosis and heart disease, only the severest forms of these 
illnesses are likely to lead to a sustained economic impact on poor households in Brazil, where 
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citizens rarely pay “out-of-pocket” for care, and therefore, only suffer from direct non-
medical expenses and lost income related to time off work (108). There are other potential 
sources of measurement error in this study. Respondents were only asked about their 
exposure to severe illness in section 14 of the 15 section questionnaire, and by this stage they 
might have given more perfunctory responses, and/or the interviewer might have asked the 
question incorrectly (126). In Brazil, where family structures are more encompassing, 
respondents may also have interpreted the question, which asked about severe illness in a 
family member, to relate to anyone in their extended family. 
Another concern for studies evaluating the welfare impact of severe illness is their 
focus on coping strategies that households might mobilise in response to such a shock (25). 
Previous evidence shows that households experiencing severe illness often re-allocate labour, 
sell livestock or assets, and take out loans to protect their income and consumption 
(22,68,84,127,128). In this study, it was not possible to evaluate households’ use of these 
coping strategies as the questionnaire did not collect information on them. Another approach 
that households have been found to use to safeguard their food consumption is to save on 
non-food consumption (65). Regrettably, in this study, unreliable reporting of household non-
food consumption in 2009 prevented us from evaluating if households used this coping 
strategy in response to severe illness. 
In addition to investigating the economic consequences of severe illness, the study 
also aimed to quantify whether receipt of CCTs had any protective effect for affected 
households. A limitation for this secondary analysis was the low statistical power that the 
study was estimated to have for evaluating 2x2 interactions. Findings were consistent with a 
policy relevant effect of CCTs between US$ -6 and US$ 4, making it difficult to draw 
recommendations from this analysis. Low power is an inherent issue when trying to detect 
small changes in an outcome that varies greatly across a population of interest. Low statistical 
power increases the risk of falsely concluding there is no effect when in fact there is one, and 
highlights the need for further research in this field with either a larger sample, or one with 
more than two time points. 
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3.6.4 How findings fit with existing literature 
Worldwide, and in Brazil, millions of poor households remain without formal income 
protection against illness (34). Determining ways to protect them against welfare losses 
related to severe illness may be key for tackling poverty (30). This is the first study in Brazil 
evaluating the longitudinal welfare impact of severe illness for poor households, and 
assessing whether it is modified by household receipt of CCTs. It demonstrates that there are 
still a large proportion of poor households across Brazil without access to formal social 
insurance in the event of severe illness. Interestingly, it suggests that severe illness with 
serious economic consequences is more common in the more industrialised Central West, 
South, and Southeast regions of Brazil, compared to the poorer rural North, and Northeast 
regions where the burden of general morbidity is known to be higher (129). This finding may 
either be an artefact of measurement error, or might imply that households in the Central 
West, South, and Southeast regions are more vulnerable to the economic consequences of 
illness (123). The study finds that households are able to protect both their labour income 
and food consumption in response to self-reported severe illness, but does not clarify if they 
would also be able to safeguard their welfare against a more objective measure of severe 
illness. Households’ dependency on costly coping strategies in response to severe illness also 
remains unclear. Poorly characterised generally, one study shows that poor households in 
Brazil are likely to withdraw children from school for work in response to unemployment of 
the household head (67). This costly coping strategy, which has been found to be more 
common in poorer households, can have long-term consequences for households, as once 
children leave school they are less likely to return (79,94,130). The lack of any discernible 
effect of severe illness on household labour income and food consumption, combined with 
no information on household coping strategies, as well as low statistical power, meant that 
this study had little scope to evaluate the existence of a protective effect of CCTs. If, as 
discussed above, intra-household labour allocation to children is a key strategy for coping 
with severe illness in Brazil, existing evidence from Colombia and Mexico, shows that CCTs 
can significantly reduce the likelihood of households withdrawing children from school in 
response to illness (79,84). It is clear that a number of unknowns remain about the welfare 
impacts of mid- to long-term severe illness on poor households in Brazil, as well as the 
protective effect of CCTs on these impacts, and further work is required in this field.  
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3.7 Concluding remarks 
As measured in this study, self-reported severe illness had surprisingly little impact on 
household labour hours, labour income, or food consumption among poor households in 
Brazil. Consequently, there was limited scope to assess any protective effect of CCTs, and the 
observed effects were modest. Further work is needed to better characterise the types of 
severe illness that have mid- to long-term economic consequences for poor households in 
Brazil; whether poor households use costly coping strategies in response to such illness; and, 
whether CCTs protect poor households from adverse consequences related to severe illness 
with mid- to long-term economic consequences.
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Chapter 4. Uptake of governmental social protection and financial 
hardship from tuberculosis in Rio de Janeiro, Brazil 
 
4.1 Research gaps addressed with survey in Rio de Janeiro, Brazil 
In line with objective (3) of this thesis, this chapter describes drug resistant (DR) tuberculosis 
(TB)-affected households’ costs, uptake of social protection, and financial hardship in Rio de 
Janeiro state, Brazil. In doing so, this chapter addresses the second research gap identified 
by the thesis for informing the potential of cash transfers to protect households from 
financial hardship related to severe illness: Lack of knowledge as to which social protection 
initiatives households affected by TB access during care, and whether they are sufficient to 
protect them from financial hardship. 
4.2 Key findings from the survey in Rio de Janeiro, Brazil 
In the study, bacteriologically confirmed DR TB is found to be associated with high total 
costs during treatment, with the main contributor indirect costs. Uptake of social protection 
is found to be quite common, in particular sick pay insurance. Uptake of social protection is 
associated with reduced financial hardship, especially experiencing catastrophic costs, 
impoverishment, and use of coping strategies simultaneously.  
4.3 Background to survey in Rio de Janeiro, Brazil 
DR TB is a major public health concern worldwide (131). Controlling DR TB relies on stopping 
its transmission, which itself depends on universal access to high-quality TB care. Even 
though most countries provide TB diagnosis and treatment free of charge, TB patients and 
their households continue to face high costs related to TB illness (12). These TB-related 
costs include “out-of-pocket” direct medical expenses (e.g. for private consultations), direct 
non-medical expenses (e.g. for transport, food, and natural remedies), as well as indirect 
costs from time away from work (12). Combined, these costs hinder patients’ access to 
diagnosis and increase their risk of adverse treatment outcomes, thus increasing the 
likelihood of TB being transmitted to people with whom they are in close contact (6,132). 
With a recommended treatment duration of up to 24 months, and with patients unable to 
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work for most of this time due to disability, treatment side-effects, discrimination in the 
workplace and/or infection control laws; DR TB patients and their households are especially 
vulnerable to TB-related costs (6,58,133–136). 
Acknowledging the need to improve TB patients access to care, the End TB Strategy 
mandates that no TB-affected household should face “catastrophic costs” due to TB (9). In 
this milestone, catastrophic costs refer to a combination of direct medical and non-medical 
expenses, and indirect costs excessive enough to cause financial hardship. There is still no 
consensus on an empirical method for measuring financial hardship from catastrophic costs 
(10). One proposed method is to measure if patients’ TB-related costs exceed 20% of their 
pre-illness annual household income (10). Another is to measure if patients are forced to 
use a coping strategy like taking out a loan, or selling assets (10,26). A third method might 
be to measure if patients’ TB-related costs push their pre-illness household income below a 
threshold of absolute poverty. Poverty is a clear indicator of financial hardship, and is known 
to be associated with adverse treatment outcomes (137). 
To protect TB-affected households’ from financial hardship, the End TB Strategy calls 
for Universal Health Coverage initiatives like decentralised care, prepayment and resource 
pooling aimed at defraying out-of-pocket direct medical expenses, to be complemented 
with other social protection initiatives aimed at defraying direct non-medical expenses, and 
reimbursing indirect costs (10,138). In recent years, most Latin American governments have 
invested in strengthening their social protection systems (139,140). In Brazil, the universal 
free Unified Health System protects people from paying for medical services, including TB 
diagnosis and treatment, and three governmental social protection policies Auxílio-Doença, 
Programa Bolsa Família, and Benefício de Prestação Continuada may help people manage 
direct non-medical expenses, and indirect costs related to illness. Details of these policies 
are provided in Table 12. 
Reviewing the published literature, DR TB-related costs appear to have been studied 
in Cambodia, Ecuador, Ethiopia, Indonesia, Kazakhstan, Peru and South Africa, but never in 
Brazil, and never accounting for patients’ receipt of social protection (6,58,133–135). This 
study aimed to describe DR TB-affected households’ costs, uptake of social protection, and 
financial hardship in Rio de Janeiro state, Brazil.  
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Table 12. Summary of Brazilian governmental social protection policies: Auxílio-Doença, 
Programa Bolsa Família, and Benefício de Prestação Continuada. All monetary values are 
expressed in 2016 US$. 
Auxílio-Doença: A governmental social insurance policy that provides sick pay to citizens 
who are normally employed but temporarily cannot work because of illness. Paid for by 
contributions from peoples’ salaries before they are ill, it only covers workers who 
contribute to social insurance. To be eligible, people must have contributed to social 
insurance for at least 12 months. The eligibility of peoples’ illness is assessed by a medical 
doctor. The programme provides a benefit equal to whichever is lowest between 
beneficiaries’ mean monthly salary in the last 12 months versus 91% of their last month’s 
salary (141). In 2014, 39% of Brazilian citizens older than 16 years of age contributed to 
social insurance and were therefore entitled to receive sick pay from Auxílio-Doença in 
the event of severe illness (142). 
Programa Bolsa Família: A governmental social assistance policy that provides 
conditional cash transfers to families with a monthly household income per capita less 
than US$ 41, and children aged 0 to 17; and families with a monthly household income 
per capita less than US$ 21 regardless of whether they have children, to reduce current 
poverty and prevent future poverty for younger generations (109). Eligible applicants do 
not need to have contributed to social insurance. The programme provides variable 
values of cash transfers to beneficiaries based on family composition (143). In 2014, 15% 
of Brazilian families received social assistance from Programa Bolsa Família (142). 
Benefício de Prestação Continuada: A governmental social assistance policy that provides 
periodic unconditional cash transfers to citizens that have a monthly household income 
per capita less than US$ 63, and are older than 65 years of age, or have a disability that 
lasts at least 24 months (109). Eligible applicants do not need to have contributed to 
social insurance. The eligibility of peoples’ disabilities is assessed by a medical doctor 
(109). Successful applicants receive a monthly flat cash transfer equal to one minimum 
monthly salary US$ 251 (109). In 2014, 1% of Brazilian citizens older than 16 years of age 
received social assistance from Benefício de Prestação Continuada (142). 
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4.4 Methodology 
4.4.1 Study design 
The study was a cross-sectional survey between June-October 2016 at the DR TB outpatient 
clinic of the Professor Hélio Fraga reference centre (CRPHF) in Rio de Janeiro municipality, 
Rio de Janeiro state, Brazil. The study population was DR TB patients attending the CRPHF 
outpatient clinic who had been receiving treatment for at least one month. At the time of 
the study, the CRPHF’s catchment area included 40 of 92 municipalities in Rio de Janeiro 
state, covering approximately 73% of the state’s population, Figure 10 (144). In May 2016, 
there were 1,601 people with DR TB in Brazil (0.77 cases per 100,000 population), with 29% 
residing in Rio de Janeiro state (145). In Brazil, DR TB treatment is integrated into the 
government-funded universal healthcare system that provides all diagnostic tests, anti-
microbial drugs, and when necessary, hospital services free of charge. National guidelines 
for DR TB treatment recommend ambulatory care under “directly observed therapy” (DOT), 
with monthly visits to a reference centre for 6-24 months (146). 
 
Figure 10. The catchment area of the Professor Hélio Fraga pneumopathy reference centre 
in Rio de Janeiro state, Brazil.  
*The municipality of Rio de Janeiro is divided into 10 programmatic areas of health delivery. The 
Professor Hélio Fraga reference centre serves programmatic areas 2.1, 4.0, 5.1, 5.2 and 5.3. 
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4.4.2 Description of the data source 
Patients were invited to participate in the study by the healthcare professional they were 
seeing during their monthly visit to the CRPHF. Structured interviews were conducted by 
two social workers using a locally adapted version of the World Health Organization’s survey 
tool for estimating TB-related costs (19). The questionnaire was shortened to exclude 
questions on pre-diagnostic healthcare seeking behaviours, and costs incurred during 
previous courses of TB treatment because of concerns about respondent fatigue and 
reporting accuracy for costs incurred far in the past. The final structured questionnaire 
collected data on participants’ demographic and socioeconomic information, direct 
expenses, indirect costs, use of coping strategies, and uptake of social protection. 
Participants’ clinical information was obtained from the online national registry, SITETB 
(145). Collected data were entered into Microsoft Excel 2016, and analysed in R version 
3.3.0. All monetary values were collected in Brazilian reais (R$), and converted to 2016 
United States dollar (US$) (R$ 3.5 = US$ 1.0) (118). 
4.4.3 Survey data management 
Measurement of DR TB-related costs. Direct expenses were measured as self-reported 
monthly expenses accessing the community DOT clinic and CRPHF extrapolated over the 
complete length of their prescribed treatment (mean = 17.6 months), added to any self-
reported expenses for transport accessing a hospital, supplementary food related to TB 
illness (e.g. additional protein) and/or expenses for private healthcare (consultation, exams, 
imaging, medicines, and other). Monthly expenses accessing the community DOT clinic were 
estimated as typical expenses for transportation and/or food during a single visit, multiplied 
by the number of visits typically made in a week, multiplied by the number of weeks in a 
month (4.3). Monthly direct expenses accessing the CRPHF were estimated as typical 
expenses for transportation and/or food during a monthly visit. Indirect costs were 
calculated, using the output-related approach, as the difference in self-reported monthly 
household income pre-illness versus during-treatment extrapolated over the complete 
length of participants’ prescribed treatment (mean = 17.6 months) (147). Total costs were 
measured as the sum of direct expenses, and indirect costs after subtracting social 
protection payments. The burden of DR TB-related costs was measured by expressing them 
as a percentage of participants’ pre-illness annual household income. Cost burdens could be 
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greater than 100% if the length of participants’ DR TB treatment was longer than 12 months 
and they reported losing close to 100% of their pre-illness monthly income. 
Measurement of DR TB-related uptake of social protection. Uptake of social protection was 
measured as self-reported uptake of sick pay insurance from Auxílio-Doença, or social 
assistance from Programa Bolsa Família, or Benefício de Prestação Continuada as a result of 
becoming ill with DR TB. The value of payments received from uptake of social protection 
was measured as self-reported monthly sick pay insurance from Auxílio-Doença, or social 
assistance from Programa Bolsa Família, or Benefício de Prestação Continuada extrapolated 
over the complete length of participants prescribed treatment (mean = 17.6 months). 
Measurement of DR TB-related financial hardship. Financial hardship was measured as 
incurring a cost burden ≥20% of pre-illness annual household income, using a coping 
strategy (taking a loan, or selling a household item), becoming impoverished, and 
experiencing all three of these financial hardships. Impoverishment was calculated as DR TB-
related costs that pushed participants’ pre-illness monthly household income per capita 
below Brazil's 2016 poverty line (US$ 49 per month) (148). 
4.4.4 Statistical analysis 
Participants’ pre-illness demographic and socioeconomic characteristics, and DR TB clinical 
characteristics were summarised by count and percent for categorical variables; and mean 
and standard deviation (SD) for continuous variables. Direct expenses, indirect costs, and 
total costs were summarised by mean and SD for comparison with other studies, and 
median and interquartile range (IQR), because the mean is hard to interpret when data are 
skewed. Proportions were compared with the Pearson’s chi-square test and means were 
compared with the Student’s t-test. Means of non-normally distributed variables were 
compared with the Mann-Whitney U test. Uptake of social protection was summarised by 
count and percent, and the mean value of social protection received by mean and SD. 
Financial hardship was summarised by count and percent. 
The association between uptake of social protection and financial hardship was investigated 
by uni- and multivariable logistic regression adjusting for demographic, socioeconomic and 
clinical variables associated with financial hardship at p<0.1, and the two a priori 
confounding variables sex and age. The likelihood ratio test (LRT) was used to assess the 
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association of exposure variables with the outcome. Associations between uptake of social 
protection and each of the four measures of financial hardship were investigated separately. 
Because previously being in paid employment was a condition for receipt of sick pay 
insurance from Auxílio-Doença, it was not adjusted for in the final multivariate model. For 
this analysis the variables race, pre-illness receipt of social protection, and type of resistance 
were re-grouped because of sparse data. All ordered categorical variables were checked for 
evidence of a linear trend using the LRT. 
4.4.5 Ethical approval 
The ethical committee of the Escola Nacional de Saúde Pública Sérgio Arouca approved all 
components of the study (1.4238.240, CAEE: 53187516.0000.5240). All patients gave 
written informed consent before participating in the study. 
4.5 Results 
4.5.1 Characteristics of study participants 
A total of 131 DR TB patients were invited to participate in the study, six had not completed 
one month’s treatment, and five did not consent to participate. In the analysis stage, one 
participant was excluded because of implausible income data. Demographic, socioeconomic 
and clinical characteristics of the 119 participants included in the final analysis are 
summarised in Table 13. Most participants were male (68%), and of mixed race (48%). 
Before DR TB illness, the greater part of participants had a monthly household income per 
capita less than one minimum salary (63%), and approximately half were the principle 
household income provider (53%). A minority of participants had a monthly household 
income (including social protection benefits) per capita below the national poverty line (5%). 
Most had acquired versus primary DR TB (55%), multi-DR TB (60%), and cavitary DR TB 
(94%). Uptake of social protection during DR TB treatment was not the norm (38%), and was 
more likely amongst male participants (p<0.001), and participants in paid employment 
before DR TB (p=0.08), Table 13. 
4.5.2 DR TB-related costs 
Mean direct expenses were US$ 809 (SD: US$ 601), representing 14% (SD: 17%) of annual 
household income, Table 14. Mean indirect costs were US$ 6,207 (SD: US$ 6,671), 
representing 81% (SD: 54%) of annual household income, Table 14. Mean social protection 
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payments were US$ 1,970 (SD: US$ 2,897), Table 14. Mean total costs, after subtracting 
social protection, were US$ 5,046 (SD: US$ 6,290), representing 64% (SD: 58%) of annual 
household income, Table 14. Total costs were positively skewed, with 95% of participants 
incurring costs lower than U$13,595, and the remaining 5% incurring total costs between U$ 
13,595 and US$ 42,753, Figure S1. Participants that accessed social protection were more 
likely to incur lower total costs (p=0.005).  
83 
Table 13. Summary of survey participants’ pre-illness demographic and socioeconomic 
characteristics, and DR TB clinical characteristics. 
  
Study 
participants 
n = 119 
n (%) 
Social protection uptake during DR 
TB treatment 
p-value‡ Yes 
n = 45 
n(%) 
No 
n = 74 
n(%) 
Demographic     
Sex    <0.001 
  Male 81 (68) 38 (84) 43 (58)  
Age    0.06 
  Mean (SD) 42 (14) 40 (14) 44 (14)  
Race    0.27 
  White 27 (23) 12 (27) 15 (20)  
  Mixed 57 (48) 16 (36) 18 (24)  
  Black 34 (29) 17 (38) 40 (54)  
  Indigenous 1 (1) 0 (0) 1 (1)  
Socioeconomic     
Elementary education    0.96 
  Completed 36 (30) 13 (29) 23 (31)  
Household head    0.16 
  Yes 63 (53) 28 (62) 35 (47)  
Paid employment    0.08 
  Yes 108 (91) 44 (98) 64 (86)  
Household income per 
capita, US$* 
   0.25 
  < 126 32 (27) 11 (24) 21 (28)  
  126 to 251 42 (35) 20 (44) 22 (30)  
  > 251 45 (38) 14 (31) 31 (42)  
Received social protection    0.59 
  No 100 (84) 39 (87) 61 (82)  
  Auxilio-Doença 3 (3) 1 (2) 2 (3)  
  Programa Bolsa Família 13 (11) 5 (11) 8 (11)  
  Benefício de Prestação 
Continuada 
3 (3) 0 (0) 3 (4)  
Poverty†    0.71 
  Yes 5 (4) 4 (5) 1 (2)  
Clinical     
Acquired DR TB     0.86 
  Yes 66 (55) 24 (53) 42 (57)  
Type of DR TB    0.13 
  Suspected 3 (3) 3 (7) 0 (0)  
  Mono-/ Poly- 35 (29) 14 (31) 21 (28)  
  Multi- 71 (60) 24 (53) 47 (64)  
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  Extensively 11 (9) 5 (11) 6 (8)  
Cavitary DR TB    1 
  Yes 94 (79) 36 (80) 58 (78)  
Treatment model    0.26 
  Clinic-based DOT 90 (76) 35 (78) 55 (74)  
  Home-based DOT 9 (8) 5 (11) 4 (5)  
  Self-administered 20 (17) 5 (11) 15 (20)  
Time to DOT clinic (hours)    0.25 
  Mean (SD) 0.5 (0.6) 0.4 (0.6) 0.6 (0.6)  
Time to CRPHF (hours)    0.22 
  Mean (SD) 4 (2) 4 (2) 4 (2)  
Month of treatment    0.96 
  2-6 30 (25) 12 (27) 18 (24)  
  7-12 43 (36) 16 (36) 27 (36)  
  13+ 46 (39) 17 (38) 29 (39)  
Abbreviations US$, United States Dollar; SD, Standard Deviation; DS, Drug Susceptible; DR, Drug 
Resistant; TB, Tuberculosis; DOT, Directly Observed Therapy; CRPHF, Professor Hélio Fraga Reference 
Centre. *Refers to pre-illness monthly household income per capita, †Defined using Brazil’s 2016 
poverty line of monthly household income per capita US$ 49 a month (148), ‡Refers to comparison 
of participants that do, and do not uptake social protection; proportions were compared with the 
Pearson’s chi-square test and means were compared with Students t-test.   
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Table 14. Summary of survey participants’ direct expenses, indirect costs, and total DR TB-
related costs. 
  
DR TB-related cost 
US$ 
n = 119 
DR TB-related cost burden 
% household income† 
n = 116‡ 
  Mean (SD) Median (IQR) Mean (SD) Median (IQR) 
Direct expenses         
 Patient         
  DOT         
    Transport 184 (224) 112 (112 to 156) 3 (6) 2 (1 to 2) 
    Food 179 (161) 112 (112 to 156) 3 (5) 2 (1 to 3) 
  CRPHF         
    Transport 122 (99) 114 (78 to 137) 2 (2) 1 (1 to 2) 
    Food 34 (40) 26 (0 to 51) 1 (1) 0 (0 to 1) 
  Hospital         
    Transport 6 (31) 0 (0 to 0) 0 (0) 0 (0 to 0) 
  Private         
    Healthcare* 19 (62) 0 (0 to 0) 0 (1) 0 (0 to 0) 
    Food supplements 25 (30) 14 (1 to 34) 0 (0) 0 (0 to 0) 
Family guardian         
  DOT         
    Transport 87 (203) 0 (0 to 67) 2 (4) 0 (0 to 1) 
    Food 64 (113) 0 (0 to 134) 1 (2) 0 (0 to 2) 
  CRPHF         
    Transport 64 (55) 76 (0 to 114) 1 (2) 1 (0 to 2) 
    Food 24 (35) 0 (0 to 40) 0 (1) 0 (0 to 1) 
Subtotal 809 (601) 616 (485 to 877) 14 (17) 8 (5 to 16) 
Indirect costs         
  Patient 5,745 (6,641) 4,526 (1,800 to 7,303) 76 (55) 72 (36 to 131) 
  Family member 462 (1,412) 0 (0 to 0) 6 (19) 0 (0 to 0) 
Subtotal  6,207 (6,671) 4,629 (2,160 to 8,167) 82 (55) 75 (38 to 143) 
Social protection         
Subtotal 1,970 (2,897) 0 (0 to 4,526) 31 (51) 0 (0 to 60) 
Total 5,046 (6,290) 3,868 (850 to 6,817) 65 (59) 60 (15 to 101) 
Abbreviations: US$, United States Dollar; SD, Standard Deviation; IQR, Interquartile Range; DOT, 
Directly Observed Therapy; CRPHF, Professor Helio Fraga Reference Centre; DR, Drug Resistant; TB, 
Tuberculosis. *Includes expenses for private consultation, examination, imaging, medicines and 
other, †Refers to annual household income including social protection, ‡Three participants were 
excluded because pre-illness annual household income was US$ 0.  
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4.5.3 Uptake of social protection 
Amongst the 45 participants that accessed social protection because of DR TB, the mean 
value of social protection received was US$ 5,210 (SD: US$ 2,290). Of these participants, 36 
(80%) received sick pay insurance from Auxilio-Doença with a mean value of US$ 5,734 (SD: 
US$ 1,877). 3 (7%) received both sick pay insurance from Auxilio-Doença and social 
assistance from Programa Bolsa Família with a mean value of US$ 5,833 (SD: US$ 846), 4 
(9%) received social assistance from Programa Bolsa Família with a mean value US$ 366 (SD: 
US$ 149), and 2 (4%) received social assistance from Benefício de Prestação Continuada 
with a mean value of US$ 4,256 (SD: US$ 0). 
4.5.4 Uptake of social protection and financial hardship 
Overall, 68% of participants incurred a cost burden ≥20% of household income, 54% used a 
coping strategy, 24% were impoverished, and 18% experienced all three types of financial 
hardship, Figure 11. In multivariable logistic regression, uptake of social protection was 
independently associated with lower risk of incurring total costs ≥20% of household income 
(OR: 0.37 [95% CI: 0.14 to 0.94], p=0.04); impoverishment (OR: 0.16 [95% CI: 0.04 to 0.54], 
p=0.002); and, experiencing all three hardships (OR: 0.01 [95% CI: 0.00 to 0.07], p<0.001); 
but not with using a coping strategy (OR 1.31 [95% CI: 0.50 to 3.47], p=0.58), Table 15. 
Univariable associations of participants’ demographic and socioeconomic, and clinical 
characteristics with financial hardship are provided in Table S9. 
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Figure 11. Summary of financial hardship across survey participants.  
n = 119. The area of each ellipse is proportional to the number of participants in that set. The area-
proportional Venn diagram was drawn using eulerAPE (149). *Refers to pre-illness annual household 
income, †Defined using Brazil’s 2016 poverty line of monthly household income per capita US$ 49 a 
month (148), ‡Two participants had pre-illness annual household income US$ 0, and were in poverty 
pre-illness, §One participant had missing data on use of coping strategies, ¶One participant was in 
poverty pre-illness, #One participant had pre-illness annual household income US$0, and was in 
poverty pre-illness.  
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Table 15. Multivariable logistic regression assessing the association between uptake of 
social protection and financial hardship. 
  Multivariable logistic regression 
  OR (95% CIs) p-value 
Financial hardship     
Total costs ≥20% of household income*† 0.37 (0.14-0.94)α 0.04 
Used coping strategy‡ 1.31 (0.50-3.47)β 0.58 
Impoverished§¶ 0.16 (0.04-0.52)γ 0.002 
All three financial hardships# 0.01 (0.00-0.07)δ <0.001 
Abbreviations: OR, Odds Ratio; CI, Confidence Interval. Socioeconomic and clinical characteristics 
associated (p<0.1) with outcomes in univariable logistic regression were included in multivariable 
logistic regression models. *Refers to pre-illness annual household income. †Three participants with 
pre-illness annual household income US$ 0 were excluded, n = 116, ‡One participant with missing 
data on use of coping strategies was excluded, n = 118, §Five participants in poverty pre-illness were 
excluded, n = 114, ¶Defined using Brazil’s 2016 poverty line of monthly household income per capita 
US$ 49 a month (148), #Six participants with either pre-illness annual household income US$ 0, 
missing data on use of coping strategies, or in poverty pre-illness were excluded, n = 113. α Mutually 
adjusted for sex, age, education, acquired DR TB, and time to DOT clinic; β Mutually adjusted for sex, 
age, pre-illness household head, pre-illness household income per capita, acquired DR TB, and time 
to DOT clinic; γ Mutually adjusted for sex, age, education, and pre-illness household income per 
capita; δ Mutually adjusted for sex, age, pre-illness household head, pre-illness household income 
per capita, acquired DR TB, and time to DOT clinic. 
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4.6 Discussion of findings 
4.6.1 Summary of main findings 
In Rio de Janeiro, Brazil, despite free TB care and a comprehensive social protection floor, 
total costs incurred by DR TB patients and their households during treatment are high. The 
main contributor to patients’ total costs is indirect costs. Many DR TB affected households 
experience financial hardship from DR TB-related costs, and some experience multiple kinds 
simultaneously. Uptake of social protection because of DR TB is not the norm, with sick pay 
insurance from Auxilio-Doença the most commonly accessed social protection initiative. 
Social protection reimburses a large proportion of patients’ indirect costs, and total costs 
are lower amongst those who take it up compared to those who don’t. Uptake of social 
protection is associated with reduced financial hardship, especially experiencing multiple 
kinds simultaneously. 
4.6.2 How findings fit with the existing literature 
To our knowledge, this study is the first to summarise DR TB-affected households’ costs, 
uptake of social protection and financial hardship in Brazil (6,58,133–135). It is also the first 
anywhere to evaluate the association between uptake of governmental social protection 
and financial hardship. In doing so, the study provides crucial evidence informing the World 
Health Organization’s goal of eliminating catastrophic costs (9). The high value of DR TB-
related costs in this study matches existing evidence in the seven countries where they have 
previously been studied, and serves to reiterate the urgent need for research into the 
potential of governmental social protection to prevent this (6,58,133–135). Results support 
trial evidence demonstrating the effectiveness of a non-governmental cash transfer 
intervention in Lima, Peru, and extends it to the context of real-world social protection 
policies available to TB patients (6). A survey from South Africa is currently the only other 
study exploring TB patients’ uptake of governmental social protection during treatment 
(58). In South Africa, results showed that less than half of TB patients access social 
protection, and suggested that patients only accessed social protection later on during 
treatment (58). Results from Rio de Janeiro, show no association between stage of 
treatment and uptake of social protection. This may indicate fewer administrative barriers 
for patients accessing social protection in Brazil. 
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4.6.3 Study strengths 
The study had several strengths. As one of the first studies to account for uptake of social 
protection when estimating household total costs, it provides a much more accurate 
estimate of the household-level financial impact of DR TB. The study also used three 
different measures of household financial hardship related to DR TB, and assessed their 
overlap using a Venn diagram. This approach provides a useful reference of the overlap of 
different measures of financial hardship, and helps to estimate the number of households 
experiencing especially severe financial hardship related to DR TB. 
4.6.4 Study limitations 
Limitations of this study include its small sample size, which meant it was not possible to 
stratify the analysis by different social protection policies. Nevertheless, there was adequate 
power to detect an association between uptake of social protection and financial hardship. 
Omission of questions relating to costs incurred during previous courses of TB treatment will 
have underestimated the full value of patients’ TB-related costs. However, to avoid recall 
bias the World Health Organization advises that only new TB cases in the intensive phase of 
treatment without a previous course of DS TB treatment are asked about these costs, which 
ex post facto in this study was only 3 people (19). Although there might have been 
measurement error from patients’ self-reported uptake of social protection because of DR 
TB, this was minimised by asking patients about specific social protection policies they might 
have received because of DR TB illness. While the 20% cost burden threshold for measuring 
financial hardship could be seen as arbitrary, the use of three measurements and a 
combined indicator for financial hardship ensure that the conclusions are robust to any 
potential misclassification. The cross-sectional design might have underestimated the 
prevalence of taking a loan or selling assets, as the risk of these activities is likely to 
accumulate over the duration of treatment (56). However, this will only have affected the 
association between receipt of social protection and financial hardship if it was differential 
by receipt of social protection. Finally, the study’s cross-sectional design might have 
underestimated uptake of social protection because of DR TB. Longitudinal follow-up would 
be necessary to capture patients’ uptake over the full duration of treatment. 
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4.7 Concluding remarks 
In Rio de Janeiro, Brazil, financial hardship is common amongst DR TB-affected households. 
Households that uptake social protection during treatment are less likely to experience 
financial hardship. Considering that the majority of households do not uptake social 
protection during treatment, further strategic efforts are needed to protect all DR TB-
affected households from financial hardship.
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Chapter 5. Comparison of two cash transfer strategies to prevent 
catastrophic costs for poor tuberculosis-affected households in low- 
and middle-income countries. 
 
5.1 Research questions addressed by comparing two cash transfer strategies 
In line with objective (4) of this thesis, this chapter aimed to assess the most effective and 
affordable way of providing cash transfers to households affected by TB to prevent them 
experiencing financial hardship. In doing so, this chapter addresses the second research gap 
identified by the thesis for informing the potential of cash transfers to protect households 
from financial hardship related to severe illness: Lack of knowledge about whether making 
poor households at risk of TB more resilient to TB-related costs, or defraying poor 
households’ costs after a family member develops TB is more effective and affordable for 
preventing financial hardship. 
5.2 Key findings from comparison of two cash transfer strategies 
In this chapter, TB-specific cash transfers provided to defray poor households’ costs after a 
family member develops TB were found to prevent TB-related financial hardship in some 
countries, while TB-sensitive cash transfers provided to make poor households at risk of TB 
more resilient to TB-related costs were found to achieve this in no countries. In countries 
where neither TB-specific cash transfers nor TB-sensitive cash transfers would be sufficient 
to prevent financial hardship, the average value of additional cash transfer needed to 
achieve this objective would be much lower using a TB-specific approach compared to a TB-
sensitive approach. Further, by only targeting poor households with a confirmed TB 
diagnosis, a TB-specific approach would require a smaller country-level budget than a TB-
sensitive approach. 
5.3 Background to comparison of two cash transfer strategies 
TB disproportionately affects poor households in low- and middle-income countries that are 
least able to afford the burden that TB-related costs represent relative to their income 
(150–155). Even when diagnosis and treatment is available free of direct charges, TB-
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affected households are known to incur hidden “out of pocket” direct medical expenses 
(e.g. for consultations) and direct non-medical expenses (e.g. for transport, additional food, 
and symptomatic medicines), as well as indirect costs from lost income (12,156). Two 
groups of households that are especially vulnerable to TB-related costs are those in 
countries’ poorest population quintile, and those affected by drug-resistant (DR) TB (12). 
Preventing catastrophic costs for TB-affected households is a priority for facilitating 
individuals’ access to TB diagnosis and treatment, increasing their likelihood of treatment 
success, and reducing onwards TB transmission (157). With this objective, the Global TB 
Programme endorses the use of additional social protection initiatives to complement 
Universal Health Coverage initiatives like fee waivers, resource pooling and patient-friendly 
service delivery (10). Cash transfers have become an especially popular social protection 
initiative in low- and middle-income countries. In the TB literature, evidence from a 
randomized trial in Peru shows that when provided as incentives to support TB treatment, 
cash transfers reduce poor TB-affected households’ likelihood of incurring catastrophic 
costs, as well as improve patients’ likelihood of TB treatment success, and uptake of 
preventative therapy amongst people they are in close contact with (e.g. family, friends, 
care giver) (45,56). Outside of the TB literature, synthesised evidence from governmental 
poverty-reduction policies in several low- and middle-income countries provides evidence 
that cash transfers increase help poor households to cope with livelihood risks (e.g. illness 
and unemployment) (61). 
Currently, there are at least two alternative approaches proposed in the tuberculosis (TB) 
literature for providing cash transfers to TB-affected households (158). The first is termed a 
“TB-specific” approach, whereby cash transfers would be targeted to poor households with 
a confirmed TB diagnosis to incentivise and enable TB treatment by defraying their TB-
related costs (158). This approach is exemplified by the cash transfer component of the 
Community Randomized Evaluation of a Socioeconomic Intervention to Prevent TB 
(CRESIPT) trial in Peru (159,160). The second is termed a “TB-sensitive” approach, whereby 
cash transfers would be targeted to poor households at high risk of developing active TB 
disease to increase their income, thereby protecting them from poverty-related risk factors 
for TB infection, progression, and adverse treatment outcomes (e.g. poor living conditions 
and undernutrition), as well as strengthen their economic resilience to TB-related costs 
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(158). This approach already exists in many low- and middle-income countries, and is 
exemplified by governmental poverty-reduction cash transfer programmes like Programa 
Bolsa Família in Brazil (37,143). 
Depending on whether cash transfers are provided with a TB-specific or a TB-
sensitive approach, their impact might vary (158). This study aimed to investigate how this 
might relate to the potential of cash transfers to prevent catastrophic costs. This study built 
on work conducted as part of my Masters dissertation, which was submitted in September 
2015, in part fulfilment for the degree of MSc in Control of Infectious Disease, at the London 
School of Hygiene and Tropical Medicine (161). 
5.4 Research methodology 
5.4.1 Study design and implementation 
With no known data sources for investigating if the potential of TB-specific and TB-sensitive 
cash transfers to prevent catastrophic costs varies, an economic modelling study was 
undertaken using published national average data gathered from a rigorous review of the 
literature. This economic modelling study was aggregated at the country level. The setting 
was low- and middle-income countries, where over 95% of TB cases live, and where formal 
institutions to protect households from the social and economic impacts of illness are 
weakest (52). The intervention being investigated was cash transfers paid to poor 
households, and the alternative approaches being compared were: (1) cash transfers 
provided to defray TB-related costs of households with a confirmed TB diagnosis (termed a 
“TB-specific” approach); versus (2) cash transfers provided to increase income of 
households with high TB risk and strengthen their economic resilience (termed a “TB-
sensitive” approach). These approaches were compared because of current uncertainty 
about the potential of each approach to prevent catastrophic costs. For transparency, the 
study was reported according to the Consolidated Health Economic Evaluation Reporting 
Standards (CHEERS) checklist (162). The completed checklist is provided in Table S10. 
Primary study outcomes were an indicator for catastrophic costs after TB-specific versus 
TB-sensitive cash transfers, and countries’ country-level cash transfer budget needed to 
prevent catastrophic costs for each of these approaches. Catastrophic costs were estimated 
over a time horizon from the month prior to TB symptom onset to TB treatment completion. 
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Countries’ country-level cash transfer budget was estimated over a time horizon of one 
year. In the one country with available data, outcomes were investigated separately for 
drug-susceptible (DS) TB and DR TB. The reason for this is that treatment of DR TB versus DS 
TB is longer and more intensive and is therefore associated with much higher TB-related 
costs (12). Using only TB-related costs incurred by patients, study outcomes were assessed 
from the patient perspective. 
5.4.2 Study population 
In this study, the target population for cash transfers provided with a TB-specific approach 
was households in countries’ poorest population quintile with a confirmed TB diagnosis. 
Guidance is not currently available for which TB-affected households should be targeted 
with a TB-specific approach. It was chosen to focus on TB-affected households in countries’ 
poorest population quintile because they are typically at greater risk of incurring 
catastrophic costs (6). Whilst it might have been preferable to focus on all TB-affected 
households that incur catastrophic costs, at the time of analysis no estimates of the size of 
this population were available in any countries included in this study. The target population 
for cash transfers provided with a TB-sensitive approach was households in poverty already 
targeted by countries’ established governmental poverty-reduction cash transfer 
programme. 
5.4.3 Study data 
The study used cross-sectional data drawn from secondary sources. Data inputs were 
countries’ mean patient TB-related cost, mean pre-illness household income, mean poverty-
reduction cash transfer, and TB-specific versus TB-sensitive target populations. Inputs were 
retrieved by reviewing TB-related cost and cash transfer literature, and countries’ national 
statistics. Because there was insufficient data across low- and middle-income countries on 
programmes providing cash transfers with a TB-specific approach, this study compared cash 
transfers offered by existing governmental poverty-reduction programmes as if they were 
provided with a TB-specific versus a TB-sensitive approach. 
TB-related cost data. Data on mean TB-related costs incurred by patients were sourced 
from articles identified by two recent publically available systematic reviews (12,156). These 
reviews were chosen because they provided a comprehensive, peer-reviewed list of TB-
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related cost surveys published before March 2013 and February 2015. TB-related cost 
surveys in identified articles were eligible if they were conducted in a low- or middle-income 
country, and reported mean total costs calculated from direct expenses and/or indirect 
costs incurred over the full duration of pre- and/or during- DS TB and/or DR TB treatment. 
Cost surveys only reporting median total costs were excluded because of difficulties 
generalising this measure to countries’ total population. Cost surveys were also excluded if 
they were conducted before 2006, the year in which the Global TB Programme 
recommended that governments should waive direct expenses for basic TB diagnostic tests 
and medicines (163). If a publication reported TB-related costs from surveys in several 
different countries, each survey country was checked separately for cash transfer and 
household income data. Data extracted from eligible TB-related cost surveys comprised: 
survey country, year of data collection, survey setting, survey sample size, local currency 
unit exchange rate, methods used to estimate TB-related costs and mean TB-related costs 
stratified into sub categories of direct, indirect and total TB-related costs. In Brazil and 
Yemen, where articles reported mean TB-related costs for different patient sub-groups (e.g. 
directly observed therapy versus self-administered therapy) an un-weighted mean overall 
estimate was calculated across subgroups (164,165). 
Cash transfer data. For countries with an eligible TB-related cost survey, existing poverty-
reduction cash transfer programmes operating in respective countries were identified using 
the publically available social safety net program inventory in the appendix of the World 
Bank Group publication “The State of Social Safety Nets 2015” (166). None of the identified 
cash transfer programmes were operated with explicit TB objectives. Cash transfer 
programmes were eligible if they were directed by a national government with the objective 
of poverty reduction and promoting family human capital development. Operational data 
on cash transfer programmes were sourced from the original reference (166) and other 
publically available online data sources identified from Google by combining the phrase 
“cash transfer” with the name of the programme and the selected country (50,84,112,167–
175). A summary of cash transfer data sources used in the study is provided in Table S11. 
Cash transfer programmes were excluded if they were targeted uniquely to senior citizens 
or pregnant women. Data extracted on eligible poverty-reduction cash transfer programmes 
comprised: name of programme, breakdown of cash transfer benefits, mean cumulative 
97 
annual cash transfers, sample size used to summarise mean cumulative annual cash 
transfers, and the range of cumulative annual cash transfers based on programme 
regulations. 
Household income data. For countries with an eligible TB-related cost survey and existing 
poverty-reduction cash transfer programme, countries’ mean household income or 
expenditure in the poorest population quintile was used to approximate household income 
of both TB-specific and TB-sensitive target populations. Publically available summary 
estimates of household income or expenditure were identified by searching countries’ 
national statistical websites and the International Household Survey Network’s (IHSN’s) 
survey catalogue (176). It was assumed that household income and expenditure were 
approximately similar. Where available, household income was preferred because of its use 
in the method included by the Global TB Programme in a pilot tool to measure and monitor 
catastrophic costs of TB-affected households (10). Data extracted from countries’ national 
statistical websites and the IHSN survey catalogue comprised: Coverage in households of 
country household income or expenditure survey, and mean household income or 
expenditure in countries’ poorest population quintile. When household income data was 
reported by population decile rather than population quintile, an un-weighted mean overall 
estimate was recalculated across the two poorest deciles. When national income surveys 
reported mean monthly or quarterly household income or expenditure, these values were 
extrapolated to mean annual estimates. 
Target population data. For countries with an eligible cost survey, cash transfer programme 
and household income or expenditure survey, the approximate size of their TB-specific 
target population was identified using the World Health Organization’s publically available 
TB data (177). Because estimates of the percentage of TB-affected households represented 
in the poorest population quintile were not available in any countries included in the study, 
the unweighted mean multiplier for TB prevalence in the poorest population quintile 
observed in India and South Africa was used to estimate the size of countries’ TB-specific 
target population (55,178). Therefore, countries TB-specific target population was extracted 
as 40% of countries’ estimated 2013 DS TB burden or 2015 DR TB burden. For country 
estimates of DR TB burden, 2015 estimates were used because 2013 estimates weren’t 
available. It was assumed that each estimated case of active TB disease in the World Health 
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Organization’s TB data represented one household with a confirmed TB diagnosis. The 
approximate size of countries’ TB-sensitive target population was identified using publically 
available estimates of countries’ 2013 poverty-reduction cash transfer programme coverage 
in households already extracted in the cash transfer data literature review (50,84,112,167–
175). Countries’ TB-specific and TB-sensitive target populations were also extracted as a 
percentage of countries’ total population in households using publically available census 
data available in the United Nations demographic yearbook (179). 
All data were extracted into Microsoft Excel 2016. To allow comparison of monetary data 
extracted in different currencies and measured in different years all extracted monetary 
values were inflated and converted to 2013 international dollars ($) using the purchasing 
power parity conversion factor that accounts for differences in the cost of living across 
countries (180,181). 
5.4.4 Data management. 
Missing values for direct or indirect costs, pre- or during-treatment were imputed. To do 
this, it was assumed that average TB-related costs followed a make-up of cost components 
equivalent to the one synthesised by Tanimura et al. in their systematic review of TB-related 
costs in low- and middle-income countries, which is that direct and indirect costs are 
equivalent to 40% and 60% of total costs respectively, and pre- and during-treatment costs 
are each equivalent to 50% of total costs respectively (12). Because only one included cost 
survey reported the standard deviation of total costs (164), it was also assumed that 
average TB-related costs had a standard deviation with the same ratio to total costs as the 
one estimated by Tanimura et al. for average total costs across all low- and middle-income 
countries, which was 1.1 (12). The assumed standard deviation and sample size of countries’ 
cost surveys were used to calculate 95% CIs for estimated TB-related costs. 
5.4.5 Data analysis. 
All analyses used published mean national data. To account for uncertainty in the value of 
extracted TB-related costs, annual household income, and cash transfers, a multiway 
analysis was conducted that allowed all three of these inputs to vary simultaneously 
according to their sampling distributions. Sampling distributions were simulated from 
10,000 computationally generated random samples, and were all assumed to have normal 
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distributions according to the central limit theorem. Random samples were generated for 
TB-related costs using a standard deviation with a ratio of 1.1 to mean estimates, which was 
the ratio estimated by Tanimura et al. for average total costs across all low- and middle-
income countries, and a sample size equivalent to countries’ cost surveys (12). For annual 
household income, a standard deviation with a ratio of 0.8 to mean estimates, and a sample 
size equivalent to countries’ household income surveys was used (182–188). The ratio of 0.8 
was the average observed across two studies investigating the household-level income 
effect of poverty-reduction cash transfer programmes in Brazil and Colombia (84,167). For 
cash transfers, a standard deviation with a ratio to mean estimates equivalent to a quarter 
of maximum cash transfers minus minimum cash transfers, and a sample size equivalent to 
the one reported in studies from which cash transfer data were extracted was used. In 
Ecuador and Ghana, sampling distributions for cash transfers were not simulated because 
respectively, all beneficiary households receive the same flat cash transfer, and the mean 
cash transfer that was extracted was estimated from all beneficiary households. Throughout 
the analysis, 95% CIs were calculated for model estimates using the quantile method. All 
analyses were run in R version 3.3.0. 
Estimation of TB-related cost burden before cash transfers. To estimate if TB-related costs 
were catastrophic for poor TB-affected households, each country’s TB-related cost burden 
without cash transfer data was calculated by expressing TB-related costs as a percentage of 
household income. A TB-related cost burden greater than or equal to 20% was measured as 
catastrophic, as this threshold has been shown to significantly increase the likelihood of TB 
patients experiencing an adverse treatment outcome, and their household engaging in 
damaging financial coping strategies (6,56). In countries where the TB-related cost burden 
was estimated to be catastrophic, the potential of cash transfers provided with a TB-specific 
versus a TB-sensitive approach to prevent catastrophic costs was then compared. 
Estimation of the potential of TB-specific cash transfers to prevent catastrophic costs. To 
estimate the potential of cash transfers provided with a TB-specific approach to prevent 
catastrophic costs, it was considered that cash transfers would be targeted to poor 
households with a confirmed TB diagnosis to defray TB-related costs incurred pre- and 
during-treatment. Thus, the value of cash transfers was subtracted from TB-related costs, 
and then countries’ TB-related cost burden was recalculated, Table 15, Equation 1. 
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Estimation of the potential of TB-sensitive cash transfers to prevent catastrophic costs. To 
estimate the potential of cash transfers provided with a TB-sensitive approach to prevent 
catastrophic costs, it was considered that cash transfers would be targeted to poor 
households at high risk of developing active TB disease, to increase their pre-illness income 
and protect them from poverty. For any beneficiary households that later developed active 
TB disease, their cash transfer increased household income would make them more resilient 
to the burden of TB-related costs incurred pre- and during-treatment. Thus, the value of 
cash transfers was added to pre-illness annual household income, and then countries’ TB-
related cost burden was recalculated, Table 15, Equation 2. 
Estimation of TB-specific and TB-sensitive cash transfer needed to prevent catastrophic 
costs. To estimate the total value of cash transfer that would be needed by poor TB-affected 
households to prevent catastrophic costs with a TB-specific versus a TB-sensitive approach, 
it was considered that for each approach, an additional cash transfer would be provided to 
targeted households to achieve this objective. Thus, countries’ household-level additional 
cash transfer needed to prevent catastrophic costs was first estimated by rearranging 
Equations 1 and 2, fixing countries’ TB-related cost burden at 20%, and considering an 
unknown value of additional cash transfer, Table 16, Equations 3ii and 4ii. Then countries’ 
household-level total cash transfer needed to prevent catastrophic costs was estimated by 
adding the value of original cash transfer to the estimated value of additional cash transfer 
needed to prevent catastrophic costs.  
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Table 16. Summary of equations used in economic modelling analysis. 
TB-related cost burden (%) 
Equation 1: after TB-specific cash transfers 
𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 𝑏𝑢𝑟𝑑𝑒𝑛 =
(𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 − 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟)
𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒
∗ 100 
Equation 2: after TB-sensitive cash transfers 
𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 𝑏𝑢𝑟𝑑𝑒𝑛 =
𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡
(𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒 + 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟)
∗ 100 
Additional cash transfer needed to prevent catastrophic costs ($) 
Equation 3: TB-specific approach 
(i) 
20 =
(𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 − 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟 − 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟)
𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒
∗ 100 
(ii) 
 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟
= (𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 − 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟) − (𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒 ∗ 0.2) 
Equation 4: TB-sensitive approach 
(i) 
20 =
𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡
(𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒 + 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟 + 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟)
∗ 100 
(ii) 
𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟
= (𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡/ 0.2) − (𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒 + 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟) 
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Estimation of TB-specific and TB-sensitive cash transfer budget needed to prevent 
catastrophic costs. To estimate the country-level budget that countries would need to 
prevent catastrophic costs for all poor households targeted with a TB-specific versus a TB-
sensitive approach, it considered that for each approach, a value of cash transfer sufficient 
to prevent catastrophic costs would be provided to all targeted households. Thus, countries’ 
estimated TB-specific and TB-sensitive household-level total cash transfer needed to 
prevent catastrophic costs were multiplied by the size of each approach’s target population, 
which for a TB-specific approach was all households with a confirmed TB diagnosis in 
countries’ poorest population quintile, and for a TB-sensitive approach was households in 
poverty already targeted by countries’ established governmental poverty-reduction cash 
transfer programme. 
5.4.6 Sensitivity analysis 
The sensitivity of study results in Brazil, Colombia, Tanzania and Mexico were tested to 
imputation of missing DS TB-related cost components by omitting rather than imputing the 
value of missing DS TB-related cost components (12). The sensitivity of study results was 
separately tested across all countries included in the study to the use of 20% as the 
threshold for measuring countries’ TB-related cost burden as catastrophic. This was done by 
repeating the analyses instead using a 10% and 30% threshold. 
5.5 Results 
Figure 12 is a flow chart of the review process for assessing the eligibility of countries for 
inclusion in this study. Argentina, Bangladesh, and South Africa had to be excluded after 
insufficient publicly available background information was identified for eligible cash 
transfer programmes in these countries. Consequently, seven countries were included in the 
data analysis.
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Figure 12. Flow chart of country eligibility and TB-related cost survey inclusion in the economic modelling 
study.  
TB, Tuberculosis. 
90 articles identified from 
Laurence et al. 2015 
49 articles identified from 
Tanimura et al. 2014 
78 articles (43 countries) after studies in 
high income countries and duplicates 
removed screened for eligible TB-related 
cost data 
55 articles (21 countries) excluded:  
48 data collected before 2006 
3 data reported from health system 
perspective 
1 data not reported for the full period pre- 
and/or during-treatment 
3 data summarised by median 
23 articles (22 countries) screened for 
eligible cash transfer programme 
21 articles (20 countries) screened for 
eligible household income data 
2 articles (2 countries) excluded:  
1 programme targeted to pregnant women 
1 programme targeted senior citizens 
12 articles (10 countries) excluded: 
12 household income data not available 
9 articles (10 countries) screened for 
eligible cash transfer programme data 
2 articles (3 countries) excluded:  
3 cash transfer programme data not 
available 
7 articles (7 countries) included 
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5.5.1 Summary of extracted data 
DS TB-related cost data. Conducted in Brazil, Colombia, Ecuador, Ghana, Mexico, Tanzania, 
and Yemen between 2006 and 2012, survey sample sizes ranged from 94 to 320 patients 
with active DS TB disease, Table 17. Surveys collected data on DS TB-related costs incurred 
pre- and during-treatment, except in Brazil (164), Colombia (189), and Tanzania (190), 
where they only collected data during-treatment, Table 17. Surveys collected both direct 
and indirect cost data, except in Mexico (191) where no data was collected characterising 
indirect costs, Table 17. In countries where data was collected, methods for estimating 
indirect costs varied in two ways: 1) reported time lost travelling and waiting to receive TB 
care was multiplied by patients’ reported income (164,192); or 2) reported time lost 
travelling and waiting to receive TB care was multiplied by an estimate of national average 
income (gross national income per capita or official wage rate) (133,164,189,190). In 
Ecuador (133), data was collected on additional costs described in the publication as 
referring to “loans, paying for additional help and other impacts throughout the course of 
TB illness”. The ambiguity of this cost category meant that it could not be classified as either 
direct or indirect costs, and was thus reported as its own subcategory. Reported mean DS 
TB-related total costs for the complete TB illness ranged from $387 to $2,382, Table 17. 
After imputing missing TB-related cost components in Brazil, Colombia, Mexico and 
Tanzania, estimated mean DS TB-related total costs ranged from $774 (95% CI: $618 to 
$930) to $5,954 (95% CI: $4,997 to $6,911), Table 17. 
Summary of DR TB-related cost data. Conducted in Ecuador in 2007, the survey sample size 
was 14 patients with active multidrug-resistant TB disease, Table 17. The survey reported 
mean DR TB-related costs incurred pre- and during-treatment, Table 17. The survey 
collected both direct and indirect cost data, Table 17. Cost data was also collected on 
additional costs. This category of costs was reported as its own subcategory. Indirect costs 
were estimated by multiplying reported time lost travelling and waiting to receive TB care 
by the estimated hourly wage in Ecuador. Mean DR TB-related total costs were $16,667 
(95% CI: $7,063 to $26,271), Table 17. 
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Table 17. Summary of TB-related cost surveys included in the economic modelling study. 
Cost survey Reported TB-related costs Estimated TB-related costs 
Country Year 
Number of 
participants 
Treatment phase  
Direct 
2013 PPP$ 
Indirect 
2013 PPP$ 
Additional 
2013 PPP$ 
Total  
2013 PPP$ 
 Total 
2013 PPP$ (95% CIs) * 
DS TB             
Brazil§ (164) 2010 218 During- 182 205   387 774 (618 to 930) † 
Ecuador (133) 2007 104 Pre- and during- 846 860 620 2,326 2,326 (1,834 to 2,818) 
Yemen§ (165) 2008/09 320 Pre- and during- 631 253   885 885 (778 to 992) 
Tanzania (190) 2012 94 During- 506 330   836 1,672 (1,300 to 2,044) † 
Ghana (192) 2009 135 Pre- and during- 326 883   1,208 1,208 (984 to 1,432) 
Colombia (189) 2010 150 During-       707 1,414 (1,165 to 1,663) † 
Mexico (191) 2007/08 180 Pre- and during- 2,382     2,382 5,954 (4,997 to 6,911) ‡ 
DR TB             
Ecuador (133) 2007 14 Pre- and during- 2,345 4,560 9,762 16,667 16,667 (7,063 to 26,271) 
Abbreviations: PPP, Purchasing Power Parity; CI, Confidence Interval; DR, Drug Resistant; DS, Drug Susceptible; TB, Tuberculosis. *According to Tanimura et 
al., estimated total costs in all countries had a standard deviation with a ratio of 1.1 to their value (12). The probability distribution of TB-related costs was 
assumed to be normal. This was justified because our analysis was at the national level and mean values were used. †According to Tanimura et al., reported 
during-treatment costs were assumed to only represent 50% of total TB-related costs (12). ‡According to Tanimura et al., reported direct expenses pre- and 
during-treatment were assumed to only represent 40% of total TB-related costs (12). §TB-related costs were extracted as an unweighted mean overall 
estimate calculated across patient subgroups.
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Summary of cash transfer data. All extracted cash transfer data refer to programmes’ 
status in 2013. Mean cumulative annual cash transfers were greatest in Brazil, Colombia, 
Ecuador, Mexico, and Yemen varying between $823 (range: $239 to $1,084) and $1,091 
(range: $1,091 to $1,091); and lowest in Ghana and Tanzania where they were $217 (range: 
$150 to $299) and $451 (range: $349 to $655) respectively, Table 18. Across countries, cash 
transfers ranged from 8% (95% CI: 8% to 8%) to 43% (95% CI: 42% to 44%) of annual 
household income. In Colombia, Ecuador, Ghana, Mexico, and Tanzania they varied 
between 13% (95% CI: 11% to 18%) and 59% (95% CI: 50% to 72%) of DS TB-related costs, 
and in Brazil and Yemen, respectively, they were 104% (95% CI: 93% to 119%) and 106% 
(95% CI: 88% to 133%) of DS-TB-related costs, Table 18. In Ecuador, cash transfers 
represented 7% (95% CI: 4% to 15%) of DR TB-related costs, Table 18. A summary of cash 
transfer data sources and additional extracted data is provided in Table S11. 
Summary of household income data. Conducted between 2005 and 2011, survey sample 
sizes ranged from 8,687 to 55,970 households (182–188). Surveys reported mean household 
income, except in Tanzania where mean household expenditure was reported. Estimated 
mean annual household income in countries’ poorest population quintiles was highest in 
Brazil, Ecuador, and Mexico varying between $4,755 and $8,692, and lowest in Colombia, 
Ghana, Tanzania, and Yemen varying between $1,617 and $2,812. A summary of annual 
household income data sources and extracted data is provided in Table S11. 
Summary of target population data. For DS TB, the size of countries’ estimated TB-specific 
target population, which was equivalent to 40% of countries’ TB burden, ranged from 3,520 
to 67,600 households, and the size of countries’ estimated TB-sensitive target population, 
which was equivalent to the number of households in poverty already targeted by countries’ 
established poverty-reduction cash transfer programme, ranged from 70,000 to 26 million 
households, Table 18. For DR TB, the size of Ecuador’s estimated TB-specific target 
population was 300 households, and the size of its estimated TB-sensitive target population 
was 450,000 households, Table 18.
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Table 18. Summary of poverty-reduction cash transfer programmes included in the economic modelling study and TB-specific versus TB-
sensitive target populations. 
Poverty-reduction cash transfer programme 
Current poverty-reduction 
cash transfer % of 
Target population  
in households 
Country Name Components 
Current cash 
transfer  
2013 PPP$ 
(Range) 
Household 
income†  
(95% CIs) § 
TB-related 
costs  
(95% CIs) § 
TB-specific 
(% of 
population) 
TB-sensitive 
(% of 
population) 
DS TB          
Brazil 
Programa 
Bolsa Familia 
(112,167) 
Flat benefit to extremely poor 
families; and variable benefits to 
poor families to support child health, 
child/adolescent education, and 
pregnant women’s health 
823  
(239 to 1,084) 
15  
(15 to 16) 
106  
(88 to 133) 
34,800  
(0.06) 
14,000,000  
(25) 
Ecuador 
Bono de 
Desarollo 
Humano (168) 
Flat benefit to poor families to 
support child health and education 
1,091  
(1,091 to 1,091) 
13  
(12 to 13) 
47  
(39 to 59) 
3,520  
(0.09) 
450,000  
(12) 
Yemen 
Social Welfare 
Fund (169) 
Flat benefit to poor families; and 
variable benefit to poor families for 
household size 
923  
(615 to 1,026) ᶲ 
43 
 (42 to 44) 
104  
(93 to 119) 
4,800  
(0.17) 
1,500,000  
(35) 
Tanzania 
Productive 
Social Safety 
Net (170–172) 
Flat benefit for poor families; and 
variable benefits to poor families to 
support child health and education 
and pregnant women’s health 
217  
(150 to 299) 
7.7  
(7.6 to 7.9) 
13  
(11 to 17) ‡ 
67,600  
(0.72) 
150,000  
(2) 
Ghana 
Livelihood 
Empowerment 
Against 
Poverty (173) 
Variable benefit to poor families for 
orphans and vulnerable children, 
disabled and those over 65 
451  
(349 to 655) 
25 
 (24 to 26) 
37  
(32 to 46) 
17,600  
(0.32) 
70,000  
(1) 
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Colombia 
Mas Familias 
en Acción 
(84,174) 
Variable benefits to poor families to 
support child health and 
child/adolescent education 
837  
(191 to 1,777) 
38 
 (37 to 39) 
59  
(50 to 72) 
6,000  
(0.06) 
26,000,000  
(25) 
Mexico 
Oportunidades* 
(50,175) 
Variable benefits to poor families to 
support family health, 
child/adolescent education, family 
nutrition 
940  
(246 to 2,063) 
20  
(19 to 20) 
16  
(14 to 19) 
10,000  
(0.04) 
6,600,000  
(27) 
DR TB            
Ecuador 
Bono de 
Desarollo 
Humano (168) 
Flat benefit to poor families to 
support child health and education  
1,091  
(1,091 to 1,091) 
13  
(12 to 13) 
7.3  
(4.2 to 15) 
300  
(0.01) 
450,000  
(12) 
Abbreviations: PPP, Purchasing Power Parity, CI, Confidence Interval, DR, Drug Resistant; DS, Drug Susceptible; TB, Tuberculosis. Apart from countries’ 
alternative target populations, all data are mean estimates. *Formerly PROGRESA. †Household income refers to average pre-illness annual household 
income in the poorest population quintile. ‡Household income was extracted as household expenditure in the poorest population quintile. §To estimate 
95% confidence intervals, all mean TB-related costs were assumed to have a standard deviation with a ratio of 1.1 to their value, all mean household 
incomes were assumed to have a standard deviation with a ratio of 0.8 to their value, and all mean cash transfers were assumed to have a standard 
deviation equal to a quarter of maximum minus minimum cash transfers. Probability distributions for all 3 input parameters were assumed to be normal. 
This was justified because our analysis was at the national level and we used mean values. ᶲBecause of changes in cash transfer programme administration 
in the study year, reported mean cash transfers were higher than the maximum value of cash transfers able to be received by beneficiary households in 
2013 (169). Mean cash transfers were assumed to be approximately equivalent to the value that would be received by an average household in the 
country's poorest population quintile based on household size.
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5.5.2 Summary of DS TB-related cost burden before cash transfers 
Before cash transfers, estimated DS TB-related cost burdens varied between 15% (95% CI: 
12% to 18%) and 125% (95% CI: 105% to 145%) of annual household income, and were 
catastrophic in Colombia, Ecuador, Ghana, Mexico, Tanzania, and Yemen where they varied 
between 27% (95% CI: 21% to 32%) and 125% (95% CI: 105% to 145%) of annual household 
income, Figure 13. 
5.5.3 Summary of the potential of TB-specific cash transfers to prevent DS TB catastrophic 
costs, and the budget needed for this approach  
If cash transfers were applied using a TB-specific approach to defray TB-related costs 
incurred by households with a confirmed DS TB diagnosis, then on average, they were 
sufficient to prevent catastrophic costs in Ecuador and Yemen, but insufficient to prevent 
them in either Colombia, Ghana, Mexico or Tanzania, Figure 13. In Colombia, Ghana, Mexico 
or Tanzania, the DS TB-related cost burden after TB-specific cash transfers varied between 
26% (95% CI: 15% to 38%) and 106% (95% CI: 86% to 126%), and the estimated value of 
household-level additional TB-specific cash transfer needed to prevent DS TB catastrophic 
costs varied between $144 (95% CI: $0 to $387) and $4,071 (95% CI: $3,122 to $5,014), 
Table 19. In the six countries where TB-related costs were originally catastrophic, the 
estimated value of household-level total TB-specific cash transfer needed to prevent DS TB 
catastrophic costs varied between $850 (95% CI: $627 to $1,079) and $5,011 (95% CI: 
$4,063 to $5,952), Table 19. According to the size of countries’ TB-specific target 
populations, this value translated into a TB-specific country-level cash transfer budget 
needed to prevent DS TB catastrophic costs varying between $4 million (95% CI: $4 million 
to $4 million) and $75 million (95% CI: $50 million to $100 million), Figure 13. 
5.5.4 Summary of the potential of TB-sensitive cash transfers to prevent DS TB 
catastrophic costs, and the budget needed for this approach 
If cash transfers were provided using a TB-sensitive approach to increase pre-illness income 
of poor households with high risk of developing active TB disease, then on average, for 
those that later develop active DS TB disease this would not be sufficient to prevent them 
from incurring catastrophic costs in any of the six countries where DS TB-related costs were 
originally catastrophic, Figure 13. In these six countries, the DS TB-related cost burden after 
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TB-sensitive cash transfers varied between 24% (95% CI: 19% to 29%) and 105% (95% CI: 
88% to 121%), and the estimated value of household-level additional TB-sensitive cash 
transfer needed to prevent DS TB catastrophic costs varied between $1,360 (95% CI: $821 to 
$14,897) and $24,115 (95% CI: $19,374 to $28,817), Table 19. The estimated value of 
household-level total TB-sensitive cash transfer needed to prevent DS TB catastrophic costs 
varied between $2,282 (95% CI: $1,743 to $2,819) and $25,055 (95% CI: $20,316 to 
$29,761), Table 19. According to the size of countries’ TB-sensitive target populations, this 
value translated into a TB-sensitive country-level cash transfer budget needed to prevent DS 
TB catastrophic costs varying between $298 million (95% CI: $219 million to $378 million) 
and $165,367 million (95% CI: $134,085 million to $196,425 million), Figure 14. 
5.5.5 Summary of the potential of TB-specific versus TB-sensitive cash transfers to 
prevent DR TB catastrophic costs, and the budget needed for each approach 
In Ecuador, the DR TB-related cost burden before cash transfers was 192% (95% CI: 86% to 
299%), Figure 13. Here, cash transfers provided with either a TB-specific or a TB-sensitive 
approach were, on average, insufficient to prevent DR TB catastrophic costs, Figure 13. The 
estimated value of TB-specific versus TB-sensitive additional cash transfer needed to 
achieve this objective was $13,782 (95% CI: $4,274 to $23,376) versus $73,275 (95% CI: 
$25,736 to $121,246); and the estimated value of household-level total TB-specific versus 
TB-sensitive cash transfers needed was $14,877 (95% CI: $5,365 to $24,467) versus $74,375 
(95% CI: $26,827 to $122,337), Table 19. According to the size of Ecuador’s DR TB-specific 
and DR TB-sensitive target population, this value translated into a country-level cash 
transfer budget needed to prevent DR TB catastrophic costs of $4 million (95% CI: $2 million 
to $7 million) with a TB-specific approach versus $33,469 million (95% CI: $12,072 million to 
$55,052 million) with a TB-sensitive approach, Figure 14. 
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Figure 13. Summary of countries’ household-level TB-related cost burden before, and after cash transfers. 
Abbreviations: DR, Drug Resistant; DS, Drug Susceptible; TB, Tuberculosis. The “Before cash transfers” bar represents countries’ mean TB-related cost burden without cash 
transfer data. The “After TB-specific cash transfers” bar represents countries’ mean TB-related cost burden after cash transfers have been subtracted from TB-related costs. 
The “After TB-sensitive cash transfers” bar represents countries’ mean TB-related cost burden after cash transfers have been added to pre-illness household income. The 
dotted line guides whether countries’ mean TB-related cost burden is above or below 20%. Error bars are 95% CIs calculated using the quantile method. Values summarised 
in Figure 13 are provided in Table S12. *For clarity, a mean TB-related cost burden of 0% after cash transfers is plotted as 0.9%. †Upper bound of 95% CI = 19.8. ‡To 
estimate 95% CIs, mean TB-related costs were assumed to have a standard deviation with a ratio of 1.1 to their value (12), mean household incomes were assumed to have 
a standard deviation with a ratio of 0.8 to their value (84,167), and mean cash transfers were assumed to have a standard deviation equal to a quarter of maximum minus 
minimum cash transfers. Probability distributions for all 3 model inputs were assumed to be normal. This was justified because our analysis was at the national level and 
mean values were used.  
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Table 19. Summary of countries’ household-level additional and total cash transfer needed to prevent catastrophic costs. 
 
Additional cash transfer 
2013 PPP$ (95% CIs) * 
Total cash transfer 
2013 PPP$ (95% CIs) * 
Country TB-specific approach TB-sensitive approach TB-specific approach TB-sensitive approach 
DS TB       
Brazil 0.0 (0.0 to 0.0) 0.0 (0.0 to 0.0) 0.0 (0.0 to 0.0) 0.0 (0.0 to 0.0) 
Ecuador 0.0 (0.0 to 0.0) † 1,842 (0.0 to 4,281) 1,091 (1,091 to 1,091) † 2,971 (1,091 to 5,372) 
Yemen 0.0 (0.0 to 0.0) 1,360 (821 to 1,897) 923 (920 to 926) 2,282 (1,743 to 2,819) 
Tanzania 880 (510 to 1,243) 5,322 (3,473 to 7,139) 1,111 (741 to 1,474) 5,553 (3,707 to 7,370) 
Ghana 399 (176 to 628) 3,800 (2,683 to 4,945) 850 (627 to 1,079) 4,251 (3,134 to 5,396) 
Colombia 144 (0.0 to 387) 4,023 (2,764 to 5,281) 981 (830 to 1,223) 4,860 (3,600 to 6,117) 
Mexico 4,071 (3,122 to 5,014) 24,115 (19,374 to 28,817) 5,011 (4,063 to 5,952) 25,055 (20,316 to 29,761) 
DR TB       
Ecuador 13,782 (4,274 to 23,376) 73,275 (25,736 to 121,246) 14,877 (5,365 to 24,467) 74,375 (26,827 to 122,337) 
Abbreviations: PPP, Purchasing Power Parity, CI, Confidence Interval; DS, Drug Susceptible; DR, Drug Resistant; TB, Tuberculosis. All data are average 
estimates. For interpretability, negative estimates and confidence intervals are reported as 0. *To estimate 95% confidence intervals, all mean TB-related 
costs were assumed to have a standard deviation with a ratio of 1.1 to their value (12), all mean household incomes were assumed to have a standard 
deviation with a ratio of 0.8 to their value (84,167), and all mean cash transfers were assumed to have a standard deviation equal to a quarter of maximum 
cash transfers minus minimum cash transfers. Probability distributions for all 3 input parameters were assumed to be normal. This was justified because our 
analysis was at the national level and mean values were used. †Because data were highly skewed median is reported instead of mean. 
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Figure 14. Summary of countries’ country-level cash transfer budget needed to prevent catastrophic costs. 
Abbreviations: GDP, Gross Domestic Product; DS, Drug Susceptible; DR, Drug Resistant; TB, Tuberculosis. All data are expressed in millions on the log10 scale. 0.5% of 
countries’ GDP and their existing poverty-reduction cash transfer budget are summarised for comparison. The “0.5% of country GDP” bar represents the upper limit that 
governments in low- and middle-income countries spend on a poverty-reduction cash transfer programme (37). The “poverty-reduction programme” bar represents 
countries’ actual poverty-reduction cash transfer programme budget. The “TB-specific approach” bar represents the mean budget that countries would need to prevent 
their TB-specific target population from incurring catastrophic costs. The “TB-sensitive approach” bar represents the mean budget that countries would need to prevent 
their TB-sensitive target population from incurring catastrophic costs. Values summarised in Figure 14 are provided in Table S13. *For clarity, a value of country-level cash 
transfer budget needed equal to $0 is plotted as $1.1. †Because data were highly skewed median is reported instead of mean. 
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5.5.6 Sensitivity analysis 
Without imputing data. Before cash transfers, the TB-related cost burden remained 
catastrophic in the same countries as when missing TB-related cost components were 
imputed, and the only difference after cash transfers was that TB-specific cash transfers 
prevented catastrophic costs in Colombia, Table S14. Across countries, TB-specific cash 
transfers remained more affordable at preventing catastrophic costs compared to TB 
sensitive cash transfers both at the household and country level, Table S15. 
With 10% threshold. Before cash transfers, in addition to Colombia, Ecuador, Ghana, 
Mexico, Tanzania, and Yemen, the DS TB-related cost burden was also catastrophic in Brazil. 
In Ecuador, the DR TB-related cost burden before cash transfers remained catastrophic. 
Across countries, TB-specific cash transfers remained more affordable than TB-sensitive 
cash transfers for preventing DS and DR TB catastrophic costs both at the household and 
country level, Table S16. 
With 30% threshold. Before cash transfers, the DS TB-related cost burden remained 
catastrophic in Colombia, Ghana, Mexico, Tanzania, and Yemen, but ceased to be 
catastrophic in Ecuador. In Ecuador, the DR TB-related cost burden before cash transfers 
remained catastrophic. Across countries, TB-specific cash transfers remained more 
affordable than TB-sensitive cash transfers for preventing DS and DR TB catastrophic costs 
both at the household and country level, Table S17. 
5.6 Discussion of findings 
5.6.1 Summary of main findings 
In the seven countries that met the study inclusion criteria, this analysis of national average 
data suggests that DS TB-related costs would be catastrophic for the average poor TB-
affected household in most low- and middle-income countries. This is concerning, and 
concordant with the limited evidence that is already available (12). If cash transfers were 
provided with a TB-specific approach to defray TB-related costs of poor households with a 
confirmed DS TB diagnosis, then in some low- and middle-income countries, they would 
likely be sufficient to prevent the average household incurring DS TB catastrophic costs. 
Alternatively, if the same value of cash transfers were provided with a TB-sensitive approach 
to increase the income and strengthen the economic resilience of poor households at high 
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risk of developing active TB disease, then across low- and middle-income countries, they 
would likely be insufficient to prevent the average household that later developed active DS 
TB disease incurring DS TB catastrophic costs. In countries where neither TB-specific nor TB-
sensitive cash transfers would be sufficient to prevent DS TB catastrophic costs, the average 
value of household-level additional cash transfer needed to achieve this objective would be 
much lower using a TB-specific approach compared to a TB-sensitive approach. Further, by 
only targeting poor households with a confirmed TB diagnosis, a TB-specific approach 
would, on average, require a much smaller country-level budget than using a TB-sensitive 
approach to target much larger numbers of poor households at high risk of developing 
active TB disease. 
Although DR TB is rare, it is associated with extreme TB-related costs (12). This 
analysis found that neither TB-specific nor TB-sensitive cash transfers would be sufficient to 
prevent DR TB catastrophic costs for the average poor DR TB-affected household. The value 
of household-level additional cash transfer needed to achieve this objective would be very 
high. Because few poor households are affected by DR TB, countries’ county-level cash 
transfer budget needed to prevent DR TB catastrophic costs would, on average, be much 
lower using a TB-specific approach compared to a TB-sensitive approach. Given that so few 
households are affected by DR TB, it may not be rational for TB-sensitive cash transfer 
programmes to aim to increase households’ annual income sufficiently to make all poor 
households resilient to the rare and extreme costs associated with DR TB. 
5.6.2 How findings fit with existing literature 
The study is consistent with, and adds to, individual level evidence supporting the potential 
of TB-specific cash transfers to prevent catastrophic costs for poor TB-affected households 
in Peru (56). It also supports individual evidence from Latin America for their ability to 
improve households’ capacity to cope with severe livelihood risks (61). By focussing on 
preventing catastrophic costs in low- and middle-income countries, it adds another 
dimension to the 2015 Cochrane review of the use of cash transfers in TB control, which did 
not find evidence on this outcome and mostly examined the use of cash transfers in the 
United States (59).  
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To our knowledge, this study is the first to compare the potential of cash transfers 
provided with a TB-specific versus a TB-sensitive approach to prevent catastrophic costs. 
The contrasting effects of defraying TB-related costs using a TB-specific approach versus 
increasing households’ resilience using a TB-sensitive approach has important and novel 
implications for protecting TB-affected households from catastrophic costs. This study also 
appears to be the first to compare the country-level cash transfer budget that would be 
needed to prevent catastrophic costs for poor TB-affected households using a TB-specific 
versus a TB-sensitive approach. The study shows that by being more effective and aiming to 
reach fewer households, a TB-specific approach would cost less than a TB-sensitive 
approach. It is important to emphasize that these findings are only valid when preventing 
catastrophic costs is the only outcome of interest. Cash transfers provided to poor 
households with a TB sensitive approach might have far-reaching effects on wellbeing, 
health promotion, and disease prevention, and further evaluation is needed to study the 
costs versus benefits of each approach (158,193). Nevertheless, the End TB Strategy 
prioritises ensuring that zero TB-affected households experience catastrophic costs (9). For 
achieving this specific milestone, the implications of this study are clear: cash transfers 
provided with a TB-specific approach are likely to achieve this goal more affordably than if 
they were provided with a TB-sensitive approach. 
This study adds to limited evidence informing the best targeting strategy for cash 
transfers aimed at enhancing TB care and prevention (158). At the country-level, showing 
that in Latin America and Central Asia a TB-sensitive approach might reach between 12% 
and 35% of countries’ population, whereas in some parts of sub-Saharan Africa it might only 
reach between 1% and 2% of countries population, this study supports speculation that the 
potential of countries to provide cash transfers with a TB-sensitive approach might follow an 
inverse care law (194), whereby poorer countries with higher TB burdens have less well 
established poverty-reduction cash transfer programmes (158). Showing also that 
approximately 40% of TB-affected households might be in the poorest population quintile, 
this study highlights the need to consider how cash transfers might be targeted to 
households that incur catastrophic costs but are outside of this population category 
(55,178). With a TB-specific approach, it would be relatively easy to modify programmes’ 
target population to include more TB-affected households, whilst with a TB-sensitive 
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approach, it might be harder to modify the target population of existing poverty-reduction 
programmes, which are usually well established parts of national social protection systems 
(166). 
5.6.3 Study strengths 
The economic model used in this study was an inexpensive way to provide preliminary 
estimates of the potential of TB-specific and TB-sensitive cash transfers to prevent 
catastrophic TB-related costs. It is also usefully highlights key issues on which judgement 
must be made in the future namely: who should be targeted for cash transfers?, how much 
should cash transfers be?, and is this affordable at the national level? The study was 
rigorously reported according the CHEERS checklist. This ensured that study assumptions 
were clearly presented and open for critique. Another strength was the study’s use of 
statistical methods to highlight the level of uncertainty around model estimates. 
5.6.4 Study limitations 
This study has several limitations and conclusions should be drawn cautiously. Insufficient 
data forced us to estimate the potential of TB-specific versus TB-sensitive cash transfers to 
prevent catastrophic costs using the value of cash transfers offered by existing 
governmental poverty-reduction cash transfer programmes. Whilst the only solution, it will 
have nonetheless under- or overestimated the potential of TB-specific cash transfers 
depending on how their actual value compares to governmental poverty-reduction cash 
transfers. Model inputs were all associated with some uncertainty, especially TB–related 
costs, which were mostly extracted from small subnational cost surveys (133,164,165,189–
192). The study attempted to account for this using a multiway analysis that allowed inputs 
to vary by their simulated sampling distributions. Inconsistent reporting of standard 
deviations for mean TB-related costs, household income and cash transfers forced us to 
make assumptions about the amount of variance around extracted values, and to generalise 
these across countries. Whilst this approach will have ignored any country specific skewness 
or kurtosis in input parameters, drawing from relevant literature ensured that estimates of 
variance were as accurate as possible (12,84,167). Inconsistent reporting of TB-related costs 
disaggregated by income quintile meant that the study had to assume that estimated TB-
related costs were representative of those incurred by affected households in countries’ 
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poorest population quintile. Because poorer households usually incur lower TB-related costs 
compared to less poor households, this is likely to have underestimated the potential of 
cash transfers to prevent catastrophic costs, and overestimated the country-level budget 
needed to achieve this (6). Whilst this analysis should provide an accurate estimate of the 
effect of cash transfers on countries’ mean TB-related cost burden, because sample 
distributions of TB-related costs are known to be positively skewed (12), the aggregate-level 
nature of the study means that results are unlikely to be representative of the majority of 
TB-affected households. Two sources of error in this study were imputation of missing TB-
related cost components in Brazil (164), Colombia (189), Tanzania (190), and Mexico (191), 
and measuring catastrophic costs using a threshold TB-related cost burden that still hasn’t 
been assessed to determine its clinical or financial relevance for TB-affected households in 
any of the countries included in the study. Sensitivity analysis showed that the potential of 
cash transfers to prevent catastrophic costs was robust to these sources of error, but the 
precise estimates of countries’ household-level additional and total cash transfer, and 
country-level cash transfer budget needed to prevent catastrophic costs were dependent on 
them. Therefore, whilst a TB-specific approach was consistently more effective and 
affordable for preventing catastrophic costs compared to a TB-sensitive approach in all 
analyses, further research is needed to precisely estimate the cost of each of these 
approaches. 
5.7 Concluding remarks 
Reviewing and analysing the literature on TB-related costs and poverty-reduction cash 
transfer programmes in low- and middle-income countries, this study compares the 
potential of cash transfers provided with a TB-specific versus a TB-sensitive approach to 
prevent catastrophic costs for poor TB-affected households. Findings suggest that providing 
cash transfers with a TB-specific approach to defray TB-related costs of households with a 
confirmed TB diagnosis will be more effective and affordable for achieving this objective 
compared to a TB-sensitive approach that increases the income and strengthens the 
economic resilience of households at high risk of developing active TB disease. The study 
also highlights an urgent need for investments to prevent catastrophic costs for households 
having to confront the severe medical, social, and economic challenges caused by DR TB. 
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Chapter 6. Conclusion 
Severe illness, like that caused by the infectious disease tuberculosis (TB), is known to cause 
financial hardship for affected households, especially those living in poverty (12,195). Cash 
transfers are a pro-poor social protection initiative that might help poor households to cope 
with the financial impact of such severe illness (5,33,37). With the overall aim of establishing 
whether cash transfers can prevent household financial hardship from severe illness, this 
thesis addressed three research gaps, Table 20. 
Table 20. Summary of research gaps addressed by the thesis. 
 
Methods: Cross-sectional survey. 
Findings: In Rio de Janeiro, fewer than 50% of households uptake social protection in 
response to DR TB. Households that uptake social protection, including cash transfers, 
are significantly less likely to experience financial hardship because of DR TB. 
2) Lack of knowledge as to which governmental social protection initiatives 
households affected by TB access during care, and whether they are sufficient to 
protect them from financial hardship. 
Methods: Systematic review, historical cohort study. 
Findings: Evidence from 5 published studies indicates that cash transfers might improve 
households’ capacity to safeguard consumption in response to shocks that have a 
negative effect on this measure of welfare. In Brazil, self-reported severe illness with 
serious economic consequences had little effect on household food consumption, and 
any modification of this effect by household receipt of cash transfers was modest. 
Methods: Economic modelling. 
Findings: Providing cash transfers to defray TB-related costs appears to be more 
effective and affordable for preventing households from experiencing financial 
hardship than providing cash transfers to reduce poverty amongst households 
vulnerable to TB. 
3) Doubt whether providing cash transfers to make poor households at risk of TB 
more resilient to TB-related costs, or to defray poor households’ costs after a 
family member develops TB is more effective and affordable for preventing 
financial hardship. 
1) Uncertainty if governmental anti-poverty cash transfers protect poor households 
from financial hardship related to severe illness. 
120 
Focusing on the three research gaps addressed by this thesis, this final chapter 
recalls the state of the evidence before the thesis, and summarises how research completed 
as part of the thesis advances that area of research. It also presents priority next steps for 
further research, discusses the policy implications of the thesis, and ends with an overall 
concluding statement. 
6.1 Governmental conditional cash transfers and household financial hardship 
from severe illness 
6.1.1 What was already known 
In settings with low coverage of formal insurance markets, severe illness was known to have 
detrimental effects on household labour income (12,13). Previous longitudinal studies 
evaluating the impact of severe illness on household consumption had shown mixed results 
(5). In some, illness was associated with decreased consumption, but in others it was not (5). 
More objective measures of severe debilitating illness, for example a long spell in hospital, 
or a change in individuals’ ability to carry out activities of daily living, were consistently 
associated with decreased household consumption, while self-reported measures of illness 
were often associated with an insignificant change in household consumption 
(13,15,22,64,65,68,123,124,195–197). Evidence showed that illness was associated with a 
greater likelihood of using coping strategies like informal borrowing, using savings, selling 
assets; and sometimes turning to costly coping strategies like taking out high interest loans, 
and withdrawing children from school (22,68,99,128,198). There was also evidence showing 
that the effect of severe illness is worse for households living below and on the poverty line 
(195). 
Social protection initiatives were considered an effective way of protecting 
households from financial hardship related to illness. For households without access to 
formal insurance, pro-poor cash transfers were one initiative with considerable potential. 
Evidence already showed that conditional cash transfers (CCTs) helped households 
accumulate savings in the form of assets (49–51). Furthermore, in Colombia, evidence 
suggested that CCTs might help households to safeguard their non-food consumption in 
response to illness, and in both Colombia and Mexico, evidence indicated that CCTs might 
also protect child school attendance in response to illness (79,197). Both of these studies 
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used self-reported measures of illness, and severity was measured as illness affecting the 
household head (79,197). Evidence from Mexico was published before 2010, and was 
included in a broad systematic review of the economic effects of CCTs on households in low- 
and middle-income countries conducted in 2010 (61,79). Whilst, this review studied the 
potential of CCTs to improve households resilience to shocks, it did not give an indication of 
the degree of protection that CCTs might provide, and results were not disaggregated by 
different types of household shock (61). 
6.1.2 What this thesis adds 
This thesis updates a 2010 systematic review of the literature relating to the effect of 
governmental anti-poverty CCTs on households’ ability to safeguard their consumption 
against household-level shocks including severe illness. It identifies a total of five studies, 
three of which were conducted after 2010, and presents quantitative summaries of the 
effect of CCTs on household consumption and use of coping strategies, including savings and 
assets, in response to specific shocks. CCTs were found to provide a reasonable degree of 
protection against reductions in household consumption in response to illness of the 
household head, but not in response to unemployment of the household head (84). With 
regards to households’ use of coping strategies, the only consistent evidence was for the 
potential of CCTs to protect child school attendance (79,84). These findings set a new 
benchmark for the current state of the evidence in this field, and provide new insight into 
the degree of protection CCTs may grant (61,84,85,91). The review highlights several 
additional research gaps that should be considered in any future research in the field of 
disabling illness, financial hardship, and cash transfers. These are highlighted below in the 
further research section of this chapter. 
Building on the updated systematic review, the thesis also presents an original 
historical cohort study investigating whether governmental CCTs help poor households in 
Brazil to maintain a constant level of food consumption in response to self-reported severe 
illness with serious economic consequences. Results provide additional insight into the 
relationship between severe illness, consumption, and CCTs, which previously had only been 
investigated in Colombia (197). Attempting to measure the economic effect of a severe 
illness leading to lost productivity, the study exposure was self-reported severe illness with 
serious economic consequences in the 4 years between baseline and follow-up in 2009. The 
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study used a robust design and controlled for potential confounding by household 
socioeconomic characteristics. Interestingly, it identified no effect of severe illness with 
serious economic consequences on either household labour income or food consumption. 
This highlights the need for further thought on ways to measure severe illness that is either 
temporarily, or permanently disabling. A basic sample size calculation indicated that the 
study had low statistical power to investigate whether receipt of CCTs modifies the 
economic consequences of severe illness for poor households. This combined with a lack of 
any detectable economic impact of severe illness provided little scope for this thesis to 
evaluate any protective effect of CCTs. With more precise measurement of severe illness 
leading to lost productivity, as well as a larger sample size it would be possible to evaluate 
this relationship more conclusively. 
6.2 Uptake of governmental social protection and household financial hardship 
from drug resistant tuberculosis 
6.2.1 What was already known 
The economic consequences of illness for households affected by TB had long been 
documented. Two systematic reviews of TB-related costs across low- and middle-income 
countries provided comprehensive summaries of the make-up of costs, and highlighted that 
whilst direct expenses are a major component of the economic impact of TB illness, on 
average, indirect costs contribute most (direct medical expenses: 20%; direct non-medical 
expenses: 20%; indirect costs: 60%) (12,156). Populations identified as especially vulnerable 
to the financial impact of TB were households in poverty, and households affected by 
multidrug-resistant TB (12). The Global TB Programme recommended that TB-related 
financial hardship be measured as either (a) TB-related costs exceeding 20% of household 
pre-illness annual household income, or (b) household use of a coping strategy like taking 
out a loan, or selling assets (10,26). 
Social protection initiatives had been endorsed as a key way to address the 
unaffordable burden of direct expenses and indirect costs experienced by TB-affected 
households (9). Initiatives recommended to minimize direct medical expenses included fee 
waivers (163). More recently, other social protection initiatives, including cash transfers had  
also been recommended to address households’ direct non-medical expenses and indirect 
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costs (9). A survey in South Africa, showed that where governmental cash transfer initiatives 
are available, as little as half of eligible TB-affected households may access them (58). 
Furthermore, many of those that do access them, only start doing so later on in their 
treatment (58). Evidence as to whether cash transfers might protect TB-affected households 
from catastrophic costs was limited to a randomised control trial in Peru, which supported 
their use in this way (56). A larger body of evidence indicated that cash transfers improved 
TB treatment outcomes, but whether they achieved this by protecting households from 
catastrophic costs was unknown (45,57). 
6.2.2 What this thesis adds 
This thesis provides a detailed breakdown of costs incurred by DR TB-affected households, 
and the percentage of households that experience financial hardship during treatment in 
Rio de Janeiro, Brazil. It adopted a broader measure of financial hardship related to DR TB. 
In addition to just evaluating whether households experienced TB-related costs exceeding 
20% of pre-illness household income, the thesis also considered whether households 
experienced impoverishment, or used a financial coping strategy separately. This provides a 
useful reference of the overlap of different types of financial hardship experienced by 
households. The thesis also considered a combined indicator of all three of these measures 
of financial hardship. Use of such an indicator helps to distinguish households that 
experience especially severe economic consequences as a result of DR TB. 
A key contribution of this thesis is its assessment of social protection uptake 
amongst households affected by DR TB. This analysis provides an indication of the 
prevalence of actual uptake of governmental cash transfers and sick pay insurance in 
response to DR TB. Because TB is known to be inextricably linked to poverty, the high 
proportion of households accessing sick pay insurance, which may only be accessed by 
formally employed workers, was a surprise (55,178). Because household receipt of social 
protection was evaluated using one self-report question, it is unclear if participants 
confused sick pay insurance with social assistance disability benefits. Future work should 
include a more detailed series of questions in order to confirm which social protection 
initiatives patients access. Further research should also investigate uptake of social 
protection amongst TB-affected households in the poorer North and Northeast regions of 
Brazil. Comparing the percentage of households that experience financial hardship and that 
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uptake social protection provides an indication of how many households should be 
prioritised for further support. The only characteristic found to differ significantly between 
households that did, and did not uptake social protection was patient sex, and history of 
paid employment prior to DR TB diagnosis. A more in-depth qualitative analysis may be able 
to establish factors that hinder households’ access to social protection. This will be key for 
deciding the type of support that should be provided to households in need of it. 
6.3 Comparison of two cash transfer strategies for preventing catastrophic costs 
for poor tuberculosis-affected households in low- and middle-income 
countries 
6.3.1 What was already known 
The TB literature had speculated about two principle implementation models for providing 
cash transfers to people with TB (158). The first, termed a “TB-specific” approach, would 
provide cash transfers to poor households with a confirmed TB diagnosis to incentivise and 
enable TB treatment by defraying their TB-related costs (158). The second, termed a “TB-
sensitive” approach, would provide cash transfers to poor households at high risk of 
developing active TB disease to increase their income, thereby protecting them from 
poverty-related TB risk factors (e.g. poor living conditions and undernutrition), as well as 
strengthening their economic resilience to TB-related costs (158). Whilst these two 
implementation strategies were well described, there was no research informing their 
potential to prevent households from experiencing catastrophic TB-related costs (158). 
There was also no attempt to elaborate which households would be targeted by a TB-
specific or TB-sensitive approach. 
6.3.2 What this thesis adds 
This thesis provides a first attempt to estimate whether a TB-specific or a TB-sensitive 
approach of providing cash transfers is more effective and affordable for protecting TB-
affected households from financial hardship. It compared how much each approach reduced 
the burden of TB-related costs, and estimated how much cash transfers would need to be 
increased to prevent households experiencing catastrophic TB-related costs. In such a way 
this thesis explored the concept of defraying costs versus building household resilience to 
them. That one approach may be more effective than the other for preventing TB-affected 
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households from experiencing catastrophic costs is an important concept, and not 
necessarily intuitive. Of course, the study presents a model representation of reality, and 
the validity of the results will have to be tested using individual-level data. Furthermore, as 
emphasised in chapter 5, findings that a TB-specific approach might be more effective than 
a TB-sensitive approach are only valid when preventing catastrophic costs is the only 
outcome of interest.  
This thesis also provides the first attempt to estimate how much it might cost at the 
country-level to provide cash transfers with either a TB-specific or TB-sensitive approach to 
prevent households from experiencing catastrophic TB-related costs. To do this, it was 
necessary to define the population that would be targeted by each cash transfer approach. 
The thesis considered that a TB-specific approach would target households affected by TB 
with a household income below the income threshold that classifies countries poorest 
population quintile, and a TB-sensitive approach would target all households in countries’ 
poorest population quintile. Basic estimates of the number of households in each of these 
groups could then be used to estimate the budget that would be necessary to provide cash 
transfers with either approach at the country-level. In the future, further clarification of who 
should be targeted with either a TB-specific or TB-sensitive approach will help to refine 
estimates of country-level budgets needed to roll out TB-specific or TB-sensitive cash 
transfers.  
6.4 Further areas for research 
The thesis was quite unique in its longitudinal evaluation of the protective effect of CCTs on 
severe illness with serious economic consequences, cross-sectional analysis of uptake of 
social protection and financial hardship amongst DR TB-affected households, and 
comparison of TB-specific versus TB-sensitive cash transfers. The thesis successfully 
provided further insight into each of the research gaps that it set out to fill. However, it was 
unable to address all three gaps completely. Furthermore, research conducted as part of 
this thesis raised additional research questions. Priority areas for further research in this 
field include:  
1. Do governmental cash transfers prevent households from using harmful coping 
strategies that have long term consequences for their welfare? 
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In addition to further clarifying if CCTs help households maintain a constant level of 
consumption in response to disabling illness, it is essential that further research also focuses 
on understanding the potential of CCTs to prevent households’ use of harmful coping 
strategies like defaulting from treatment, taking out high interest loans, selling productive 
assets, or withdrawing children from school to work (25). This will help elucidate the 
potential of cash transfers to prevent both the short-, and long-term financial consequences 
of severe illness. For this research, as highlighted in this thesis, it will be important that 
severe illness is measured as precisely as possible. One accurate way of measuring this 
exposure might be to use a locally validated assessment tool to evaluate changes in working 
household members’ ability to carry out activities of daily living (15,199). Another precise 
way would be to focus on specific mid- to long-term illnesses, for example, mental health, 
TB, cancer, heart disease, or trauma leading to loss of mobility. Studies taking this approach 
should ensure that they have an appropriate control group, and a sample size large enough 
to investigate the relationship between receipt of different social protection initiatives and 
financial hardship. Further thought should also be given to the best way to measure 
households’ use of coping strategies. One effective way may be to use a “coping” score (56). 
Previous research has also differentiated coping strategies according to their severity (24). 
Ideally, any future study evaluating the protective effect of governmental CCTs 
would take a longitudinal form with repeated measures of study participants financial 
situation and receipt of cash transfers over the course of treatment and recovery (56). It is 
currently unclear if such a data source exits. Modern data linkage of administrative health 
and social records might be one suitable source of data for further research in this field. This 
type of data might be available at the Center for Integration of Data and Health Knowledge 
(CIDACS) project in Salvador, Brazil, which has already linked health and social records to 
evaluate the impact of CCTs on notifiable disease incidence (200,201). However, such an 
approach would only work for outcomes that are collected routinely in administrative data 
(e.g. income, and consumption). Primary data collection is likely to remain essential for 
further research into the effect of cash transfers on more specific outcomes like households’ 
use of coping strategies. 
2. Do households experience any barriers accessing cash transfers in response to 
severe illness? 
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This thesis explored uptake of social protection amongst households affected by DR TB in 
Rio de Janeiro. It found that some households experiencing financial hardship did not 
uptake social protection. Therefore, another research priority is to understand if TB-affected 
households experience barriers accessing social protection initiatives. Most of the social 
protection accessed by DR TB-affected households in Rio de Janeiro was sick pay insurance. 
As this is only available to TB patients that have contributed to social insurance for at least 
12 months prior to their diagnosis, a future research priority will be to understand factors 
that support and hinder access of informally employed or unemployed patients to social 
assistance cash transfers from either Programa Bolsa Família or Benefício de Prestação 
Continuada. Anecdotal reports from social workers highlight a lack of knowledge amongst 
TB patients about their rights to social protection. They also point to high levels of 
discrimination when patients attempt to access social protection. Another potential barrier 
that is reported in other settings, is the accessibility of social assistance administration 
centres (202). Research is needed to investigate exclusion rates amongst eligible TB 
patients, and characterise the prevalence of different access barriers. It will be important 
that such a study is conducted in a representative way, as household location is likely to be a 
strong determinant of both the coverage of different social protection initiatives, and 
barriers faced by households needing to access them. 
3. What are the costs versus benefits of providing cash transfers with the specific aim 
of defraying health costs compared to a broader approach to reduce poverty 
amongst poor households at risk of severe illness? 
Further, more detailed modelling, as well as individual-level research is needed to validate 
whether providing cash transfers with the specific aim of defraying health costs is more 
effective for preventing financial hardship compared to a broader approach to reduce 
poverty amongst poor households at risk of severe illness. For a more complete 
understanding, it will be important to account for any additional effects of these two 
approaches on preventing illness, which will in turn avert households from experiencing 
associated financial hardship. For infectious diseases like TB, preliminary evidence already 
supports the potential of a broad anti-poverty cash transfer approach to reduce individuals’ 
risk of disease by addressing poverty-related risk factors (e.g. poor living conditions and 
undernutrition) (203). Both approaches may be expected to prevent disease transmission by 
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improving treatment adherence (6). Any future comparison of the costs of implementing 
each approach should also account for the additional human and physical resources that 
would have to be mobilised from the provider’s perspective. A disease-specific approach 
would require a completely new infrastructure, whereas a broader approach may build on 
countries’ existing national social protection system. Better understanding of the distinct 
impacts and costs of each cash transfer approach would help to inform a more complete 
comparison of their costs and benefits. 
6.5 Implications for policy 
In recent years, public health, and in particular TB control, has emphasised the need to 
identify initiatives that may protect households from financial hardship related to severe 
illness (10,11). Before this thesis, limited research had focused on evaluating the potential 
of cash transfers to achieve this. This thesis contributed original findings which may be used 
to inform future formulation of policy for the use of cash transfers to prevent financial 
hardship from illness. 
Overall, evidence from across this thesis indicates that cash transfers have the 
potential to enhance poor households’ ability to cope with financial hardship related to 
severe illness. Specifically, synthesis of published evidence suggested that governmental 
CCTs may help households to maintain a constant level of consumption in response to 
household-level shocks. Also in Rio de Janeiro, Brazil, income replacement from either social 
insurance sick pay, or social assistance cash transfers was associated with a lower likelihood 
of experiencing financial hardship. Finally, across seven low- and middle-income countries, 
the value of existing anti-poverty cash transfers available to poor households consistently 
reduced the burden of catastrophic TB-related costs. From a policy perspective, findings 
from this thesis also suggested that as currently implemented cash transfers may not 
provide complete protection against financial hardship from severe illness, and may need to 
be supplemented or completed with other initiatives (e.g. an additional variable cash 
transfer, or preferential or automatic access to other social protection initiatives) (39). 
Existing evidence from Peru shows that microcredit is unlikely to be an effective 
complementary initiative for supporting poor households affected by severe illness (204). In 
this thesis, the need for additional support was most apparent for DR TB-affected 
households. Globally, only 20% of people with DR TB are estimated to begin treatment, and 
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only 52% of those that start treatment are estimated to successfully complete it (150). 
Preventing financial hardship for this population may help them complete their treatment 
and should constitute a “special case” for future investments. 
This thesis highlighted that in addition to evaluating whether cash transfers can 
protect households from financial hardship, it is also essential to consider the ease with 
which households are able to access them. Findings from this thesis suggest that some 
households in need of financial support as a result of severe illness may not uptake social 
protection. Further research is urgently needed to characterise whether these households 
face specific barriers trying to access governmental initiatives. At this stage, anecdotal 
evidence suggests that patients have poor knowledge of their right to social protection. 
Based on this, it might help to provide patients with a flow-diagram of the different social 
protection initiatives available to them, and ensure that they either have, or know how to 
acquire all of the formal documentation necessary to apply for social protection. Evidence 
that some patients in need of support do not access social protection also provides early 
grounds to engage with authorities that are responsible for social protection 
implementation to explore whether cash transfer initiatives may be made more inclusive of 
specific populations like those affected by DR TB.  
Findings from this thesis indicate that where preventing financial hardship from 
severe illness is a priority, providing cash transfers specifically to defray patients’ health 
costs may be more effective at achieving this than a broader approach to reduce poverty. 
However, it is rare that achieving this outcome will be the only objective of a public health 
program. Research has already shown that a broad approach aiming to reduce poverty has 
positive effects across a range of disease risk factors (e.g. reducing malnutrition, HIV 
prevalence, and adverse treatment outcomes) (57,205–207,43,208). In the TB field, in 
addition to a TB-specific or a TB-sensitive approach for providing cash transfers, it has been 
proposed that one efficient and cost-effective strategy might be to integrate both of these 
approaches into a so-called “TB-inclusive” approach (158). Findings from this thesis 
demonstrating the greater potential of TB-specific cash transfers to prevent catastrophic 
costs, and the existing coverage of TB-sensitive cash transfer programmes, may support this 
integrated approach. For a TB-inclusive approach, existing poverty-reduction programmes 
could be adapted to include an additional variable TB-specific benefit, which beneficiary 
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households would be eligible to receive upon receipt of a confirmed TB diagnosis. To finance 
such an approach, stakeholders from across TB control, development, and finance sectors 
could coordinate to determine how much each would be willing to contribute given their 
separate objectives (209,210). From a TB prevention perspective, such an investment would 
be expected to reduce delays for TB diagnosis (132), reduce the risk of adverse treatment 
outcomes (6), and thus potentially contribute to reduced national TB incidence (211). From 
the perspective of social development, reduced national TB incidence would be expected to 
enable previously vulnerable households to invest more in human capital, increase their 
labour productivity, and thus contribute to long-term sustainable economic growth (60). 
Because households affected by human immunodeficiency virus (HIV), mental health, 
diabetes and other non-communicable diseases are also known to incur high direct 
expenses and indirect costs (5,98), any efforts to prevent catastrophic costs for TB-affected 
households should aim to collaborate with these other areas of public health. Whichever 
approach for providing cash transfers to prevent TB-related catastrophic costs is chosen, it 
will be key to ensure that it is not implemented in isolation from Universal Health Coverage 
initiatives including more decentralised and patient-friendly TB service delivery. Income 
protection initiatives and Universal Health Coverage initiatives should be developed and 
implemented hand-in-hand (10). 
6.6 Overall conclusions 
Evidence from across this thesis indicates that cash transfers have the potential to enhance 
poor households’ ability to cope with financial hardship related to severe illness, and that a 
policy promoting their use in this way is likely to have beneficial effects for vulnerable 
households. Preliminary evidence also suggests that the effect and affordability of cash 
transfers may differ depending on whether they are given to defray health costs of 
households with a confirmed diagnosis of severe illness, or increase the income and 
strengthen the economic resilience of households at high risk of becoming severely ill. 
Further research is now needed to understand 1) if cash transfers as currently implemented 
are sufficient to ensure that every household is able to meet their basic needs and avoid 
using costly coping strategies in response to severe illness, 2) whether households 
experience barriers accessing cash transfers in response to severe illness, 3) the most cost-
effective approach of providing cash transfers to address financial hardship from severe 
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illness. Together, evidence generated from this thesis provides original insights into the 
potential of cash transfers to protect households from financial hardship related to severe 
illness, and outlines a clear map for further research.  
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End TB Strategy: universal health coverage and social protection for preventing financial 
hardship. 
 
Despite most countries offering tuberculosis (TB) diagnosis and treatment free of charge, 
TB-related costs remain an important barrier for accessing TB care [1]. TB-related costs 
include: direct medical expenses (e.g., consultations), direct non-medical expenses (e.g., 
transport and food accessing health services), and lost income from time off work related to 
disability, discrimination, and/or infection control laws [2]. With the treatment duration of 
drug-resistant (DR) TB lasting up to 24 months, affected households are especially 
vulnerable to TB-related costs [1]. In Cambodia, Ecuador, Ethiopia, Indonesia, Kazakhstan, 
and Peru, average DR TB-related costs range between 75%-223% of annual household 
income [3–7]. 
 
The World Health Organization’s (WHO’s) End TB Strategy mandates that by 2025 nobody 
should experience financial hardship because of TB [8]. Countries are encouraged to 
monitor progress towards this milestone by collecting regular estimates of the prevalence of 
financial hardship due to TB [9]. Financial hardship might be measured as total costs 
exceeding 20% of pre-illness annual household income; relying on a financial coping strategy 
(i.e., taking a loan/selling assets); or, total costs that are impoverishing [9, 10].  
 
To prevent financial hardship from TB, countries should facilitate people’s access to 
universal health coverage (UHC) and social protection [9]. Worldwide, Brazil, is increasingly 
seen as a model country for inclusive social development. Here, the national Unified Health 
System provides all health services free of charge, and three governmental social protection 
policies Auxilio-Doenca, Bolsa Familia and Beneficio da Prestacao Continuada (BPC) help 
people manage financial consequences of illness [11–13]. Currently, it is unknown if these 
measures protect the most vulnerable TB-affected households, those experiencing DR TB, 
from financial hardship. 
 
Evaluating uptake of social protection and financial hardship amongst DR TB-affected 
households in Rio de Janeiro. 
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In May 2016, there were 1,601 people with DR TB in Brazil (0.77 cases per 100,000 
population), with 29% residing in Rio de Janeiro state [14]. To evaluate if uptake of social 
protection during treatment is associated with reduced risk of experiencing financial 
hardship, we conducted a cross-sectional survey between June-October 2016. We surveyed 
people with DR TB who had been receiving treatment for at least one month, and were 
attending the outpatient clinic of the Professor Helio Fraga reference centre (CRPHF) in Rio 
de Janeiro state. Ethical approval was obtained from the Escola Nacional de Saúde Pública 
Sérgio Arouca ethics committee (1.4238.240, CAEE: 53187516.0000.5240). All participants 
gave written informed consent before participating. 
 
Data were collected by two social workers, using a local adaptation of the field-testing 
version of the WHO’s TB patient cost survey instrument detailed and available online [15]. 
Questions on pre-diagnostic healthcare-seeking behaviours, and costs incurred during 
previous courses of TB treatment were excluded because of concerns about reporting 
accuracy for events experienced far in the past. The revised questionnaire was pretested for 
clarity on three patients. Monetary values were collected in Brazilian reais (R$), and 
converted to 2016 United States dollar (US$) (R$3.5=US$1.0) [16]. 
 
We measured direct expenses as monthly expenses accessing directly observed therapy 
(DOT) and the CRPHF extrapolated over participants’ prescribed treatment (mean: 17.6 
months), added to any expenses for TB-related transport accessing a hospital, 
supplementary food and/or private healthcare. Lost income was the difference in monthly 
household income pre-illness versus during-treatment extrapolated over participants’ 
prescribed treatment [17]. Social protection was the monthly value of payments received 
because of DR TB extrapolated over participants’ prescribed treatment. All values were self-
reported. Total costs were calculated as direct expenses plus lost income after subtracting 
social protection. 
 
The exposure variable, was uptake of governmental social protection from Auxilio-Doenca, 
Bolsa Familia and/or BPC because of DR TB. The outcome, financial hardship, included 
separately incurring total costs ≥20% of pre-illness annual household income; using a 
financial coping strategy; incurring total costs that pushed pre-illness monthly household 
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income per capita below Brazil’s 2016 poverty line (US$48.6 a month) [18]; and, 
experiencing all three situations simultaneously. We investigated the association between 
uptake of social protection and these four measures of financial hardship by multivariable 
logistic regression adjusting for socioeconomic and clinical variables associated with the 
outcome at p<0.1, and the two a priori confounding variables sex and age. The likelihood 
ratio test was used to assess the association of exposure variables with dependent variables. 
 
Summary of social protection uptake and financial hardship amongst DR TB-affected 
households in Rio de Janeiro. 
 
In the survey period, 131 people were invited to participate in the survey, six had not 
completed one month’s treatment, five did not give consent to participate, and one was 
excluded from the analysis because of implausible income data, leaving 119 participants 
(68% male; mean age: 42; ethnicity: 48% brown, 29% black, 23% white, 1% indigenous). 
Before DR TB, most participants had a pre-illness monthly household income per capita less 
than one minimum salary (63%), and were the principle household income provider (53%). 
Some received social protection before DR TB (16%). Most had acquired versus primary DR 
TB (55%), and multidrug-resistant TB (3% suspected, 29% mono-/poly-resistant, 60% 
multidrug-resistant, 9% extensively drug-resistant).  
 
Overall, 38% of participants reported uptake of social protection because of DR TB. Amongst 
them, 80% received Auxilio-Doenca, 7% received Auxilio-Doenca and Bolsa Familia, 9% 
received Bolsa Familia, and 4% received BPC. Participants taking-up social protection were 
more likely to be male (p=0.005), younger (p=0.06), and in paid employment before DR TB 
(p=0.08). 
 
Mean direct expenses were US$809 (SD: US$601), representing 14% (SD: 17%) of annual 
household income. Mean lost income was US$6,207 (SD: US$6,671), representing 81% (SD: 
54%) of annual household income. Mean social protection payments were US$1,970 (SD: 
US$2,897). Mean total costs, after subtracting social protection, were US$5,046 (SD: 
US$6,290), representing 64% (SD: 58%) of annual household income. Participants taking-up 
social protection were more likely to incur lower total costs (p=0.005). 
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Overall, 68% of participants incurred total costs ≥20% of household income, 54% used a 
coping strategy, 24% were impoverished, and 18% experienced all three hardships, Figure 1. 
In multivariable logistic regression, uptake of social protection was independently 
associated with lower risk of incurring total costs ≥20% of household income (p=0.04); 
impoverishment (p=0.002); and, experiencing all three hardships (p<0.001); but not with 
using a coping strategy (p=0.58), Table 1. 
 
 
FIGURE 1: Summary of financial hardship across study participants. 
n=119. The area of each ellipse is proportional to the number of participants in that set. The area-
proportional Venn diagram was drawn using eulerAPE [25]. *Refers to pre-illness annual household 
income, †Defined using Brazil’s 2016 poverty line of monthly household income per capita US$48.6 a 
month [18], ‡Two participants had pre-illness annual household income US$0, and were in poverty 
pre-illness, §One participant had missing data on use of coping strategies, ¶One participant was in 
poverty pre-illness, #One participant had pre-illness annual household income US$0, and was in 
poverty pre-illness. 
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TABLE 1 Multivariable logistic regression assessing the association between uptake of social protection and financial hardship. 
  Multivariable logistic regression 
  OR (95% CIs) p-value 
Financial hardship     
Total costs ≥20% of household income*† 0.37 (0.14-0.94)α 0.04 
Used coping strategy‡ 1.31 (0.50-3.47)β 0.58 
Impoverished§¶ 0.16 (0.04-0.54)γ 0.002 
All three financial hardships# 0.01 (0.00-0.07)δ <0.001 
Socioeconomic and clinical characteristics associated (p<0.1) with outcomes in univariable logistic regression were included in multivariable logistic 
regression models. *Refers to pre-illness annual household income. †Three participants with pre-illness annual household income US$0 were excluded, 
n=116, ‡One participant with missing data on use of coping strategies was excluded, n=118, §Five participants in poverty pre-illness were excluded, n=114, 
¶Defined using Brazil’s 2016 poverty line of monthly household income per capita US$48.6 a month [18], #Six participants with either pre-illness annual 
household income US$0, missing data on use of coping strategies, or in poverty pre-illness were excluded, n=113. α Mutually adjusted for sex, age, 
education, acquired DR TB, and time to DOT clinic; β Mutually adjusted for sex, age, pre-illness household head, pre-illness household income per capita, 
acquired DR TB, and time to DOT clinic; γ Mutually adjusted for sex, age, education, and pre-illness household income per capita; δ Mutually adjusted for 
sex, age, pre-illness household head, pre-illness household income per capita, acquired DR TB, and time to DOT clinic. OR, odds ratio; CI, confidence 
interval.
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Summary of lessons learnt, and next steps forward. 
 
In Rio de Janeiro, total costs incurred during treatment result in financial hardship for many 
DR TB-affected households. The main contributor to total costs is lost income. Uptake of 
governmental social protection because of DR TB is common, and is associated with reduced 
likelihood of experiencing financial hardship, especially multiple kinds simultaneously.  
 
To our knowledge, this is the first attempt to evaluate the association between uptake of 
governmental social protection and financial hardship amongst DR TB-affected households 
[3–7]. Our results are consistent with trial evidence from Lima, Peru, demonstrating the 
effectiveness of a non-governmental social protection intervention to defray TB-related 
catastrophic costs, and extends it to real-world governmental measures [19]. A survey from 
South Africa explores uptake of governmental social protection amongst people with TB, but 
does not evaluate its association with financial hardship [5].  
 
Limitations include the survey’s small sample size, which barred stratification of our analysis 
by potential effect modifiers (e.g., uptake of distinct social protection measures). 
Nevertheless, there was adequate power to detect an association between our exposure 
and outcome. The survey’s cross-sectional design might have underestimated the 
prevalence of using a coping strategy and uptake of social protection, as the risk of these 
activities likely accumulates over treatment. Our use of four indicators of financial hardship 
ensures our conclusions are robust to any potential misclassification. 
 
Our results highlight that even where UHC and social protection measures are available, 
efforts are still needed to protect all DR TB-affected households from financial hardship. In 
Rio de Janeiro state, some municipalities provide vouchers to defray patients’ transport 
expenses for CRPHF visits. Sharing of these experiences between municipal authorities 
should be encouraged. Peoples’ access to social protection should also be facilitated, for 
example, by explicit inclusion of the disabling profile of DR TB in the eligibility criteria of 
BPC, the government’s disability grant. Strengthening of labour unions would also support 
transitions to a more formal labour market, which would enable greater access to Auxilio-
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Doenca [20]. Helping previously employed people to restart work when they are fit would 
also avoid long absences from work. 
 
Whilst UHC and social protection is available across Brazil, marked socioeconomic 
differences limits the generalisability of our results to other regions. For a more complete 
understanding of the association between uptake of social protection and financial hardship 
there is need for a nationally representative sample of DR TB-affected households. This 
should be followed up over time to better capture the complex dynamics of financial 
hardship. 
 
Outside of Brazil, access to UHC and social protection remains low in many countries [21]. 
Nevertheless, progress is being made on both these fronts worldwide [22, 23]. A country-
level modelling study highlights seven other low- and middle-income countries where 
governmental social protection is available to TB-affected households [24]. Individual-level 
research is now needed to investigate if TB-affected households are accessing these 
measures, and like we have done in Rio de Janeiro, evaluate if their uptake is associated 
with reduced risk of financial hardship.  
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Abstract 
 
Background: Illness-related costs for patients with tuberculosis (TB) ≥20% of pre-illness 
annual household income predict adverse treatment outcomes and have been termed 
“catastrophic.” Social protection initiatives, including cash transfers, are endorsed to help 
prevent catastrophic costs. With this aim, cash transfers may either be provided to defray 
TB-related costs of households with a confirmed TB diagnosis (termed a “TB-specific” 
approach); or to increase income of households with high TB risk to strengthen their 
economic resilience (termed a “TB-sensitive” approach). The impact of cash transfers 
provided with each of these approaches might vary. We undertook an economic modelling 
study from the patient perspective to compare the potential of these 2 cash transfer 
approaches to prevent catastrophic costs. 
 
Methods and findings: Model inputs for 7 low- and middle-income countries (Brazil, 
Colombia, Ecuador, Ghana, Mexico, Tanzania, and Yemen) were retrieved by literature 
review and included countries' mean patient TB-related costs, mean household income, 
mean cash transfers, and estimated TB-specific and TB-sensitive target populations. 
Analyses were completed for drug-susceptible (DS) TB-related costs in all 7 out of 7 
countries, and additionally for drug-resistant (DR) TB-related costs in 1 of the 7 countries 
with available data. All cost data were reported in 2013 international dollars ($). The target 
population for TB-specific cash transfers was poor households with a confirmed TB 
diagnosis, and for TB-sensitive cash transfers was poor households already targeted by 
countries’ established poverty-reduction cash transfer programme. Cash transfers offered in 
countries, unrelated to TB, ranged from $217 to $1,091/year/household. Before cash 
transfers, DS TB-related costs were catastrophic in 6 out of 7 countries. If cash transfers 
were provided with a TB-specific approach, alone they would be insufficient to prevent DS 
TB catastrophic costs in 4 out of 6 countries, and when increased enough to prevent DS TB 
catastrophic costs would require a budget between $3.8 million (95% CI: $3.8 million–$3.8 
million) and $75 million (95% CI: $50 million–$100 million) per country. If instead cash 
transfers were provided with a TB-sensitive approach, alone they would be insufficient to 
prevent DS TB-related catastrophic costs in any of the 6 countries, and when increased 
enough to prevent DS TB catastrophic costs would require a budget between $298 million 
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(95% CI: $219 million–$378 million) and $165,367 million (95% CI: $134,085 million–
$196,425 million) per country. DR TB-related costs were catastrophic before and after TB-
specific or TB-sensitive cash transfers in 1 out of 1 countries. Sensitivity analyses showed our 
findings to be robust to imputation of missing TB-related cost components, and use of 10% 
or 30% instead of 20% as the threshold for measuring catastrophic costs. Key limitations 
were using national average data and not considering other health and social benefits of 
cash transfers. 
 
Conclusions: A TB-sensitive cash transfer approach to increase all poor households’ income 
may have broad benefits by reducing poverty, but is unlikely to be as effective or affordable 
for preventing TB catastrophic costs as a TB-specific cash transfer approach to defray TB-
related costs only in poor households with a confirmed TB diagnosis. Preventing DR TB-
related catastrophic costs will require considerable additional investment whether a TB-
sensitive or a TB-specific cash transfer approach is used.  
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Author summary 
 
Why was this study done? 
 Household costs related to active drug-susceptible (DS) or drug-resistant (DR) 
tuberculosis (TB) disease include costs for consultations, transport to and from 
clinics, increased food needs and lost income. If these costs are greater than or equal 
to one-fifth (20%) of the household’s annual income, then the patient is at risk of 
unsuccessful TB treatment and these high costs are termed “catastrophic costs.” 
 The World Health Organization’s End TB Strategy prioritises preventing TB-affected 
households from facing catastrophic costs and proposes cash transfers as one way to 
achieve this. However, there are at least 2 approaches by which cash transfers could 
be provided to TB-affected households. In the first, they are provided to 
defray/reimburse households’ TB-related costs (termed a “TB-specific” approach). In 
the second, they are provided to increase households’ pre-illness income to prevent 
poverty and strengthen their economic resilience (termed a “TB-sensitive” 
approach). 
 Lack of available individual-level data sources has meant that no studies have 
compared a TB-specific versus a TB-sensitive cash transfer approach. A literature 
review combined with a secondary data analysis was an effective way to bring 
together relevant data from several different sources and model the potential of 
cash transfers provided by these 2 approaches to prevent catastrophic costs. 
 
What did the researchers do and find? 
 We performed a rigorous review of public data sources available on the internet, 
extracting national average data published between 2005 and 2013 for the 7 low- 
and middle-income economy countries of Brazil, Colombia, Ecuador, Ghana, Mexico, 
Tanzania, and Yemen. The data values we extracted included the countries’ mean 
value of TB patient costs, mean household income, mean cash transfers, and the 
expected size of the population that would be targeted with either TB-specific or TB-
sensitive cash transfers. In all 7 countries these analyses were completed for DS TB, 
and in 1 of the 7 countries we were also able to complete these analyses for DR TB. 
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 Expressing TB patient costs as a percentage of household income, we found that 
average DS TB costs were catastrophic in 6 out of the 7 countries included in the 
study. In these 6 countries, TB-specific cash transfers prevented DS TB catastrophic 
costs in only 2, whilst TB-sensitive cash transfers did not prevent DS TB catastrophic 
costs in any of them. In the 1 country with available data, average DR TB costs were 
catastrophic, and neither TB-specific nor TB-sensitive cash transfers were sufficient 
to prevent this. 
 For both TB-specific and TB-sensitive approaches, we then estimated the total value 
that cash transfers would need to be increased to in order to prevent the countries’ 
average DS or DR TB costs from being catastrophic for DS or DR TB-affected 
household. Based on this, we also estimated the average budget that each country 
would need to prevent catastrophic costs for all DS or DR TB-affected households. 
We found that a TB-specific approach was much more affordable than a TB-sensitive 
approach. 
 
What do these findings mean? 
 The potential of cash transfers to prevent TB-related catastrophic costs is greater if 
they are provided to defray/reimburse poor households’ costs (TB-specific approach) 
rather than to increase the income and strengthen the economic resilience of poor 
households with high TB risk (TB-sensitive approach).  
 Where cash transfers are insufficient to prevent catastrophic costs, it will be cheaper 
to supplement their value to achieve this objective using a TB-specific approach 
rather than a TB-sensitive approach. 
 Important study limitations were that the study was at the country-level, so we 
might have underestimated the potential of cash transfers to prevent catastrophic 
costs. Also, we did not assess other health and social benefits of cash transfers, so 
the impact of TB-specific versus TB-sensitive cash transfers was only judged from the 
perspective of preventing catastrophic costs. 
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Introduction 
 
Tuberculosis (TB) disproportionately affects poor households in low- and middle-income 
countries that are least able to afford the burden that TB-related costs represent relative to 
their income [1–6]. Even when diagnosis and treatment is available free of direct charges, 
TB-affected households are known to incur hidden “out of pocket” direct medical costs (e.g., 
for consultations) and direct nonmedical costs (e.g., for transport, additional food and 
symptomatic medicines), as well as indirect costs from lost income [7,8]. Combined, these 
costs can have severe consequences for affected households. They hinder patients’ access 
to care and increase their odds of adverse TB treatment outcomes, which are abandoning or 
failing treatment, dying during treatment, or having recurrent TB within 30 months of 
starting TB treatment [9–15]. They also force some households to engage in damaging 
financial coping strategies, which sometimes referred to collectively as dissaving, include 
taking out a loan, selling productive assets, reducing consumption expenditure to below 
basic needs, taking children out of education, and/or taking out large loans [16]. Two groups 
of households that are especially vulnerable to TB-related costs are those in the countries’ 
poorest population quintile and those affected by drug-resistant (DR) TB [7]. 
 
Addressing households’ TB-related costs is essential for ensuring that people with active TB 
disease are able to access TB diagnosis and treatment. Acknowledging this, the World 
Health Organization’s End TB Strategy includes a high-level financial risk protection 
milestone for 2020: “zero TB-affected households facing catastrophic costs due to TB” 
[17,18]. In this milestone, “catastrophic costs” refers to a combination of direct medical, 
direct nonmedical, and indirect costs excessive enough to increase a patient’s risk of 
adverse TB treatment outcome and/or force their household to engage in damaging 
financial coping strategies [19]. By encompassing all 3 cost components, the term 
“catastrophic costs” is distinct from the term “catastrophic health expenditure,” which only 
considers direct medical costs and is used to monitor progress towards financial risk 
protection as part of universal health coverage [19]. As part of the End TB Strategy, research 
has focussed on developing an empirical measure of catastrophic costs. Recently, total TB-
related costs greater than or equal to 20% of TB-affected households’ pre-illness annual 
income have been found to significantly increase the likelihood of TB patients experiencing 
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an adverse treatment outcome and their household engaging in damaging coping strategies 
[14,15]. As the only indicator established to be clinically and financially relevant for 
assessing a household’s ability to pay for TB care, this measurement of catastrophic costs 
has tentatively been included by the Global TB Programme in a pilot tool to monitor 
catastrophic costs of TB-affected households worldwide [19]. 
 
Preventing catastrophic costs for TB-affected households is a priority for facilitating 
individuals’ access to TB diagnosis and treatment, increasing their likelihood of treatment 
success and reducing onwards TB transmission [18]. With this objective, the Global TB 
Programme endorses social protection initiatives including cash transfers, food baskets, 
social insurance and labour market measures to complement universal health coverage 
initiatives like prepayment, resource pooling, and patient-friendly service delivery [19]. In 
the TB literature, evidence from a randomized trial in Peru shows that when provided as 
incentives to support TB treatment, cash transfers reduce poor TB-affected households’ 
likelihood of incurring catastrophic costs, as well as improve patients’ likelihood of TB 
treatment success, and uptake of preventative therapy amongst people they are in close 
contact with (e.g., family, friends, care giver) [15,20]. Outside of the TB literature, 
synthesised evidence from governmental poverty-reduction policies in several low- and 
middle-income countries provides evidence that cash transfers increase poor households’ 
income and consumption expenditure, help them cope with livelihood risks (e.g., illness and 
unemployment), and support family investments in the human capital of their children (e.g., 
sending them to school and taking them to regular health checks) [21–23]. 
 
Currently, there are at least 2 alternative approaches proposed in the TB literature for 
providing cash transfers to TB-affected households [24]. The first is termed a “TB-specific” 
approach, whereby cash transfers would be targeted to poor households with a confirmed 
TB diagnosis to incentivise and enable TB treatment by defraying their TB-related costs [24]. 
This approach is exemplified by the cash transfer component of the Community Randomized 
Evaluation of a Socioeconomic Intervention to Prevent TB (CRESIPT) trial in Peru [25,26]. The 
second is termed a “TB-sensitive” approach, whereby cash transfers would be targeted to 
poor households at high risk of developing active TB disease to increase their income, 
thereby protecting them from poverty-related risk factors for TB infection, progression, and 
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adverse treatment outcomes (e.g., poor living conditions and undernutrition), as well as 
strengthen their economic resilience to TB-related costs [24]. This approach already exists in 
many low- and middle-income countries, and is exemplified by governmental poverty-
reduction cash transfer programmes like Programa Bolsa Familia in Brazil [27,28]. 
 
Depending on whether cash transfers are provided with a TB-specific or a TB-sensitive 
approach, their impact might vary [24]. We aimed to investigate how this might relate to the 
potential of cash transfers to prevent catastrophic costs. 
 
Methods 
 
With no known data sources for investigating if the potential of TB-specific and TB-sensitive 
cash transfers to prevent catastrophic costs varies, we undertook an economic modelling 
study using published national average data gathered from a rigorous review of the 
literature. Our economic modelling study was aggregated at the country level. The setting 
was low- and middle-income countries where over 95% of TB cases live and where formal 
institutions to protect households from the social and economic impacts of illness are 
weakest [29]. The intervention being investigated was cash transfers paid to poor 
households, and the alternative approaches being compared were: (1) cash transfers 
provided to defray TB-related costs of households with a confirmed TB diagnosis (termed a 
“TB-specific” approach); versus (2) cash transfers provided to increase income of 
households with high TB risk and strengthen their economic resilience (termed a “TB-
sensitive” approach). These approaches were compared because of current uncertainty 
about the potential of each approach to prevent catastrophic costs. Using only TB-related 
costs incurred by patients, study outcomes were assessed from the patient perspective. 
 
Primary study outcomes were an indicator for catastrophic costs after TB-specific versus TB-
sensitive cash transfers, and the countries’ country-level cash transfer budget needed to 
prevent catastrophic costs for each of these approaches. Catastrophic costs were estimated 
over a time horizon from the month prior to TB symptom onset to TB treatment completion. 
The countries’ country-level cash transfer budgets were estimated over a time horizon of 1 
year. In the 1 country with available data, outcomes were investigated separately for drug-
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susceptible (DS) TB and DR TB. The reason for this is that treatment of DR TB versus DS TB is 
longer and more intensive and is therefore associated with much higher TB-related costs [7]. 
The study used cross-sectional data drawn from secondary sources. Data inputs were 
countries’ mean patient TB-related cost, mean pre-illness household income, mean poverty-
reduction cash transfer, and TB-specific versus TB-sensitive target populations. Inputs were 
retrieved by reviewing TB-related cost and cash transfer literature and countries’ national 
statistics. Because there was insufficient data across low- and middle-income countries on 
programmes providing cash transfers with a TB-specific approach, this study compared cash 
transfers offered by existing governmental poverty-reduction programmes as if they were 
provided with a TB-specific versus a TB-sensitive approach. 
 
For transparency, the study was reported according to the Consolidated Health Economic 
Evaluation Reporting Standards (CHEERS) checklist [30]. The completed checklist is provided 
in S1 CHEERS checklist. The study’s prospective analysis is provided in S1 Text. In the present 
analysis, we did not attempt to model the potential of TB-inclusive cash transfers to prevent 
catastrophic costs, and results from key informant interviews are reported elsewhere [31]. 
Extraction of cash transfer target population data, estimation of 95% confidence intervals 
(95% CIs), and our sensitivity analyses were added in the peer review process. Key study 
definitions are listed in Box 1. 
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Box 1. Summary of key study definitions 
TB-specific cash transfer: Assistance in the form of cash to poor households with a 
confirmed TB diagnosis to defray their TB-related costs and thus enable their access to TB 
diagnosis and treatment [24].  
TB-sensitive cash transfer: Assistance in the form of cash to poor households at high risk of 
developing active TB disease to relieve poverty by increasing their income and 
strengthening their economic resilience [24]. 
Direct costs: The sum of direct medical costs and direct nonmedical costs [7]. 
(i) Direct medical costs: Expenses paid for medical examinations and TB medicines because 
of TB illness (e.g., consultation fees, hospitalisation fees, and fees for diagnostic tests). 
(ii) Direct nonmedical costs: Expenses paid for nonmedical items related to TB illness and 
care (e.g., patient or guardian transportation, additional food, natural nonprescribed 
remedies). 
Indirect costs: Income estimated to be lost due to time off work because of TB illness and 
care (e.g., patient or guardian lost income) [7]. 
Pretreatment costs: The sum of direct and indirect costs incurred between the onset of TB 
symptoms and receipt of confirmed TB diagnosis. 
During-treatment costs: The sum of direct and indirect costs incurred between confirmed 
TB diagnosis to completion of TB treatment. 
Total costs: The sum of pre- and during-treatment costs. 
TB-related cost burden: Total TB-related costs expressed as a percentage of annual 
household income.  
Catastrophic costs: A value of total TB-related costs excessive enough to increase a patient’s 
risk of an adverse TB treatment outcome and/or force them to engage in damaging financial 
coping strategies (e.g., taking out a loan or selling household items) [14]. 
Adverse TB treatment outcome: Abandoning or failing treatment, dying during treatment, 
or having recurrent TB within 30 months of starting TB treatment [14].  
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Study population 
In this study, the target population for cash transfers provided with a TB-specific approach 
was households in countries’ poorest population quintile with a confirmed TB diagnosis. 
Guidance is not currently available for which TB-affected households should be targeted 
with a TB-specific approach. We chose to focus on TB-affected households in countries’ 
poorest population quintile because they are typically at greater risk of incurring 
catastrophic costs [14]. Whilst it might have been preferable to focus on all TB-affected 
households that incur catastrophic costs, at the time of analysis no estimates of the size of 
this population were available in any countries included in this study. The target population 
for cash transfers provided with a TB-sensitive approach was households in poverty already 
targeted by countries’ established governmental poverty-reduction cash transfer 
programme. 
 
Data sources 
 
TB-related cost data. Data on mean TB-related costs incurred by patients were sourced 
from articles identified by 2 recent publically available systematic reviews [7,8]. These 
reviews were chosen because they provided a comprehensive, peer-reviewed list of TB-
related cost surveys published before March 2013 and February 2015. TB-related cost 
surveys in identified articles were eligible if they were conducted in a low- or middle-income 
country and reported mean total costs calculated from direct costs and/or indirect costs 
incurred over the full duration of pre- and/or during-DS TB and/or DR TB treatment. We 
excluded cost surveys only reporting median total costs because of difficulties generalising 
this measure to countries’ total population. We also excluded cost surveys that were 
conducted before 2006, the year in which the Global TB Programme recommended that 
governments should waive direct costs for basic TB diagnostic tests and medicines [32]. If a 
publication reported TB-related costs from surveys in several different countries, each 
survey country was checked separately for cash transfer and household income data. Data 
extracted from eligible TB-related cost surveys comprised: survey country, year of data 
collection, survey setting, survey sample size, local currency unit exchange rate, methods 
used to estimate TB-related costs, and mean TB-related costs stratified into subcategories of 
direct, indirect, and total TB-related costs. In Brazil and Yemen, where articles reported 
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mean TB-related costs for different patient subgroups (e.g., directly observed therapy 
versus self-administered therapy), an unweighted mean overall estimate was calculated 
across subgroups [33,34]. 
 
Cash transfer data. For countries with an eligible TB-related cost survey, existing poverty-
reduction cash transfer programmes operating in respective countries were identified using 
the publically available social safety net program inventory in the appendix of the World 
Bank Group publication “The State of Social Safety Nets 2015” [35]. None of the identified 
cash transfer programmes were operated with explicit TB objectives. Cash transfer 
programmes were eligible if they were directed by a national government with the objective 
of poverty reduction and promoting family human capital development. Operational data 
on cash transfer programmes were sourced from the original reference [35] and other 
publically available online data sources identified from Google by combining the phrase 
“cash transfer” with the name of the programme and the selected country [36–47]. A 
summary of cash transfer data sources used in the study is provided in S1 Table. Cash 
transfer programmes were excluded if they were targeted uniquely to senior citizens or 
pregnant women. Data extracted on eligible poverty-reduction cash transfer programmes 
comprised: name of programme, breakdown of cash transfer benefits, mean cumulative 
annual cash transfers, sample size used to summarise mean cumulative annual cash 
transfers, and the range of cumulative annual cash transfers based on programme 
regulations. 
 
Household income data. For countries with an eligible TB-related cost survey and existing 
poverty-reduction cash transfer programme, we used countries’ mean household income or 
expenditure in the poorest population quintile to approximate household income of both 
TB-specific and TB-sensitive target populations. Publically available summary estimates of 
household income or expenditure were identified by searching countries’ national statistical 
websites and the International Household Survey Network’s (IHSN’s) survey catalogue [48]. 
We assumed that household income and expenditure were approximately similar. Where 
available, household income was preferred because of its use in the method included by the 
Global TB Programme in a pilot tool to measure and monitor catastrophic costs of TB-
affected households [19]. Data extracted from countries’ national statistical websites and 
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the IHSN survey catalogue comprised: coverage in households of country household income 
or expenditure survey, and mean household income or expenditure in countries’ poorest 
population quintile. When household income data was reported by population decile rather 
than population quintile, an un-weighted mean overall estimate was recalculated across the 
two poorest deciles. When national income surveys reported mean monthly or quarterly 
household income or expenditure, these values were extrapolated to mean annual 
estimates. 
 
Target population data. For countries with an eligible cost survey, cash transfer 
programme, and household income or expenditure survey, we identified the approximate 
size of their TB-specific target population using the World Health Organization’s publically 
available TB data [49]. Because estimates of the percentage of TB-affected households 
represented in the poorest population quintile were not available in any countries included 
in the study, we used the unweighted mean multiplier for TB prevalence in the poorest 
population quintile observed in India and South Africa to estimate the size of countries’ TB-
specific target population [50,51]. Therefore, countries’ TB-specific target population was 
extracted as 40% of the countries’ estimated 2013 DS TB burdens or 2015 DR TB burdens. 
For country estimates of DR TB burden, we used 2015 estimates because 2013 estimates 
weren’t available. We assumed that each estimated case of active TB disease in the World 
Health Organization’s TB data represented 1 household with a confirmed TB diagnosis. We 
identified the approximate size of countries’ TB-sensitive target population using publically 
available estimates of countries’ 2013 poverty-reduction cash transfer programme coverage 
in households already extracted in the cash transfer data literature review [35–46]. 
Countries’ TB-specific and TB-sensitive target populations were also extracted as a 
percentage of countries’ total population in households using publically available census 
data available in the United Nations demographic yearbook [52]. 
 
All data were extracted into Microsoft Excel 2016. 
 
Currency and price data.  
To allow comparison of monetary data extracted in different currencies and measured in 
different years, all extracted monetary values were inflated and converted to 2013 
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international dollars using the purchasing power parity conversion factor that accounts for 
differences in the cost of living across countries [53,54]. 
 
Data management.  
In countries that had missing values for direct or indirect costs pre- or during-treatment, we 
estimated their value. To do this, we assumed that average TB-related costs followed a 
make-up of cost components equivalent to the one synthesised by Tanimura et al. in their 
systematic review of TB-related costs in low- and middle-income countries, which is that 
direct and indirect costs are equivalent to 40% and 60% of total costs respectively, and pre- 
and during-treatment costs are each equivalent to 50% of total costs respectively [7]. 
Because only 1 included cost survey reported the standard deviation of total costs [33], we 
also assumed that average TB-related costs had a standard deviation with the same ratio to 
total costs as the one estimated by Tanimura et al. for average total costs across all low- and 
middle-income countries, which was 1.1 [7]. We used the assumed standard deviation and 
the sample size of countries’ cost surveys to calculate 95% CIs for estimated TB-related 
costs. 
 
Data analysis. 
All analyses used published mean national data. To account for uncertainty in the value of 
extracted TB-related costs, annual household income, and cash transfers, we conducted a 
multiway analysis that allowed all 3 of these inputs to vary simultaneously according to their 
sampling distributions. Sampling distributions were simulated from 10,000 computationally 
generated random samples and were all assumed to have normal distributions according to 
the central limit theorem. Random samples were generated for TB-related costs using a 
standard deviation with a ratio of 1.1 to mean estimates, which was the ratio estimated by 
Tanimura et al. for average total costs across all low- and middle-income countries, and a 
sample size equivalent to countries’ cost surveys [7]. For annual household income, we used 
a standard deviation with a ratio of 0.8 to mean estimates, which was the average observed 
across 2 studies investigating the household-level income effect of poverty-reduction cash 
transfer programmes in Brazil and Colombia [37,44] and a sample size equivalent to 
countries’ household income surveys [55–61]. For cash transfers, we used a standard 
deviation with a ratio to mean estimates equivalent to a quarter of maximum cash transfers 
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minus minimum cash transfers, and a sample size equivalent to the one reported in studies 
from which we extracted mean cash transfers. In Ecuador and Ghana, we did not simulate 
sampling distributions for cash transfers because, respectively, all beneficiary households 
receive the same flat cash transfer, and the mean cash transfer we extracted was estimated 
from all beneficiary households. Throughout our analysis, 95% CIs were calculated for model 
estimates using the quantile method. All analyses were run in R version 3.3.0. 
 
Estimation of TB-related cost burden before cash transfers. To estimate if TB-related costs 
were catastrophic for poor TB-affected households, we calculated each country’s TB-related 
cost burden without cash transfer data by expressing TB-related costs as a percentage of 
household income. A TB-related cost burden greater than or equal to 20% was measured as 
catastrophic, as this threshold has been shown to significantly increase the likelihood of TB 
patients experiencing an adverse treatment outcome, and their household engaging in 
damaging financial coping strategies [14,15]. In countries where the TB-related cost burden 
was estimated to be catastrophic, we then compared the potential of cash transfers 
provided with a TB-specific versus a TB-sensitive approach to prevent catastrophic costs. 
 
Estimation of the potential of TB-specific cash transfers to prevent catastrophic costs. To 
estimate the potential of cash transfers provided with a TB-specific approach to prevent 
catastrophic costs, we considered that cash transfers would be targeted to poor households 
with a confirmed TB diagnosis to defray TB-related costs incurred pre- and during-
treatment. Thus, we subtracted the value of cash transfers from TB-related costs and then 
recalculated countries’ TB-related cost burden (Box 2, Equation 1).  
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Box 2. Summary of equations used in data analysis 
TB-related cost burden (%) 
Equation 1: after TB-specific cash transfers 
𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 𝑏𝑢𝑟𝑑𝑒𝑛 =
(𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 − 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟)
𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒
∗ 100 
Equation 2: after TB-sensitive cash transfers 
𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 𝑏𝑢𝑟𝑑𝑒𝑛 =
𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡
(𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒 + 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟)
∗ 100 
Additional cash transfer needed to prevent catastrophic costs ($) 
Equation 3: TB-specific approach 
(i) 
20 =
(𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 − 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟 + 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟)
𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒
∗ 100 
(ii) 
 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟
= (𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡 − 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟) − (𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒 ∗ 0.2) 
 
Equation 4: TB-sensitive approach 
(i) 
20 =
𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡
(𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒 + 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟 + 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟)
∗ 100 
(ii) 
𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟
= (𝑇𝐵 𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑐𝑜𝑠𝑡/ 0.2) − (𝑝𝑟𝑒 𝑖𝑙𝑙𝑛𝑒𝑠𝑠 𝐻𝐻 𝑖𝑛𝑐𝑜𝑚𝑒 + 𝑐𝑎𝑠ℎ 𝑡𝑟𝑎𝑛𝑠𝑓𝑒𝑟) 
 
Estimation of the potential of TB-sensitive cash transfers to prevent catastrophic costs. To 
estimate the potential of cash transfers provided with a TB-sensitive approach to prevent 
catastrophic costs, we considered that cash transfers would be targeted to poor households 
at high risk of developing active TB disease, to increase their pre-illness income and protect 
them from poverty. For any beneficiary households that later developed active TB disease, 
their cash transfer-increased household income would make them more resilient to the 
burden of TB-related costs incurred pre- and during-treatment. Thus, we added the value of 
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cash transfers to pre-illness annual household income and then recalculated countries’ TB-
related cost burden (Box 2, Equation 2).  
 
Estimation of TB-specific and TB-sensitive cash transfer needed to prevent catastrophic 
costs. To estimate the total value of cash transfer that would be needed by poor TB-affected 
households to prevent catastrophic costs with a TB-specific versus a TB-sensitive approach, 
we considered that for each approach, an additional cash transfer would be provided to 
targeted households to achieve this objective. Thus, we first estimated countries’ 
household-level additional cash transfer needed to prevent catastrophic costs by 
rearranging Equations 1 and 2, fixing countries’ TB-related cost burden at 20%, and 
considering an unknown value of additional cash transfer (Box 2, Equations 3ii and 4ii). Then 
we estimated countries’ household-level total cash transfer needed to prevent catastrophic 
costs by adding the value of original cash transfer to our estimated value of additional cash 
transfer needed to prevent catastrophic costs. 
 
Estimation of TB-specific and TB-sensitive cash transfer budget needed to prevent 
catastrophic costs. To estimate the country-level budget that countries would need to 
prevent catastrophic costs for all poor households targeted with a TB-specific versus a TB-
sensitive approach, we considered that for each approach a value of cash transfer sufficient 
to prevent catastrophic costs would be provided to all targeted households. Thus, we 
multiplied countries’ estimated TB-specific and TB-sensitive household-level total cash 
transfer needed to prevent catastrophic costs by the size of each approach’s target 
population, which for a TB-specific approach was all households with a confirmed TB 
diagnosis in the countries’ poorest population quintile, and for a TB-sensitive approach was 
households in poverty already targeted by countries’ established governmental poverty-
reduction cash transfer programme. 
 
Sensitivity analysis. 
We tested the sensitivity of our results in Brazil, Colombia, Tanzania, and Mexico to 
imputation of missing DS TB-related cost components by repeating our analysis omitting 
rather than imputing the value of missing DS TB-related cost components [7]. We separately 
tested the sensitivity of our results across all countries included in the study to the use of 
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20% as the threshold for measuring countries’ TB-related cost burden as catastrophic. We 
did this by repeating our analyses instead using a 10% and 30% threshold.  
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Results 
 
Fig 1 is a flow chart of the review process for assessing the eligibility of countries for 
inclusion in this study. Argentina, Bangladesh, and South Africa had to be excluded after 
insufficient publically available background information was identified for eligible cash 
transfer programmes in these countries. Consequently, 7 countries were included in the 
data analysis. 
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Fig 1. Flow chart of country eligibility and TB-related cost survey inclusion in the study.  
TB, Tuberculosis. 
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Summary of DS TB-related cost data  
Conducted in Brazil, Colombia, Ecuador, Ghana, Mexico, Tanzania, and Yemen between 
2006 and 2012, survey sample sizes ranged from 94 to 320 patients with active DS TB 
disease (Table 1). Surveys collected data on DS TB-related costs incurred pre- and during-
treatment, except in Brazil [33], Colombia [62], and Tanzania [63], where they only collected 
data during-treatment (Table 1). Surveys collected both direct and indirect cost data, except 
in Mexico [64] where no data was collected characterising indirect costs (Table 1). In 
countries where data was collected, methods for estimating indirect costs varied in 2 ways: 
1) reported time lost travelling and waiting to receive TB care was multiplied by patients’ 
reported income [33,65]; or 2) reported time lost travelling and waiting to receive TB care 
was multiplied by an estimate of national average income (gross national income per capita 
or official wage rate) [33,62,63,66]. In Ecuador [66], data was collected on additional costs 
described in the publication as referring to “loans, paying for additional help and other 
impacts throughout the course of TB illness.” The ambiguity of this cost category meant that 
it could not be classified as either direct or indirect costs and was thus reported as its own 
subcategory. Reported mean DS TB-related total costs for the complete TB illness ranged 
from $387 to $2,382 (Table 1). After imputing missing TB-related cost components in Brazil, 
Colombia, Mexico and Tanzania, estimated mean DS TB-related total costs ranged from 
$774 (95% CI: $618–$930) to $5,954 (95% CI: $4,997–$6,911), Table 1.
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Table 1. Summary of TB-related cost surveys included in the study 
Cost survey 
  
Reported TB-related costs   
Estimated TB-related 
costs 
Country Year 
Number of 
participants 
  
Treatment 
phase  
Direct 
2013 PPP$ 
Indirect 
2013 
PPP$ 
Additional  
2013 PPP$ 
Total  
2013 
PPP$ 
  
 Total 
2013 PPP$ (95% CIs) * 
DS TB                 
Brazil§ [33] 2010 218   During- 182 205   387   774 (618–930) † 
Ecuador 
[66] 
2007 104   
Pre- and 
during- 
846 860 620 2,326   2,326 (1,834–2,818) 
Yemen§ 
[34] 
2008/09 320   
Pre- and 
during- 
631 253   885   885 (778–992) 
Tanzania 
[63] 
2012 94   During- 506 330   836   1,672 (1,300–2,044) † 
Ghana [65] 2009 135   
Pre- and 
during- 
326 883   1,208   1,208 (984–1,432) 
Colombia 
[62] 
2010 150   During-       707   1,414 (1,165–1,663) † 
Mexico 
[64] 
2007/08 180   
Pre- and 
during- 
2,382     2,382   5,954 (4,997–6,911) ‡ 
DR TB                 
Ecuador 
[66] 
2007 14   
Pre- and 
during- 
2,345 4,560 9,762 16,667   16,667 (7,063–26,271) 
Abbreviations: PPP, Purchasing Power Parity; CI, Confidence Interval; DR, Drug Resistant; DS, Drug Susceptible; TB, Tuberculosis. *According to Tanimura et al., estimated 
total costs in all countries had a standard deviation with a ratio of 1.1 to their value [7]. The probability distribution of TB-related costs was assumed to be normal. This was 
justified because our analysis was at the national level and we used mean values. †According to Tanimura et al., reported during-treatment costs were assumed to only 
represent 50% of total TB-related costs [7]. ‡According to Tanimura et al., reported direct costs pre- and during-treatment were assumed to only represent 40% of total TB-
related costs [7]. §TB-related costs were extracted as an unweighted mean overall estimate calculated across patient subgroups.
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Summary of DR TB-related cost data  
Conducted in Ecuador in 2007, the survey sample size was 14 patients with active multidrug-
resistant TB disease, Table 1. The survey reported mean DR TB-related costs incurred pre- 
and during-treatment (Table 1). The survey collected both direct and indirect cost data 
(Table 1). Cost data was also collected on additional costs. This category of costs was 
reported as its own subcategory. Indirect costs were estimated by multiplying reported time 
lost travelling and waiting to receive TB care by the estimated hourly wage in Ecuador. 
Mean DR TB-related total costs were $16,667 (95% CI: $7,063–$26,271), Table 1.  
 
Summary of cash transfer data  
All extracted cash transfer data refer to programmes’ status in 2013. Mean cumulative 
annual cash transfers were greatest in Brazil, Colombia, Ecuador, Mexico, and Yemen 
varying between $823 (range: $239–$1,084) and $1,091 (range: $1,091–$1,091); and lowest 
in Ghana and Tanzania where they were $217 (range: $150–$299) and $451 (range: $349–
$655), respectively (Table 2). Across countries, cash transfers ranged from 7.7% (95% CI: 
7.6%–7.9%) to 43% (95% CI: 42%–44%) of annual household income. In Colombia, Ecuador, 
Ghana, Mexico, and Tanzania they varied between 13% (95% CI: 11%–17%) and 59% (95% 
CI: 50%–72%) of DS TB-related costs, and in Brazil and Yemen, respectively, they were 104% 
(95% CI: 93%–119%) and 106% (95% CI: 88%–133%) of DS-TB-related costs (Table 2). In 
Ecuador, cash transfers represented 7.3% (95% CI: 4.2%–15%) of DR TB-related costs (Table 
2). A summary of cash transfer data sources and additional extracted data is provided in S1 
Table.
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Table 2. Summary of poverty-reduction cash transfer programmes included in the study and TB-specific versus TB-sensitive target populations.  
Poverty-reduction cash transfer programme 
 Current poverty-reduction 
cash transfer % of 
 
 Target population,  
in households 
Country Name Components 
Current cash 
transfer  
2013 PPP$ 
(Range) 
 
Household 
income†  
(95% CIs) § 
TB-related costs  
(95% CIs) § 
  
TB-specific 
(% of 
population) 
TB-sensitive 
(% of 
population) 
DS TB             
Brazil 
Programa 
Bolsa Familia  
[36,37] 
Flat benefit to extremely poor 
families; and variable benefits 
to poor families to support child 
health, child/adolescent 
education, and pregnant 
women’s health 
823  
(239–1,084) 
 
15  
(15–16) 
106  
(88–133) 
  
34,800  
(0.06) 
14,000,000  
(25) 
Ecuador 
Bono de 
Desarollo 
Humano [38] 
Flat benefit to poor families to 
support child health and 
education  
1,091  
(1,091–1,091) 
 
13  
(12–13) 
47  
(39–59) 
  
3,520  
(0.09) 
450,000  
(12) 
Yemen 
Social 
Welfare 
Fund [39] 
Flat benefit to poor families; 
and variable benefit to poor 
families for household size 
923  
(615–1,026) ᶲ 
 
43 
 (42–44) 
104  
(93–119) 
  
4,800  
(0.17) 
1,500,000  
(35) 
Tanzani
a 
Productive 
Social Safety 
Net [40–42] 
Flat benefit for poor families; 
and variable benefits to poor 
families to support child health 
and education and pregnant 
women’s health 
217  
(150–299) 
 
7.7  
(7.6–7.9) 
13  
(11–17) ‡ 
  
67,600  
(0.72) 
150,000  
(2) 
Ghana 
Livelihood 
Empowerme
nt Against 
Poverty [43] 
Variable benefit to poor families 
for orphans and vulnerable 
children, disabled and those 
over 65 
451  
(349–655) 
 
25 
 (24–26) 
37  
(32–46) 
  
17,600  
(0.32) 
70,000  
(1) 
Colombi
a 
Mas Familias 
en Accion 
[44,45] 
Variable benefits to poor 
families to support child health 
and child/adolescent education 
837  
(191–1,777) 
 
38 
 (37–39) 
59  
(50–72) 
  
6,000  
(0.06) 
26,000,000  
(25) 
Mexico 
Oportunidad
es* [46,47] 
Variable benefits to poor 
families to support family 
health, child/adolescent 
education, family nutrition 
940  
(246–2,063) 
 
20  
(19–20) 
16  
(14–19) 
  
10,000  
(0.04) 
6,600,000  
(27) 
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DR TB               
Ecuador 
Bono de 
Desarollo 
Humano [38] 
Flat benefit to poor families to 
support child health and 
education  
1,091  
(1,091–1,091) 
 
13  
(12–13) 
7.3  
(4.2–15) 
  
300  
(0.01) 
450,000  
(12) 
Apart from countries’ alternative target populations, all data are mean estimates. Abbreviations: PPP, purchasing power parity, CI, confidence interval, DR, drug-resistant; 
DS, drug-susceptible; TB, tuberculosis. *Formerly PROGRESA. †Household income refers to average pre-illness annual household income in the poorest population quintile. 
‡Household income was extracted as household expenditure in the poorest population quintile. §To estimate 95% confidence intervals, all mean TB-related costs were 
assumed to have a standard deviation with a ratio of 1.1 to their value, all mean household incomes were assumed to have a standard deviation with a ratio of 0.8 to their 
value, and all mean cash transfers were assumed to have a standard deviation equal to a quarter of maximum minus minimum cash transfers. Probability distributions for 
all 3 input parameters were assumed to be normal. This was justified because our analysis was at the national level and we used mean values. ᶲBecause of changes in cash 
transfer programme administration in the study year, reported mean cash transfers were higher than the maximum value of cash transfers able to be received by 
beneficiary households in 2013 [39]. We assumed that mean cash transfers were approximately equivalent to the value that would be received by an average household in 
the country's poorest population quintile based on household size.
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Summary of household income data 
Conducted between 2005 and 2011, survey sample sizes ranged from 8,687 to 55,970 
households [55–61]. Surveys reported mean household income, except in Tanzania where 
mean household expenditure was reported. Estimated mean annual household income in 
countries’ poorest population quintiles was highest in Brazil, Ecuador, and Mexico varying 
between $4,755 and $8,692, and lowest in Colombia, Ghana, Tanzania, and Yemen varying 
between $1,617 and $2,812. A summary of annual household income data sources and 
extracted data is provided in S1 Table. 
 
Summary of target population data 
For DS TB, the size of countries’ estimated TB-specific target population, which was 
equivalent to 40% of countries’ TB burden, ranged from 3,520 to 67,600 households, and 
the size of countries’ estimated TB-sensitive target population, which was equivalent to the 
number of households in poverty already targeted by countries’ established poverty-
reduction cash transfer programme, ranged from 70,000 to 26 million households (Table 2). 
For DR TB, the size of Ecuador’s estimated TB-specific target population was 300 
households, and the size of its estimated TB-sensitive target population was 450,000 
households (Table 2). 
 
Summary of DS TB-related cost burden before cash transfers  
Before cash transfers, estimated DS TB-related cost burdens varied between 15% (95% CI: 
12%–18%) and 125% (95% CI: 105%–145%) of annual household income, and were 
catastrophic in Colombia, Ecuador, Ghana, Mexico, Tanzania, and Yemen where they varied 
between 27% (95% CI: 21%–32%) and 125% (95% CI: 105%–145%) of annual household 
income (Fig 2). 
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Fig 2. Summary of countries’ household-level TB-related cost burden before, and after cash transfers. 
The “Before cash transfers” bar represents countries’ mean TB-related cost burden without cash transfer data. The “After TB-specific cash transfers” bar represents 
countries’ mean TB-related cost burden after cash transfers have been subtracted from TB-related costs. The “After TB-sensitive cash transfers” bar represents countries’ 
mean TB-related cost burden after cash transfers have been added to countries’ pre-illness household income. The dotted line guides whether countries’ mean TB-related 
cost burden is above or below 20%. Error bars represent 95% CIs calculated using the quantile method. The values used to build Fig 2 are provided in S2 Table. *For clarity, 
a mean TB-related cost burden of 0% after cash transfers is plotted as 0.9%. †Upper bound of 95% CI = 19.8. ‡To estimate 95% CIs, all mean TB-related costs were assumed 
to have a standard deviation with a ratio of 1.1 to their value [7], all mean household incomes were assumed to have a standard deviation with a ratio of 0.8 to their value 
[37,44], and all mean cash transfers were assumed to have a standard deviation equal to a quarter of maximum minus minimum cash transfers. Probability distributions for 
all 3 input parameters were assumed to be normal. This was justified because our analysis was at the national level and we used mean values. DR, drug-resistant; DS, drug-
susceptible; TB, tuberculosis. 
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Summary of the potential of TB-specific cash transfers to prevent DS TB catastrophic costs, 
and the budget needed for this approach  
If cash transfers were applied using a TB-specific approach to defray TB-related costs 
incurred by households with a confirmed DS TB diagnosis, then on average, they were 
sufficient to prevent catastrophic costs in Ecuador and Yemen, but insufficient to prevent 
them in either Colombia, Ghana, Mexico, or Tanzania (Fig 2). In Colombia, Ghana, Mexico, or 
Tanzania, the DS TB-related cost burden after TB-specific cash transfers varied between 26% 
(95% CI: 15%–38%) and 106% (95% CI: 86%–126%), and the estimated value of household-
level additional TB-specific cash transfer needed to prevent DS TB catastrophic costs varied 
between $144 (95% CI: $0.0–$387) and $4,071 (95% CI: $3,122–$5,014), Table 3. In the six 
countries where TB-related costs were originally catastrophic, the estimated value of 
household-level total TB-specific cash transfer needed to prevent DS TB catastrophic costs 
varied between $850 (95% CI: $627–$1,079) and $5,011 (95% CI: $4,063–$5,952), Table 3. 
According to the size of countries’ TB-specific target populations, this value translated into a 
TB-specific country-level cash transfer budget needed to prevent DS TB catastrophic costs 
varying between $3.8 million (95% CI: $3.8 million–$3.8 million) and $75 million (95% CI: 
$50 million–$100 million), Fig 3. 
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Table 3. Summary of countries’ household-level additional and total cash transfer needed to prevent catastrophic costs. 
 
Additional cash transfer, 2013 PPP$ (95% CIs) * Total cash transfer, 2013 PPP$ (95% CIs) * 
Country  TB-specific approach TB-sensitive approach TB-specific approach TB-sensitive approach 
DS TB         
Brazil 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 
Ecuador 0.0 (0.0–0.0) † 1,842 (0.0–4,281) 1,091 (1,091–1,091) † 2,971 (1,091–5,372) 
Yemen 0.0 (0.0–0.0) 1,360 (821–1,897) 923 (920–926) 2,282 (1,743–2,819) 
Tanzania 880 (510–1,243) 5,322 (3,473–7,139) 1,111 (741–1,474) 5,553 (3,707–7,370) 
Ghana 399 (176–628) 3,800 (2,683–4,945) 850 (627–1,079) 4,251 (3,134–5,396) 
Colombia 144 (0.0–387) 4,023 (2,764–5,281) 981 (830–1,223) 4,860 (3,600–6,117) 
Mexico 4,071 (3,122–5,014) 24,115 (19,374–28,817) 5,011 (4,063–5,952) 25,055 (20,316–29,761) 
DR TB         
Ecuador 13,782 (4,274–23,376) 73,275 (25,736–121,246) 14,877 (5,365–24,467) 74,375 (26,827–122,337) 
All data are average estimates. For interpretability, negative estimates and confidence intervals are reported as 0. Abbreviations: PPP, purchasing power parity, CI, 
confidence interval; DS, drug-susceptible; DR, drug-resistant; TB, tuberculosis. *To estimate 95% confidence intervals, all mean TB-related costs were assumed to have a 
standard deviation with a ratio of 1.1 to their value [7], all mean household incomes were assumed to have a standard deviation with a ratio of 0.8 to their value [37,44], 
and all mean cash transfers were assumed to have a standard deviation equal to a quarter of maximum cash transfers minus minimum cash transfers. Probability 
distributions for all 3 input parameters were assumed to be normal. This was justified because our analysis was at the national level and we used mean values. †Because 
data were highly skewed we reported median instead of mean.
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Fig 3. Summary of countries’ country-level cash transfer budget needed to prevent catastrophic costs.  
All data are expressed in millions on the log10 scale. We summarise 0.5% of countries’ GDP and their existing poverty-reduction cash transfer budget for comparison. The 
“0.5% of country GDP” bar represents the upper limit that governments in low- and middle-income countries spend on a poverty-reduction cash transfer programme [27]. 
The “poverty-reduction programme” bar represents countries’ actual poverty-reduction cash transfer programme budget. The “TB-specific approach” bar represents the 
mean budget that countries would need to prevent their TB-specific target population from incurring catastrophic costs. The “TB-sensitive approach” bar represents the 
mean budget that countries would need to prevent their TB-sensitive target population from incurring catastrophic costs. The values used to build Fig 3 are provided in S3 
Table. *For clarity, a value of country-level cash transfer budget needed equal to $0 is plotted as $1.1. †Because data were highly skewed we reported median instead of 
mean. GDP, gross domestic product; DS, drug-susceptible; DR, drug-resistant; TB, tuberculosis.
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Summary of the potential of TB-sensitive cash transfers to prevent DS TB catastrophic 
costs, and the budget needed for this approach 
If cash transfers were provided using a TB-sensitive approach to increase pre-illness 
income of poor households with high risk of developing active TB disease, then on average, 
for those that later develop active DS TB disease, this would not be sufficient to prevent 
them from incurring catastrophic costs in any of the 6 countries where DS TB-related costs 
were originally catastrophic (Fig 2). In these 6 countries, the DS TB-related cost burden 
after TB-sensitive cash transfers varied between 24% (95% CI: 19%–29%) and 105% (95% 
CI: 88%–121%), and the estimated value of household-level additional TB-sensitive cash 
transfer needed to prevent DS TB catastrophic costs varied between $1,360 (95% CI: $821–
$1,897) and $24,115 (95% CI: $19,374–$28,817), Table 3. The estimated value of 
household-level total TB-sensitive cash transfer needed to prevent DS TB catastrophic 
costs varied between $2,282 (95% CI: $1,743–$2,819) and $25,055 (95% CI: $20,316–
$29,761), Table 3. According to the size of countries’ TB-sensitive target populations, this 
value translated into a TB-sensitive country-level cash transfer budget needed to prevent 
DS TB catastrophic costs varying between $298 million (95% CI: $219 million–$378 million) 
and $165,367 million (95% CI: $134,085 million–$196,425 million), Fig 3. 
 
Summary of the potential of TB-specific versus TB-sensitive cash transfers to prevent DR 
TB catastrophic costs, and the budget needed for each approach  
In Ecuador, the DR TB-related cost burden before cash transfers was 192% (95% CI: 86%–
299%), Fig 2. Here, cash transfers provided with either a TB-specific or a TB-sensitive 
approach were, on average, insufficient to prevent DR TB catastrophic costs (Fig 2). The 
estimated value of TB-specific versus TB-sensitive additional cash transfer needed to 
achieve this objective was $13,782 (95% CI: $4,274–$23,376) versus $73,275 (95% CI: 
$25,736–$121,246); and the estimated value of household-level total TB-specific versus TB-
sensitive cash transfers needed was $14,877 (95% CI: $5,365–$24,467) versus $74,375 
(95% CI: $26,827–$122,337), Table 3. According to the size of Ecuador’s DR TB-specific and 
DR TB-sensitive target population, this value translated into a country-level cash transfer 
budget needed to prevent DR TB catastrophic costs of $4.5 million (95% CI: $1.6 million–
$7.3 million) with a TB-specific approach versus $33,469 million (95% CI: $12,072 million–
$55,052 million) with a TB-sensitive approach (Fig 3). 
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Sensitivity analysis without imputing data  
Before cash transfers, the TB-related cost burden remained catastrophic in the same 
countries as when missing TB-related cost components were imputed, and the only 
difference after cash transfers was that TB-specific cash transfers prevented catastrophic 
costs in Colombia (S4 Table). Across countries, TB-specific cash transfers remained more 
affordable at preventing catastrophic costs compared to TB-sensitive cash transfers both at 
the household and country level (S5 Table). 
 
Sensitivity analysis with 10% threshold  
Before cash transfers, in addition to Colombia, Ecuador, Ghana, Mexico, Tanzania, and 
Yemen, the DS TB-related cost burden was also catastrophic in Brazil. In Ecuador, the DR 
TB-related cost burden before cash transfers remained catastrophic. Across countries, TB-
specific cash transfers remained more affordable than TB-sensitive cash transfers for 
preventing DS and DR TB catastrophic costs both at the household and country level (S6 
Table). 
 
Sensitivity analysis with 30% threshold  
Before cash transfers, the DS TB-related cost burden remained catastrophic in Colombia, 
Ghana, Mexico, Tanzania, and Yemen, but ceased to be catastrophic in Ecuador. In 
Ecuador, the DR TB-related cost burden before cash transfers remained catastrophic. 
Across countries, TB-specific cash transfers remained more affordable than TB-sensitive 
cash transfers for preventing DS and DR TB catastrophic costs both at the household and 
country level (S7 Table). 
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Discussion 
 
In the 7 countries that met our inclusion criteria, our analysis of national average data 
suggests that DS TB-related costs would be catastrophic for the average poor TB-affected 
household in most low- and middle-income countries. This is concerning and concordant 
with the limited evidence that is already available [7]. If cash transfers were provided with 
a TB-specific approach to defray TB-related costs of poor households with a confirmed DS 
TB diagnosis, then in some low- and middle-income countries, they would likely be 
sufficient to prevent the average household incurring DS TB catastrophic costs. 
Alternatively, if the same value of cash transfers were provided with a TB-sensitive 
approach to increase the income and strengthen the economic resilience of poor 
households at high risk of developing active TB disease, then across low- and middle-
income countries, they would likely be insufficient to prevent the average household that 
later developed active DS TB disease incurring DS TB catastrophic costs. In countries where 
neither TB-specific nor TB-sensitive cash transfers would be sufficient to prevent DS TB 
catastrophic costs, the average value of household-level additional cash transfer needed to 
achieve this objective would be much lower using a TB-specific approach compared to a 
TB-sensitive approach. Further, by only targeting poor households with a confirmed TB 
diagnosis, a TB-specific approach would, on average, require a much smaller country-level 
budget than using a TB-sensitive approach to target much larger numbers of poor 
households at high risk of developing active TB disease. 
 
Although DR TB is rare, it is associated with extreme TB-related costs [7]. Neither TB-
specific nor TB-sensitive cash transfers would be sufficient to prevent DR TB catastrophic 
costs for the average poor DR TB-affected household. The value of household-level 
additional cash transfer needed to achieve this objective would be very high. Because few 
poor households are affected by DR TB, countries’ county-level cash transfer budget 
needed to prevent DR TB catastrophic costs would, on average, be much lower using a TB-
specific approach compared to a TB-sensitive approach. Given that so few households are 
affected by DR TB, it may not be rational for TB-sensitive cash transfer programmes to aim 
to increase households’ annual income sufficiently to make all poor households resilient to 
the rare and extreme costs associated with DR TB. 
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To our knowledge, our study is the first to compare the potential of cash transfers 
provided with a TB-specific versus a TB-sensitive approach to prevent catastrophic costs. 
The contrasting effects of defraying TB-related costs using a TB-specific approach versus 
increasing households’ pre-illness income using a TB-sensitive approach has important and 
novel implications for protecting TB-affected households from catastrophic costs. We 
believe our study is also the first to compare the country-level cash transfer budget that 
would be needed to prevent catastrophic costs for poor TB-affected households using a 
TB-specific versus a TB-sensitive approach. We show that by being more effective and 
aiming to reach fewer households, a TB-specific approach would cost less than a TB-
sensitive approach. It is important to emphasize that these findings are only valid when 
preventing catastrophic costs is the only outcome of interest. Cash transfers provided to 
poor households with a TB-sensitive approach might have far-reaching effects on 
wellbeing, health promotion, and disease prevention, and further evaluation is needed to 
study the costs versus benefits of each approach [24,67]. Nevertheless, the End TB Strategy 
prioritises ensuring that 0 TB-affected households experience catastrophic costs [17]. For 
achieving this specific milestone, the implications of our study are clear: cash transfers 
provided with a TB-specific approach are likely to achieve this goal more affordably than if 
they were provided with a TB-sensitive approach. 
 
Our study adds to limited evidence informing the best targeting strategy for cash transfers 
aimed at enhancing TB care and prevention [24]. At the country-level, showing that in Latin 
America and Central Asia a TB-sensitive approach might reach between 12% and 35% of 
countries’ population, whereas in some parts of sub-Saharan Africa it might only reach 
between 1% and 2% of countries population, this study supports speculation that the 
potential of countries to provide cash transfers with a TB-sensitive approach might follow 
an inverse care law [68], whereby poorer countries with higher TB burdens have less well 
established poverty-reduction cash transfer programmes [24]. Showing also that 
approximately 40% of TB-affected households might be in the poorest population quintile, 
this study highlights the need to consider how cash transfers might be targeted to 
households that incur catastrophic costs but are outside of this population category 
[50,51]. With a TB-specific approach, it would be relatively easy to modify programmes’ 
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target population to include more TB-affected households, whilst with a TB-sensitive 
approach, it might be harder to modify the target population of existing poverty-reduction 
programmes, which are usually well-established parts of national social protection systems 
[35]. 
 
This study has several limitations, and conclusions should be drawn cautiously. Insufficient 
data forced us to estimate the potential of TB-specific versus TB-sensitive cash transfers to 
prevent catastrophic costs using the value of cash transfers offered by existing 
governmental poverty-reduction cash transfer programmes. Whilst the only solution, it will 
have nonetheless under- or overestimated the potential of TB-specific cash transfers 
depending on how their actual value compares to governmental poverty-reduction cash 
transfers. Our inputs were all associated with some uncertainty, especially TB-related 
costs, which were mostly extracted from small subnational cost surveys [33,34,62–66]. We 
attempted to account for this using a multiway analysis that allowed inputs to vary by their 
simulated sampling distributions. Inconsistent reporting of standard deviations for mean 
TB-related costs, household income, and cash transfers forced us to make assumptions 
about the amount of variance around extracted values and to generalise these across 
countries. Whilst we ensured that our estimates of variance were as accurate as possible 
by drawing from relevant literature [7,37,44], this approach will have ignored any country-
specific skewness or kurtosis in input parameters. Inconsistent reporting of TB-related 
costs disaggregated by income quintile meant that we had to assume that estimated TB-
related costs were representative of those incurred by affected households in countries’ 
poorest population quintile. Because poorer households usually incur lower TB-related 
costs compared to less poor households, this is likely to have underestimated the potential 
of cash transfers to prevent catastrophic costs, and overestimated the country-level 
budget needed to achieve this [14]. Whilst our analysis should provide an accurate 
estimate of the effect of cash transfers on countries’ mean TB-related cost burden, 
because sample distributions of TB-related costs are known to be positively skewed [7], the 
aggregate-level nature of our study means that our results are unlikely to be 
representative of the majority of TB-affected households. Two sources of error in this 
study were imputation of missing TB-related cost components in Brazil [33], Colombia [62], 
Tanzania [63], and Mexico [64], and measuring catastrophic costs using a threshold TB-
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related cost burden that still hasn’t been assessed to determine its clinical or financial 
relevance for TB-affected households in any of the countries included in the study. 
Sensitivity analysis showed that the potential of cash transfers to prevent catastrophic 
costs was robust to these sources of error, but the precise estimates of countries’ 
household-level additional and total cash transfer and country-level cash transfer budget 
needed to prevent catastrophic costs were dependent on them. Therefore, whilst a TB-
specific approach was consistently more effective and affordable for preventing 
catastrophic costs compared to a TB-sensitive approach in all our analyses, further 
research is needed to precisely estimate the cost of each of these approaches. 
 
Our study is consistent with, and adds to, individual level evidence supporting the potential 
of TB-specific cash transfers to prevent catastrophic costs for poor TB-affected households 
in Peru [15]. Whilst our study questions the ability of TB-sensitive cash transfers to prevent 
households from engaging in damaging coping strategies, it supports individual evidence 
from Latin America for their ability to improve households’ coping capacity in response to 
severe livelihood risks [21]. By focussing on preventing catastrophic costs in low- and 
middle-income countries, it adds another dimension to the 2015 Cochrane review of the 
use of cash transfers in TB control, which did not find evidence on this outcome and mostly 
examined the use of cash transfers in the United States [69]. For future research, the 
validity of our results should be tested using individual-level primary data from future TB-
related cost surveys, secondary data that includes information on households’ TB 
exposure, income and social protection status [70], and/or experimental data from 
interventions like the ongoing CRESIPT trial in Peru [25,26]. This work should also look to 
explore the effect of TB-specific and TB-sensitive cash transfers on other proxy measures of 
catastrophic costs like household dissaving (e.g., taking out a loan and/or selling household 
items) [15,16]. For a more complete understanding of the impact of providing cash 
transfers with a TB-specific versus a TB-sensitive approach, future research should also aim 
to incorporate this study’s data into an epidemiological model that accounts for their 
respective effects on TB-related catastrophic costs, and the additional effects of a TB-
sensitive approach on individuals’ risk of TB infection and progression by addressing 
poverty-related risk factors (e.g., poor living conditions and undernutrition) [71,72]. 
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In addition to studying the potential of cash transfers to prevent TB-related catastrophic 
costs, future research should also prioritise investigating the effect of other forms of social 
protection on this outcome. For example, in Mexico [64], food assistance might effectively 
defray households’ high direct nonmedical food costs [73], and in Ghana [65], facilitating 
patients’ access to sickness benefits and their prompt reintegration into the labour market 
might help to avoid high indirect costs [74]. Obviously, social protection should not be 
implemented in isolation of other healthcare initiatives to reduce costs. Further research 
should also aim to evaluate the complementary effects of social protection and efforts to 
reduce out of pocket direct medical costs. For example, combining social protection with 
further investments to maximize ambulatory community-based care might be especially 
effective for preventing catastrophic costs in Ecuador, where patients incur high direct 
medical costs for hospitalisation [66,75,76]. Multidisciplinary research platforms like the 
Health and Social Protection Action Research & Knowledge Sharing (SPARKS) Network will 
be key for facilitating this sort of research [77]. 
 
Our analysis compares cash transfers provided with a TB-specific versus TB-sensitive 
approach. Interestingly, it has been proposed that one efficient and cost-effective strategy 
might be to integrate both TB-specific and TB-sensitive approaches into a so-called “TB-
inclusive” approach [24]. Results from our study demonstrating the greater potential of TB-
specific cash transfers to prevent catastrophic costs, and the existing coverage of TB-
sensitive cash transfer programmes, may support this integrated approach. For a TB-
inclusive approach, existing poverty-reduction programmes could be adapted to include an 
additional variable TB-specific benefit, which beneficiary households would be eligible to 
receive upon receipt of a confirmed TB diagnosis. To finance such an approach, 
stakeholders from across TB control, development, and finance sectors could coordinate to 
determine how much each would be willing to contribute given their separate objectives 
[78,79]. From a TB prevention perspective, such an investment would be expected to 
reduce delays for TB diagnosis [10], reduce the risk of adverse treatment outcomes [14], 
and thus potentially contribute to reduced national TB incidence [80]. From the 
perspective of social development, reduced national TB incidence would be expected to 
enable previously vulnerable households to invest more in human capital, increase their 
labour productivity, and thus contribute to long-term sustainable economic growth [81]. 
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Because households affected by human immunodeficiency virus (HIV), mental health 
issues, diabetes, and other noncommunicable diseases are also known to incur high direct 
and indirect costs [82,83], any efforts to prevent catastrophic costs for TB-affected 
households should aim to collaborate with these other areas of public health. Whichever 
approach for providing cash transfers to prevent TB-related catastrophic costs is chosen, it 
will be key to ensure that it is not implemented in isolation from universal health coverage 
initiatives including more decentralised and patient-friendly TB service delivery. Social 
protection initiatives and universal health coverage initiatives should be developed and 
implemented hand-in-hand [19]. 
 
Our finding that neither a TB-specific nor a TB-sensitive approach might be sufficient to 
prevent DR TB catastrophic costs highlights the urgent need for considerable investments 
in social protection and universal health coverage initiatives targeted to households 
affected by this disease. Globally, only 20% of people with DR TB are estimated to begin 
treatment, and only 52% of those that start treatment are estimated to successfully 
complete it [1]. Therefore, DR TB-affected households should constitute a “special case” 
for future investments to prevent catastrophic costs. 
 
Reviewing and analysing the literature on TB-related costs and poverty-reduction cash 
transfer programmes in low- and middle-income countries, our study compares the 
potential of cash transfers provided with a TB-specific versus a TB-sensitive approach to 
prevent catastrophic costs for poor TB-affected households. Our findings suggest that 
providing cash transfers with a TB-specific approach to defray TB-related costs of 
households with a confirmed TB diagnosis will be more effective and affordable for 
achieving this objective compared to a TB-sensitive approach that increases the income 
and strengthens the economic resilience of households at high risk of developing active TB 
disease. Our findings also highlight an urgent need for investments to prevent catastrophic 
costs for households having to confront the severe medical, social, and economic 
challenges caused by DR TB.  
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S2 Table. Summary of countries’ household-level TB-related cost burden before, and after 
cash transfers. The “Before cash transfers” column represents countries’ mean TB-related 
cost burden without cash transfer data. The “After TB-specific cash transfers” column 
represents countries’ mean TB-related cost burden after cash transfers have been 
subtracted from TB-related costs. The “After TB-sensitive cash transfers” column represents 
countries’ mean TB-related cost burden after cash transfers have been added to countries’ 
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countries’ actual poverty-reduction cash transfer programme budget. The “TB-specific 
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TB-specific versus a TB-sensitive approach. The “cash transfer budget, in millions” column 
represents the mean budget that countries would need to prevent catastrophic costs for 
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TB-sensitive approach. The “total cash transfer” column represents the total value that 
countries’ average TB-affected household would need to prevent catastrophic costs using a 
TB-specific versus a TB-sensitive approach. The “cash transfer budget, in millions” column 
represents the mean budget that countries’ would need to prevent catastrophic costs for 
their TB-specific versus TB-sensitive target populations. PPP, purchasing power parity; CI, 
confidence interval; DS, drug-susceptible; DR, drug-resistant; TB, tuberculosis. 
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Abstract S1. Accepted abstract for 48th Union World Conference on Lung Health. 
Title: During-treatment Catastrophic Costs for Drug-Resistant Tuberculosis Patients With 
and Without Social Protection; A Patient Survey in Rio de Janeiro, Brazil. 
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Background: Illness-related costs for tuberculosis (TB) patients ≥20% of annual household 
income predict adverse treatment outcomes so are termed catastrophic. Drug-resistant TB 
(DR-TB) patients experience especially high costs. In Brazil, two social protection policies, 
Auxílio-doença and Benefício de Prestação Continuada (BPC), might help to protect them 
from incurring catastrophic costs. We undertook a patient survey to estimate the proportion 
of DR-TB patients experiencing catastrophic costs during-treatment amongst those with and 
without income replacement from these policies. 
 
Methods: From June-October 2016, 120 DR-TB patients being accompanied at the Professor 
Helio Fraga reference centre in Rio de Janeiro were interviewed about household income 
and receipt of Auxílio-doença or BPC pre-/during-treatment, and direct and indirect costs 
incurred during-treatment. Direct costs were calculated from transport, food, private 
healthcare and non-prescribed remedy costs incurred during-treatment. Indirect costs were 
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calculated from reported lost income related to TB illness, net of income replacement from 
Auxílio-doença or BPC. We calculated patients’ cost burden as the sum of direct and indirect 
costs as a proportion of pre-treatment annual household income, and the proportion of 
patients experiencing catastrophic costs using a threshold cost burden ≥20%. Costs were 
reported in 2016 US$. 
 
Results: 41 (34%) and 3 (2%) DR-TB patients reported income replacement from Auxílio-
doença and BPC during-treatment respectively, with a mean value of US$5,966 (SD: 
US$1,883). For patients with and without income replacement, mean direct costs were 
US$774 (SD: US$394) versus US$722 (SD: US$325); and mean net indirect costs were 
US$3,564 (SD: US$7,578) versus US$4,353 (SD: US$5,782), respectively. In the two groups, 
the mean cost burden was 42% (SD: 40%) versus 527% (SD: 2,468%), and the proportion 
experiencing catastrophic costs was 50% (95%CI: 35%-65%) versus 75% (95%CI: 65%-85%), 
p=0.01, respectively. 
 
Conclusion: Social protection policies might prevent catastrophic costs for some DR-TB 
patients. Further investment is needed to prevent catastrophic costs for all DR-TB patients. 
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Full title: Towards zero TB-affected households facing catastrophic costs: the role of 
governmental cash transfer programmes. 
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Background: Financial costs incurred by Tuberculosis (TB) patients have previously been 
defined as catastrophic when they exceed 20% of an affected households’ annual income. 
The post-2015 END TB strategy endorses social protection policies, including cash transfer 
programmes, to eliminate all TB patients’ catastrophic costs by 2020. 
 
Methods: We used published data in nine selected countries to estimate the potential of 
governmental cash transfer programmes to mitigate TB patients’ catastrophic costs. 
Countries were eligible if they had a governmental family targeted cash transfer 
programme, published TB patient average cost data and had a recent household income and 
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expenditure survey. The potential of programmes to mitigate catastrophic costs was 
calculated as: the percentage point (%pt) difference in average TB patient costs as a 
percentage of countries’ average annual household income in the poorest quintile, before 
and after addition of the total value of cash transfers expected to be received by beneficiary 
households over one year. Where cash transfers did not reduce average TB patient costs to 
below 20% of average annual household income, we calculated the additional value of cash 
necessary to achieve this. For analysis, all monetary values were inflated and converted to 
2013 international dollars using purchasing power parity conversion factor. 
 
Results: Before addition of cash transfers, average TB patient costs were catastrophic in six 
out of nine selected countries. Across countries, the potential of cash transfers received 
over one year to mitigate TB patients’ catastrophic costs by adding to average annual 
household income varied widely (0.3%pt difference to 31%pt difference). After addition of 
cash transfers, average TB patient costs remained catastrophic in all six of the countries in 
which they were originally greater than 20% of average annual household income (22% to 
78%). In these countries the value of additional cash necessary to mitigate catastrophic 
costs ranged from $108 to $6200. 
 
Conclusions: While governmental cash transfer programmes might reduce the severity of TB 
patients’ catastrophic costs, additional innovations may be needed to confront the 
challenge of eliminating TB catastrophic costs by 2020.  
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Table S1. Review search terms. 
((((cash OR income) AND condition*) AND (benefit* OR transfer*)) AND ((income OR consump* 
OR expenditure* OR welfare OR idiosyncratic) AND (risk OR shock OR change OR fluctuation OR 
unemployment OR illness OR death)) AND (mitigat* OR manag* OR insur* OR smooth OR shar* 
OR protect* OR cope OR coping OR secur* OR compensat* OR remittance* OR loan* OR credit) 
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Table S2. Maryland Scientific Methods Scale (1). 
Maryland 
SMS 
level 
Criteria used to score SMS level 
1 
Either (a) a cross-sectional comparison of treated groups with untreated groups, or 
(b) a before-and-after comparison of treated group, without an untreated 
comparison group. No use of control variables in statistical analysis to adjust for 
differences between treated and untreated groups or periods. 
2 
Use of adequate control variables and either (a) a cross-sectional comparison of 
treated groups with untreated groups, or (b) a before-and-after comparison of 
treated group, without an untreated comparison group. In (a), control variables or 
matching techniques used to account for cross-sectional differences between 
treated and controls groups. In (b), control variables are used to account for before-
and-after changes in macro level factors. 
3 
Comparison of outcomes in treated group after an intervention, with outcomes in 
the treated group before the intervention, and a comparison group used to provide 
a counterfactual (e.g. difference in difference). Justification given to choice of 
comparator group that is argued to be similar to the treatment group. Evidence 
presented on comparability of treatment and control groups. Techniques such as 
regression and (propensity score matching may be used to adjust for difference 
between treated and untreated groups, but there are likely to be important 
unobserved differences remaining. 
4 
Quasi-randomness in treatment is exploited, so that it can be credibly held that 
treatment and control groups differ only in their exposure to the random allocation 
of treatment. This often entails the use of an instrument or discontinuity in 
treatment, the suitability of which should be adequately demonstrated and 
defended. 
5 
Reserved for research designs that involve explicit randomisation into treatment and 
control groups, with Randomised Control Trials (RCTs) providing the definitive 
example. Extensive evidence provided on comparability of treatment and control 
groups, showing no significant differences in terms of levels or trends. Control 
variables may be used to adjust for treatment and control group differences, but this 
adjustment should not have a large impact on the main results. Attention paid to 
problems of selective attrition from randomly assigned groups, which is shown to be 
of negligible importance. There should be limited or, ideally, no occurrence of 
‘contamination’ of the control group with the treatment. 
Abbreviations: SMS, Scientific Methods Scale.
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Table S3. Loss to follow up and missing data in the 2005 Avaliação do Impacto do Bolsa Família dataset. 
  
Overall 
n (%) 
n = 68,395 
LTFU Missing 
Yes 
n (%) 
n = 18,096 
OR (95% CIs) p-value 
Yes 
n (%) 
n = 7207 
OR (95% CIs) p-value 
Household characteristics               
Region       <0.001     <0.001 
  Central Western 8255 (12) 3348 (19) 1.0   855 (12) 1.0   
  North 12,483 (18) 1802 (10) 0.3 (0.2 to 0.3)   1003 (14) 0.8 (0.7 to 0.8)   
  Northeast 22,579 (33) 4682 (26) 0.4 (0.4 to 0.4)   3206 (44) 1.4 (1.3 to 1.6)   
  South 4024 (6) 1288 (7) 0.7 (0.6 to 0.8)   400 (6) 1 (0.8 to 1.1)   
  Southeast 21,054 (31) 6976 (39) 0.7 (0.7 to 0.8)   1743 (24) 0.8 (0.7 to 0.9)   
Location       0.98     <0.001 
  Rural 12,848 (19) 3395 (19) 1.0   2397 (33) 1.0   
  Urban 54,033 (79) 14,282 (79) 1 (1 to 1.1)   3296 (46) 0.3 (0.3 to 0.3)   
  Missing 1514 (2) 419 (2)     1514 (21)     
Situation       <0.001     <0.001 
  Condominium 13,118 (19) 3388 (19) 1.0   1316 (18) 1.0   
  Informal settlement 4299 (6) 1316 (7) 1.3 (1.2 to 1.4)   327 (5) 0.7 (0.7 to 0.8)   
  Tenement 7172 (10) 1907 (11) 1 (1 to 1.1)   686 (10) 1 (0.9 to 1)   
  Detached 43,806 (64) 11,485 (63) 1 (1 to 1.1)   4878 (68) 1.1 (1.1 to 1.2)   
Piped water       <0.001     <0.001 
  Yes 55,461 (81) 15,390 (85) 1.0   5190 (72) 1.0   
  No 12,934 (19) 2706 (15) 0.7 (0.7 to 0.7)   2017 (28) 1.8 (1.7 to 1.9)   
BPC elder       <0.001     <0.001 
  Yes 490 (1) 96 (1) 1.0   113 (2) 1.0   
  No 67,877 (99) 17,997 (99) 1.5 (1.2 to 1.9)   7066 (98) 0.4 (0.3 to 0.5)   
  Missing 28 (0) 3 (0)     28 (0)     
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BPC disabilty       <0.001     0.31 
  Yes 549 (1) 107 (1) 1.0   65 (1) 1.0   
  No 67,818 (99) 17,986 (99) 1.5 (1.2 to 1.9)   7114 (99) 0.9 (0.7 to 1.1)   
  Missing 28 (0) 3 (0)     28 (0)     
Bolsa Alimentação       0.63     0.13 
  Yes 745 (1) 203 (1) 1.0   91 (1) 1.0   
  No 67,622 (99) 17,890 (99) 1 (0.8 to 1.1)   7088 (98) 0.8 (0.7 to 1.1)   
  Missing 28 (0) 3 (0)     28 (0)     
Programa Cartao Alimentação       0.32     0.26 
  Yes 242 (0) 71 (0) 1.0   31 (0) 1.0   
  No 68,125 (100) 18,022 (100) 0.9 (0.7 to 1.2)   7148 (99) 0.8 (0.6 to 1.2)   
  Missing 28 (0) 3 (0)     28 (0)     
Bolsa Escola       <0.001     0.002 
  Yes 13,031 (19) 3162 (17) 1.0   1272 (18) 1.0   
  No 55,336 (81) 14,931 (83) 1.2 (1.1 to 1.2)   5907 (82) 1.1 (1 to 1.2)   
  Missing 28 (0) 3 (0)     28 (0)     
Vale Gas       <0.001     <0.001 
  Yes 8707 (13) 2005 (11) 1.0   1053 (15) 1.0   
  No 59660 (87) 16,088 (89) 1.2 (1.2 to 1.3)   6126 (85) 0.8 (0.8 to 0.9)   
  Missing 28 (0) 3 (0)     28 (0)     
PETI       0.007     0.001 
  Yes 668 (1) 147 (1) 1.0   99 (1) 1.0   
  No 67,699 (99) 17,946 (99) 1.3 (1.1 to 1.5)   7080 (98) 0.7 (0.5 to 0.8)   
  Missing 28 (0) 3 (0)     28 (0)     
Programa Bolsa Família       <0.001     <0.001 
  Yes 22,638 (33) 5390 (30) 1.0   1985 (28) 1.0   
  No 45,729 (67) 12,703 (70) 1.2 (1.2 to 1.3)   5194 (72) 1.3 (1.3 to 1.4)   
  Missing 28 (0) 3 (0)     28 (0)     
Monthly food consumption; 
US$ 
      <0.001     <0.001 
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  0 to 40 5265 (8) 1750 (10) 1.0   510 (7) 1.0   
  41 to 80 17,819 (26) 4890 (27) 0.8 (0.7 to 0.8)   1636 (23) 0.9 (0.9 to 1.1)   
  81 to 120 18,018 (26) 4639 (26) 0.7 (0.7 to 0.7)   1598 (22) 0.9 (0.8 to 1)   
  121 to 160 11,636 (17) 2777 (15) 0.6 (0.6 to 0.7)   1195 (17) 1.1 (1 to 1.2)   
  161+ 15,209 (22) 3914 (22) 0.7 (0.7 to 0.7)   1820 (25) 1.3 (1.1 to 1.4)   
  Missing 448 (1) 126 (1)     448 (6)     
Individual characteristics               
Household position       <0.001     <0.001 
  Responsible 15,426 (23) 4285 (24) 1.0   2359 (33) 1.0   
  Other 52,969 (77) 13,811 (76) 0.9 (0.9 to 1)   4848 (67) 0.6 (0.5 to 0.6)   
Sex       0.55     <0.001 
  Male 33,098 (48) 8723 (48) 1.0   4116 (57) 1.0   
  Female 35,297 (52) 9373 (52) 1 (1 to 1.1)   3091 (43) 0.7 (0.6 to 0.7)   
Age, years       0.01     <0.001 
  0 to 16 27,380 (40) 7408 (41) 1.0   1347 (19)     
  16 to 34 21,085 (31) 5561 (31) 1 (0.9 to 1)   2907 (40) 3.1   
  35 to 54 14,521 (21) 3749 (21) 0.9 (0.9 to 1)   2224 (31) 3.5 (3.3 to 3.8)   
  55+ 5409 (8) 1378 (8) 0.9 (0.9 to 1)   729 (10) 3 (2.7 to 3.3)   
Ethnicity       <0.001     0.08 
  White 22,561 (33) 6992 (39) 1.0   2179 (30) 1.0   
  Black 6799 (10) 1671 (9) 0.7 (0.7 to 0.8)   699 (10) 1.1 (1 to 1.2)   
  Mixed 37,835 (55) 9127 (50) 0.7 (0.7 to 0.7)   3743 (52) 1 (1 to 1.1)   
  Oriental 506 (1) 148 (1) 0.9 (0.8 to 1.1)   67 (1) 1.4 (1.1 to 1.8)   
  Indigenous 194 (0) 52 (0) 0.8 (0.6 to 1.1)   19 (0) 1 (0.6 to 1.6)   
  Missing 500 (1) 106 (1)     500 (7) 0 (0 to 0)   
Literacy       0.15     <0.001 
  Yes 50,174 (73) 13,348 (74) 1.0   5586 (78) 1.0   
  No 18,221 (27) 4748 (26) 1 (0.9 to 1)   1621 (22) 0.8 (0.7 to 0.8)   
Pregnant       0.14     0.03 
225 
  Yes 593 (1) 173 (1) 1.0   47 (1) 1.0   
  No 67,781 (99) 17,920 (99) 0.9 (0.7 to 1)   7139 (99) 1.4 (1 to 1.9)   
  Missing 21 (0) 3 (0)     21 (0)     
Self-rated health       <0.001     <0.001 
  Very good 9578 (14) 2906 (16) 1.0   857 (12) 1.0   
  Good 38,991 (57) 10,224 (56) 0.8 (0.8 to 0.9)   3915 (54) 1.1 (1.1 to 1.2)   
  Regular 16,181 (24) 4061 (22) 0.8 (0.7 to 0.8)   1962 (27) 1.4 (1.3 to 1.5)   
  Bad 2796 (4) 718 (4) 0.8 (0.7 to 0.9)   362 (5) 1.5 (1.3 to 1.7)   
  Very bad 604 (1) 139 (1) 0.7 (0.6 to 0.8)   65 (1) 1.2 (0.9 to 1.6)   
  Don't know 238 (0) 47 (0) 0.6 (0.4 to 0.8)   39 (1) 2 (1.4 to 2.8)   
  Missing 7 (0) 1 (0)     7 (0)     
Chronic health condition       0.003     0.22 
  Yes 13,284 (19) 3653 (20) 1.0   1361 (19) 1.0   
  No 55,111 (81) 14,443 (80) 0.9 (0.9 to 1)   5846 (81) 1 (1 to 1.1)   
Work       0.92     <0.001 
  Yes 22,325 (33) 5888 (33) 1.0   5503 (76) 1.0   
  No 11792 (17) 3134 (17) 1 (1 to 1.1)   502 (7) 0.1 (0.1 to 0.2)   
  Never 34,266 (50) 9068 (50) 1 (1 to 1)   1190 (17) 0.1 (0.1 to 0.1)   
  Missing 12 (0) 6 (0)     12 (0)     
Work branch       <0.001     <0.001 
  Agriculture 5613 (8) 1234 (7) 1.0   2637 (37) 1.0   
  Industry 1215 (2) 358 (2) 1.5 (1.3 to 1.7)   163 (2) 0.2 (0.2 to 0.2)   
  Civil construction 1706 (2) 464 (3) 1.3 (1.2 to 1.5)   215 (3) 0.2 (0.1 to 0.2)   
  Trade 2955 (4) 859 (5) 1.5 (1.3 to 1.6)   590 (8) 0.3 (0.3 to 0.3)   
  Transport 726 (1) 206 (1) 1.4 (1.2 to 1.7)   128 (2) 0.2 (0.2 to 0.3)   
  Other services 8568 (13) 2411 (13) 1.4 (1.3 to 1.5)   1340 (19) 0.2 (0.2 to 0.2)   
  Public administration 1258 (2) 283 (2) 1 (0.9 to 1.2)   146 (2) 0.2 (0.1 to 0.2)   
  Unemployed 46,070 (67) 12,208 (67) 1.3 (1.2 to 1.4)   1704 (24) 0 (0 to 0.1)   
.  Missing 284 (0) 73 (0)     284 (4)     
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Work hours; hours       <0.001     <0.001 
.  0 46,058 (67) 12,202 (67) 1.0   1692 (23) 1.0   
  1 to 24 4107 (6) 924 (5) 0.8 (0.8 to 0.9)   1136 (16) 10 (9.2 to 10.9)   
  25 to 48 13,393 (20) 3607 (20) 1 (1 to 1.1)   2546 (35) 6.2 (5.8 to 6.6)   
  48+ 3639 (5) 1031 (6) 1.1 (1 to 1.2)   635 (9) 5.5 (5 to 6.1)   
  Missing 1198 (2) 332 (2)     1198 (17)     
Work salary; US$       <0.001     <0.001 
.  0 46,058 (67) 12,202 (67) 1.0   1692 (23) 1.0   
.  1 to 59 3758 (5) 869 (5) 0.8 (0.8 to 0.9)   385 (5) 3 (2.7 to 3.4)   
.  60 to 118 4015 (6) 955 (5) 0.9 (0.8 to 0.9)   391 (5) 2.8 (2.5 to 3.2)   
.  119 to 236 8972 (13) 2522 (14) 1.1 (1 to 1.1)   996 (14) 3.3 (3 to 3.6)   
.  237+  2088 (3) 778 (4) 1.7 (1.5 to 1.8)   239 (3) 3.4 (2.9 to 3.9)   
.  Missing 3504 (5) 770 (4)     3504 (49)     
Social insurance       <0.001     <0.001 
  Yes 6897 (10) 2068 (11) 1.0   921 (13) 1.0   
  No 60,897 (89) 15,855 (88) 0.8 (0.8 to 0.9)   5685 (79) 0.7 (0.6 to 0.7)   
.  Missing 601 (1) 173 (1)     601 (8)     
Abbreviations: LTFU, Loss to follow up; OR, Odds ratio; CIs, Confidence intervals; BPC, Benficio de Prestação Continuada; PETI, Programa de Erradicação do 
Trabalho Infantil; US$, United States dollar. In 2005 R$ 1 = US$ 0.4. 
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Table S4. Missing data in the 2009 Avaliação do Impacto do Bolsa Família dataset. 
  
Overall 
n (%) 
n = 47,010 
Missing 
Yes 
n (%) 
n = 21,965 
OR (95% CIs) p-value 
Household characteristics         
Region       <0.001 
  Central Western 4736 (10) 2564 (12) 1.0   
  North 9791 (21) 4500 (20) 0.7 (0.7 to 0.8)   
  Northeast 16,597 (35) 6958 (32) 0.6 (0.6 to 0.7)   
  South 2587 (6) 1495 (7) 1.2 (1.1 to 1.3)   
  Southeast 13,299 (28) 6448 (29) 0.8 (0.8 to 0.9)   
Location       0.24 
  Rural 8887 (19) 4100 (19) 1.0   
  Urban 37,132 (79) 16,874 (77) 1 (0.9 to 1)   
  Missing 991 (2) 991 (5)     
Situation       <0.001 
  Condominium 14,121 (30) 6593 (30) 1.0   
  Informal settlement 3296 (7) 1399 (6) 0.8 (0.8 to 0.9)   
  Tenement 12,363 (26) 5724 (26) 1 (0.9 to 1)   
  Detached 17,217 (37) 8236 (37) 1.1 (1 to 1.1)   
  Missing 13 (0) 13 (0)     
Piped water       0.66 
  Yes 39,508 (84) 18,370 (84) 1.0   
  No 7341 (16) 3434 (16) 1 (1 to 1.1)   
  Missing 161 (0) 161 (1)     
BPC elder       0.65 
  Yes 389 (1) 176 (1) 1.0   
  No 46,330 (99) 21,498 (98) 1.1 (0.9 to 1.3)   
  Missing 291 (1) 291 (1)     
BPC disabilty       0.35 
  Yes 436 (1) 212 (1) 1.0   
  No 46,285 (98) 21,464 (98) 0.9 (0.8 to 1.1)   
  Missing 289 (1) 289 (1)     
Bolsa Alimentação       0.08 
  Yes 454 (1) 190 (1) 1.0   
  No 45,803 (97) 21,022 (96) 1.2 (1 to 1.4)   
  Missing 753 (2) 753 (3)     
Programa Cartao Alimentação       0.66 
  Yes 28 (0) 14 (0) 1.0   
  No 46,230 (98) 21,199 (97) 0.9 (0.4 to 1.8)   
  Missing 752 (2) 752 (3)     
Bolsa Escola       <0.001 
  Yes 1412 (3) 739 (3) 1.0   
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  No 44,788 (95) 20,416 (93) 0.8 (0.7 to 0.9)   
  Missing 810 (2) 810 (4)     
Vale Gas       0.002 
  Yes 290 (1) 159 (1) 1.0   
  No 45,868 (98) 20,954 (95) 0.7 (0.6 to 0.9)   
  Missing 852 (2) 852 (4)     
PETI       0.22 
  Yes 404 (1) 175 (1) 1.0   
  No 46,284 (98) 21,468 (98) 1.1 (0.9 to 1.4)   
  Missing 322 (1) 322 (1)     
Programa Bolsa Família       <0.001 
  Yes 24,306 (52) 11,103 (51) 1.0   
  No 22,704 (48) 10,862 (49) 1.1 (1.1 to 1.1)   
Monthly food consumption; US$       <0.001 
  0 to 40 3555 (8) 1437 (7) 1.0   
  41 to 80 6025 (13) 2320 (11) 0.9 (0.9 to 1)   
  81 to 120 6692 (14) 2447 (11) 0.9 (0.8 to 0.9)   
  121 to 160 6443 (14) 2360 (11) 0.9 (0.8 to 0.9)   
  161+ 17,950 (38) 7056 (32) 1 (0.9 to 1)   
  Missing 6345 (13) 6345 (29)     
Husband ill       <0.001 
  Yes 1887 (4) 965 (4) 1.0   
  No 44,771 (95) 20,648 (94) 0.8 (0.8 to 0.9)   
  Missing 352 (1) 352 (2)     
Wife ill       <0.001 
  Yes 1311 (3) 670 (3) 1.0   
  No 45,297 (96) 20,893 (95) 0.8 (0.7 to 0.9)   
  Missing 402 (1) 402 (2)     
Other member ill       0.001 
  Yes 3729 (8) 1830 (8) 1.0   
  No 42,979 (91) 19,833 (90) 1 (1 to 1.1)   
  Missing 302 (1) 302 (1)     
Individual characteristics         
Household position       <0.001 
  Household responsible 10,801 (23) 5532 (25) 1.0   
  Other 35,645 (76) 15,869 (72) 0.8 (0.7 to 0.8)   
  Missing 564 (1) 564 (3)     
Sex       <0.001 
  Male 22,565 (48) 10,902 (50) 1.0   
  Female 24,427 (52) 11,045 (50) 0.9 (0.9 to 0.9)   
  Missing 18 (0) 18 (0)     
Age, years       <0.001 
  0 to 16 15,639 (33) 6237 (28) 1.0   
  16 to 34 14,905 (32) 7213 (33) 1.4 (1.4 to 1.5)   
  35 to 54 11,378 (24) 5936 (27) 1.6 (1.6 to 1.7)   
  55+ 4899 (10) 2390 (11) 1.4 (1.4 to 1.5)   
229 
  Missing 189 (0) 189 (1)     
Ethnicity       <0.001 
  White 13,984 (30) 6404 (29) 1.0   
  Black 5213 (11) 2378 (11) 1 (0.9 to 1.1)   
  Mixed 25,593 (54) 11,190 (51) 0.9 (0.9 to 1)   
  Oriental 250 (1) 131 (1) 1.3 (1 to 1.7)   
  Indigenous 170 (0) 62 (0) 0.7   
  Missing 1800 (4) 1800 (8)     
Literacy       <0.001 
  Yes 37,308 (79) 17,251 (79) 1.0   
  No 8820 (19) 3832 (17) 0.9 (0.9 to 0.9)   
  Missing 882 (2) 882 (4)     
Pregnant       0.97 
  Yes 282 (1) 127 (1) 1.0   
  No 45,192 (96) 20,302 (92) 1 (0.8 to 1.3)   
  Missing 1536 (3) 1536 (7)     
Health state       <0.001 
  Very good 6669 (14) 2811 (13) 1.0   
  Good 27,950 (59) 13,011 (59) 1.2 (1.1 to 1.3)   
  Regular 9306 (20) 4339 (20) 1.2 (1.1 to 1.3)   
  Bad 1967 (4) 975 (4) 1.4 (1.2 to 1.5)   
  Very bad 492 (1) 228 (1) 1.2 (1 to 1.4)   
  Don't know 63 (0) 38 (0) 2.1 (1.3 to 3.5)   
  Missing 563 (1) 563 (3)     
Chronic health condition       0.08 
  Yes 7184 (15) 3204 (15) 1.0   
  No 38,818 (83) 17,753 (81) 1.1 (1 to 1.1)   
  Missing 1008 (2) 1008 (5)     
Work       <0.001 
  Yes 16,313 (35) 9976 (45) 1.0   
  No 6945 (15) 2595 (12) 0.4 (0.4 to 0.4)   
  Never 22,583 (48) 8225 (37) 0.4 (0.4 to 0.4)   
  Missing 1169 (2) 1169 (5)     
Work branch       <0.001 
  Agriculture 3446 (7) 2307 (11) 1.0   
  Industry 860 (2) 457 (2) 0.6 (0.5 to 0.7)   
  Civil construction 981 (2) 535 (2) 0.6 (0.5 to 0.7)   
  Trade 2082 (4) 1101 (5) 0.6 (0.5 to 0.6)   
  Transport 412 (1) 229 (1) 0.6 (0.5 to 0.8)   
  Other services 6185 (13) 3394 (15) 0.6 (0.6 to 0.7)   
  Public administration 744 (2) 350 (2) 0.4 (0.4 to 0.5)   
  Unemployed 29,528 (63) 10,820 (49) 0.3 (0.3 to 0.3)   
  Missing 2772 (6) 2772 (13)     
Work hours; hours       <0.001 
  0 29,528 (63) 10,820 (49) 1.0   
  1 to 24 2770 (6) 1451 (7) 1.9 (1.8 to 2.1)   
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  25 to 48 7939 (17) 4114 (19) 1.9 (1.8 to 2)   
  48+ 2496 (5) 1303 (6) 1.9 (1.7 to 2.1)   
  Missing 4277 (9) 4277 (19)     
Work salary; US$       <0.001 
  0 29,528 (63) 10,820 (49) 1.0   
  1 to 59 670 (1) 242 (1) 1 (0.8 to 1.2)   
  60 to 118 807 (2) 310 (1) 1.1 (0.9 to 1.2)   
  119 to 236 1587 (3) 608 (3) 1.1 (1 to 1.2)   
  237+  7645 (16) 3212 (15) 1.3 (1.2 to 1.3)   
  Missing 6773 (14) 6773 (31)     
Social insurance       <0.001 
  Yes 5377 (11) 2811 (13) 1.0   
  No 38,745 (82) 16,266 (74) 0.7 (0.6 to 0.7)   
  Missing 2888 (6) 2888 (13)     
Abbreviations: LTFU, Loss to follow up; OR, Odds ratio; CIs, Confidence intervals; BPC, Benficio de 
Prestação Continuada; PETI, Programa de Erradicação do Trabalho Infantil; US$, United States dollar. 
All monetary values are deflated to 2005 constant values. In 2005 R$ 1 = US$ 0.4.
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Table S5. Complete case analysis of severe illness and household per capita weekly labour hours, monthly labour income, and monthly food 
consumption. 
  
Unexposed 
n (%) 
n = 5034 
Exposed 
n (%) 
n = 638 
Difference in Difference 
(95% CIs) 
p-value 
Weekly labour hours PC, hours         
  2005 8.6 (8.3 to 8.9) 8.8 (8 to 9.6) -0.5 (-1.4 to 0.5) 0.31 
  2009 8.4 (8.1 to 8.7) 8.2 (7.5 to 8.9)     
Monthly labour income PC, US$         
  2005 26.7 (25.8 to 27.6) 26.3 (23.9 to 28.6) -0.5 (-4.2 to 3.1) 0.77 
  2009 30.1 (29.1 to 31.1) 29.1 (26.7 to 31.6)     
Monthly food consumption PC, US$       0.98 
  2005 26.8 (25.7 to 27.8) 28 (25.1 to 30.9) 0.1 (-4.3 to 4.4)   
  2009 44 (43 to 45.1) 45.3 (42.4 to 48.2)     
Abbreviations: CIs, Confidence intervals; PC, Per capita; US$, United States dollar. Selected marginal effects are reported. Data is not weighted using attrition 
weights. All values are mutually adjusted for household region of residence, location of residence, number of household members aged 0 to 6 years, number 
of household members aged 7 to 15, % of family members working and contributing to social insurance, total income per capita (net of social assistance), and 
receipt of Programa Bolsa Família or one of its predecessors: Bolsa Escola, Bolsa Alimentação, Cartao Alimentação, or Programa de Erradicação do Trabalho 
Infantil all at baseline; household responsible sex, age category, age squared, ethnicity, literacy, and self-rated health all at baseline; and, household exposure 
to drought or flooding, loss of crops or livestock, or death between 2005 and 2009. All monetary values are deflated to 2005 constant values. In 2005 R$ 1 = 
US$ 0.4.
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Table S6. Complete case analysis of severe illness and household per capita weekly labour hours, monthly labour income, and monthly food consumption, by 
receipt of conditional cash transfer at study baseline. 
  
Unexposed 
n (%) 
n = 5034 
Exposed 
n (%) 
n = 638 
Difference in difference 
(95% CIs) 
Difference in effect of severe 
illness by receipt of CCTs 
(95% CIs) 
Weekly labour hours PC, hours         
 No receipt of CCTs         
   2005 9 (8.6 to 9.3) 9 (8 to 10.1) -1 (-2.5 to 0.5) 1.8 (-1.2 to 4.8) 
   2009 8.6 (8.2 to 8.9) 7.6 (6.7 to 8.6)     
 Receipt of CCTs         
   2005 8.5 (7.8 to 9.2) 8.1 (6.4 to 9.8) 0.8 (-1.8 to 3.5)   
   2009 8.6 (8 to 9.3) 9 (7.2 to 10.8)     
Monthly labour income PC, US$         
 No receipt of CCTs         
   2005 27.6 (26.5 to 28.6) 26 (23.3 to 28.8) -2.4 (-6.6 to 1.7) 5.3 (-3.8 to 14.5) 
   2009 30.8 (29.7 to 32) 26.9 (24.1 to 29.7)     
 Receipt of CCTs         
   2005 25.4 (23.5 to 27.2) 25.3 (20.5 to 30.1) 2.9 (-5.3 to 11.1)   
   2009 31.3 (29.2 to 33.4) 34.2 (28.1 to 40.3)     
Monthly food consumption PC, US$         
 No receipt of CCTs         
   2005 27.1 (25.9 to 28.3) 28.7 (25.3 to 32) -1.2 (-6.2 to 3.7) 5 (-5.2 to 15.1) 
   2009 44.2 (43 to 45.4) 44.6 (41.2 to 48)     
 Receipt of CCTs         
   2005 26.2 (23.9 to 28.5) 23.4 (17.5 to 29.3) 3.8 (-5.1 to 12.6)   
   2009 43.6 (41.3 to 45.8) 44.5 (38.7 to 50.3)     
Abbreviations: CCT, Conditional Cash transfer; PC, Per capita; US$, United States dollar. Selected marginal effects are reported. Data is not weighted using attrition weights. 
All values are mutually adjusted for household region of residence, location of residence, number of household members aged 0 to 6 years, number of household members 
aged 7 to 15, % of family members working and contributing to social insurance, and total income per capita (net of social assistance) all at baseline; household responsible 
sex, age category, age squared, ethnicity, literacy, and self-rated health all at baseline; and, household exposure to drought or flooding, loss of crops or livestock, or death 
between 2005 and 2009. All monetary values are deflated to 2005 constant values. In 2005 R$ 1 = US$ 0.4. 
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Table S7. Severe illness reported to be worst in 2009 and household per capita weekly labour hours, monthly labour income, and monthly food 
consumption. 
  
Unexposed 
n (%) 
n = 12,042 
Exposed, 
n (%) 
n = 750 
Difference in Difference  
(95% CIs) 
Weekly labour hours PC, hours       
.  2005 9.5 (9.3 to 9.7) 9.2 (8.4 to 10) 1 (-0.1 to 2) 
.  2009 9.7 (9.4 to 9.9) 10.3 (9.4 to 11.3)   
Monthly labour income PC, US$       
.  2005 28 (27.3 to 28.7) 26.6 (24.1 to 29) 3 (-0.9 to 6.9) 
.  2009 33.4 (32.4 to 34.5) 35 (31.4 to 38.6)   
Monthly food consumption PC, US$       
.  2005 26 (25.6 to 26.5) 26.8 (24.9 to 28.7) 2.2 (-1.5 to 5.9) 
.  2009 42.3 (41.5 to 43) 45.2 (41.8 to 48.7)   
Abbreviations: CIs, Confidence intervals; PC, Per capita; US$, United States dollar. Selected marginal effects are reported. Data is weighted using attrition 
weights. Values are pooled across the five imputed datasets using Rubin’s rule. All values are mutually adjusted for household region of residence, location 
of residence, number of household members aged 0 to 6 years, number of household members aged 7 to 15, % of family members working and contributing 
to social insurance, total income per capita (net of social assistance), and receipt of Programa Bolsa Família or one of its predecessors: Bolsa Escola, Bolsa 
Alimentação, Cartao Alimentação, or Programa de Erradicação do Trabalho Infantil all at baseline; household responsible sex, age category, age squared, 
ethnicity, literacy, and self-rated health all at baseline; and, household exposure to drought or flooding, loss of crops or livestock, or death between 2005 and 
2009. All monetary values are deflated to 2005 constant values. In 2005 R$ 1 = US$ 0.4. 
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Table S8. Severe illness reported to be worst in 2009 and household per capita weekly labour hours, monthly labour income, and monthly food consumption, 
by receipt of conditional cash transfer at study baseline. 
  
Unexposed, n (%) 
n = 12,042 
Exposed, n (%) 
n = 750 
Difference in difference  
(95% CIs) 
Difference in effect of severe 
illness by receipt of CCTs (95% CIs) 
Weekly labour hours PC, hours         
No receipt of CCTs         
.   2005 10.2 (9.9 to 10.5) 9.3 (8 to 10.6) 0.9 (-0.9 to 2.7) 0.8 (-1.7 to 3.2) 
.   2009 10.4 (10 to 10.8) 10.9 (8.8 to 12.1)     
Receipt of CCTs         
.   2005 9.1 (8.8 to 9.3) 8.5 (7.5 to 9.5) 1.7 (0 to 3.4)   
.   2009 9.8 (9.5 to 10.2) 10.9 (9.5 to 12.3)     
Monthly labour income PC, US$         
No receipt of CCTs         
.   2005 32 (31.1 to 33) 28.9 (25.5 to 32.3) 0.6 (-5.5 to 6.7) 4.7 (-3.7 to 13) 
.   2009 37 (35.5 to 38.6) 34.5 (28.6 to 40.4)     
Receipt of CCTs         
.   2005 25.3 (24.7 to 26) 24.8 (22 to 27.7) 5.3 (-0.5 to 11)   
.   2009 32.6 (31.3 to 33.8) 37.4 (32.6 to 42.2)     
Monthly food consumption PC, US$         
No receipt of CCTs         
.   2005 27.9 (27.3 to 28.6) 28.8 (25.7 to 32) 2.9 (-2.5 to 8.4) -1.2 (-8.8 to 6.3) 
.   2009 45.4 (44.1 to 46.6) 49.2 (44.3 to 54.2)     
Receipt of CCTs         
.   2005 24.7 (24.1 to 25.2) 25.2 (23 to 27.4) 1.7 (-3.5 to 6.9)   
.   2009 39.7 (38.7 to 40.7) 42 (37.2 to 46.8)     
Abbreviations: CCT, Conditional Cash transfer; PC, Per capita; US$, United States dollar. Selected marginal effects are reported. Data is weighted using attrition weights. Values 
are pooled across the five imputed datasets using Rubin’s rule. All values are mutually adjusted for household region of residence, location of residence, number of household 
members aged 0 to 6 years, number of household members aged 7 to 15, % of family members working and contributing to social insurance, and total income per capita (net 
of social assistance) all at baseline; household responsible sex, age category, age squared, ethnicity, literacy, and self-rated health all at baseline; and, household exposure to 
drought or flooding, loss of crops or livestock, or death between 2005 and 2009. All monetary values are deflated to 2005 constant values. In 2005 R$ 1 = US$ 0.4.
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Figure S1. Sample distribution of total DR TB-related costs. 
 
Abbreviations: US$, United States dollar. n = 119.
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Table S9. Summary of univariable association of pre-illness demographic and socioeconomic characteristics, and DR TB clinical characteristics 
with financial hardship. 
  
Total costs ≥20% of 
household income*† 
Used coping strategy‡ Impoverishment§¶ 
All three financial 
hardships# 
OR (95% CIs) p-value OR (95% CIs) p-value OR (95% CIs) p-value OR (95% CIs) p-value 
Demographic                 
Sex                 
  Female 1 0.80 1 0.88 1 0.06 1 0.20 
  Male 0.9 (0.36-2.11)   0.94 (0.43-2.04)   0.43 (0.18-1.04)   0.53 (0.20-1.42)   
Age                 
  Mean (SD) 1.02 (0.99-1.04) 0.29 1.00 (0.97-1.02) 0.76 1.00 (0.97-1.03) 0.99 0.99 (0.96-1.02) 0.52 
Ethnicity                 
  White 1 0.41 1 0.27 1 0.13 1 0.29 
  Brown 1.91 (0.65-5.76)   1.94 (0.77-5.03)   1.15 (0.37-4.04)   1.67 (0.45-8.08)   
  Black/Indigenous 1.83 (0.69-4.86)   2.18 (0.79-6.21)   2.72 (0.68-9.72)   2.88 (0.76-14.2)   
Socioeconomic                 
Elementary education                 
  Incomplete 1 0.07 1 0.16 1 0.05 1 0.15 
  Completed 0.47 (0.20-1.08)   0.57 (0.25-1.25)   0.36 (0.11-0.98)   0.44 (0.12-1.31)   
Household head                 
  No 1 0.77 1 0.02 1 0.16 1 0.02 
  Yes 1.12 (0.51-2.49)   2.42 (1.16-5.15)   1.86 (0.79-4.59)   3.34 (1.2-10.91)   
Household income per capita 
(US$)** 
            
  
  
  <126 1 0.51 1 0.006 1 0.002 1 0.001 
  126 to 251 0.81 (0.29-2.2)   0.40 (0.14-1.08)   0.15 (0.05-0.47)   0.13 (0.03-0.44)   
  >251 1.39 (0.48-3.95)   0.21 (0.07-0.55)   0.23 (0.08-0.65)   0.16 (0.04-0.51)   
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Received social protection                 
  Yes 1 0.88 1 0.88 1 0.27 1 0.73 
  No 1.08 (0.35-3.03)   1.08 (0.40-2.91)   2.01 (0.61-9.15)   1.26 (0.37-5.84)   
Clinical                 
Aquired DR TB                 
  No 1 0.001 0.86 0.01 1 0.96 1 0.086 
  Yes 4.13 (1.81-9.95)   2.57 (1.23-5.50)   1.45 (0.62-3.53)   2.39 (0.89-7.21)   
Type of DR TB                 
  Suspected/ Mono-/ Poly- 1 0.53 1 0.98 1 0.39 1 0.79 
  Multi-/ Extensively 1.32 (0.55-3.05)   1.01 (0.46-2.21)   0.98 (0.4-2.52)   1.15 (0.42-3.5)   
Cavitary DR TB                 
  No 1 0.18 1 0.27 1 0.96 1 0.75 
  Yes 1.91 (0.74-4.85)   0.60 (0.23-1.47)   1.03 (0.38-3.12)   0.83 (0.28-2.8)   
Time to DOT clinic (hours)                 
  Mean (SD) 2.36 (1.18-5.17) 0.01 2.23 (1.22-4.29) 0.009 1.68 (0.88-3.21) 0.12 1.91 (0.94-3.94) 0.07 
Time to CRPHF (hours)                 
  Mean (SD) 1.03 (0.84-1.28) 0.75 1.09 (0.90-1.32) 0.40 1.13 (0.9-1.42) 0.29 1.12 (0.87-1.44) 0.38 
Month of treatment                 
  2-6 1 0.93 1 0.46 1 0.70 1 0.98 
  7-12 0.82 (0.28-2.31)   0.80 (0.31-2.03)   1.57 (0.52-5.13)   1.01 (0.29-3.77)   
  13+ 0.87 (0.30-2.41)   1.36 (0.54-3.47)   1.15 (0.38-3.76)   1.12 (0.34-4.02)   
Abbreviations: SD, standard deviation; DS, drug susceptible; TB, tuberculosis; DR, drug resistant; DOT, directly observed therapy; CRPHF, Professor Helio 
Fraga reference centre. *Refers to pre-illness annual household income. †Three participants with pre-illness annual household income US$ 0 were 
excluded, n=116, ‡One participant with missing data on use of coping strategies was excluded, n=118, §Four participants in poverty pre-illness were 
excluded, n=115, ¶Defined using Brazil’s 2016 national poverty line of US$ 1.34, #Five participants with either pre-illness annual household income US$ 0, 
missing data on use of coping strategies, or in poverty pre-illness were excluded, n=114,**Refers to pre-illness monthly household income per capita. 
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Table S10. Consolidated Health Economic Evaluation Reporting Standards checklist for study comparing two cash transfer strategies to prevent 
catastrophic costs for poor tuberculosis affected households in low- and middle-income countries (2). 
Section/item 
Item 
No 
 Recommendation Quoted text addressing recommendation 
Title and abstract    
Title  1 
Identify the study as an 
economic evaluation or use 
more specific terms such as 
“cost-effectiveness 
analysis”, and describe the 
interventions compared. 
Title: "Comparison of two cash transfer strategies to prevent catastrophic costs for poor 
tuberculosis-affected households in low- and middle-income countries: An economic 
modelling study" 
Abstract  2 
Provide a structured 
summary of objectives, 
perspective, setting, 
methods (including study 
design and inputs), results 
(including base case and 
uncertainty analyses), and 
conclusions. 
Abstract: "Background. Illness-related costs for patients with tuberculosis (TB) ≥20% of pre-
illness annual household income predict adverse treatment outcomes and have been termed 
“catastrophic”. Social protection initiatives, including cash transfers, are endorsed to help 
prevent catastrophic costs. With this aim, cash transfers may either be provided to defray TB-
related costs of households with a confirmed TB diagnosis (termed a “TB-specific” approach); 
or to increase income of households with high TB risk to strengthen their economic resilience 
(termed a “TB-sensitive” approach). The impact of cash transfers provided with each of these 
approaches might vary. We undertook an economic modelling study from the patient 
perspective to compare the potential of these two cash transfer approaches to prevent 
catastrophic costs. 
Methods and Findings. Inputs in the seven low- and middle-income countries Brazil, 
Colombia, Ecuador, Ghana, Mexico, Tanzania and Yemen were retrieved by literature review, 
and included countries' mean patient TB-related costs, mean household income, mean cash 
transfers, and estimated TB-specific and TB-sensitive target populations. Analyses were 
completed for drug-susceptible (DS) TB-related costs in all 7/7 countries, and additionally for 
drug-resistant (DR) TB-related costs in the 1/7 countries with available data. All cost data 
were reported in 2013 international dollars ($). The target population for TB-specific cash 
transfers was poor households with a confirmed TB diagnosis, and for TB-sensitive cash 
transfers was poor households already targeted by countries’ established poverty-reduction 
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cash transfer programme. Cash transfers offered in countries, unrelated to TB, ranged from 
$217 to $1,091/year/household. Before cash transfers, DS TB-related costs were catastrophic 
in 6/7 countries. If cash transfers were provided with a TB-specific approach, alone they 
would be insufficient to prevent DS TB catastrophic costs in 4/6 countries, and when 
increased enough to prevent DS TB catastrophic costs would require a budget between $4 
million (95%CI: $4-$4 million) and $50 million (95%CI: $41-$60 million) per country. If instead 
cash transfers were provided with a TB-sensitive approach, alone they would be insufficient to 
prevent DS TB-related catastrophic costs in any of the 6 countries, and when increased 
enough to prevent DS TB catastrophic costs would require a budget between $298 million 
(95%CI: $219-$378 million) and $165 billion (95%CI: $134-$196 billion) per country. DR TB-
related costs were catastrophic before and after TB-specific or TB-sensitive cash transfers in 
1/1 countries. Sensitivity analyses showed our findings to be robust to imputation of missing 
TB-related cost components, and use of 10% or 30% instead of 20% as the threshold for 
measuring catastrophic costs. Key limitations were using national average data, and not 
considering other health and social benefits of cash transfers. 
Conclusions. A TB-sensitive cash transfer approach to increase all poor households’ income 
may have broad benefits by reducing poverty, but is unlikely to be as effective or affordable 
for preventing TB catastrophic costs as a TB-specific cash transfer approach to defray TB-
related costs only in poor households with a confirmed TB diagnosis. Preventing DR TB-
related catastrophic costs will require considerable additional investment whether a TB-
sensitive or a TB-specific cash transfer approach is used" 
 
Introduction    
Background and 
objectives 
3 
Provide an explicit 
statement of the broader 
context for the study. 
Present the study question 
and its relevance for health 
policy or practice decisions. 
Introduction, paragraph 4: "Depending on whether cash transfers are provided with a TB-
specific or a TB-sensitive approach, their impact might vary. We aimed to investigate how this 
might relate to the potential of cash transfers provided with either a TB-specific approach or a 
TB-sensitive approach to prevent catastrophic costs." 
Methods    
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Target population 
and subgroups 
4 
Describe characteristics of 
the base case population 
and subgroups analysed, 
including why they were 
chosen.  
Methods, paragraph 4: "In this study, the target population for cash transfers provided with a 
TB-specific approach was households in countries’ poorest population quintile with a 
confirmed TB diagnosis. Guidance is not currently available for which TB-affected households 
should be targeted with a TB-specific approach. We chose to focus on TB-affected households 
in countries’ poorest population quintile because they are typically at greater risk of incurring 
catastrophic costs (14). Whilst it might have been preferable to focus on all TB-affected 
households that incur catastrophic costs, at the time of analysis no estimates of the size of 
this population were available in any countries included in this study. The target population 
for cash transfers provided with a TB-sensitive approach was households in poverty already 
targeted by countries’ established governmental poverty-reduction cash transfer 
programme." 
Setting and 
location 
5 
State relevant aspects of 
the system(s) in which the 
decision(s) need(s) to be 
made.  
Methods, paragraph 1: "The setting was low- and middle-income countries, where over 95% 
of TB cases live, and where formal institutions to protect households from the social and 
economic impacts of illness are weakest." 
Study perspective  6 
Describe the perspective of 
the study and relate this to 
the costs being evaluated. 
Methods, paragraph 1: "Using only TB-related costs incurred by patients, study outcomes 
were assessed from the patient perspective." 
Comparators  7 
Describe the interventions 
or strategies being 
compared and state why 
they were chosen. 
Methods, paragraph 1: "The intervention being investigated was cash transfers paid to poor 
households in low- and middle-income countries, and the alternative approaches being 
compared were cash transfers provided with either a TB-specific or a TB-sensitive approach. 
These approaches were compared because of current uncertainty about the impact and 
country-level cost of each approach." 
Time horizon  8 
State the time horizon(s) 
over which costs and 
consequences are being 
evaluated and say why 
appropriate. 
Methods, paragraph 2: "Catastrophic costs were estimated over a time horizon from the 
month prior to TB symptom onset to TB treatment completion. Countries’ country-level cash 
transfer budget were estimated over a time horizon of one year." 
Discount rate  9 
Report the choice of 
discount rate(s) used for 
costs and outcomes and say 
why appropriate. 
This study did not use a discount rate for costs. 
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Choice of health 
outcomes 
10 
Describe what outcomes 
were used as the 
measure(s) of benefit in the 
evaluation and their 
relevance for the type of 
analysis performed. 
Methods, paragraph 2: "Primary study outcomes were an indicator for catastrophic costs 
after TB-specific versus TB-sensitive cash transfers, and countries’ country-level cash transfer 
budget needed to prevent catastrophic costs for each of these approaches." 
Measurement of 
effectiveness 
11a  
Single study-based 
estimates: Describe fully 
the design features of the 
single effectiveness study 
and why the single features 
of the single effectiveness 
study and why the single 
study was a sufficient 
source of clinical 
effectiveness data. 
This study used single study-based estimates of average TB-related costs, cash transfers and 
household income as input parameters for the seven countries included in the analysis. 
Methods, paragraph 5 describes how included TB-related cost data were identified by 
systematic review. Results, paragraph 2 and 3 provides a summary of TB-related cost data 
sources used in the study 
Methods, paragraph 6 describes how included cash transfer data were identified by rigorous 
review of data from the World Bank Atlas of Social Protection Indicators of Resilience and 
Equity. Table S11 provides a summary of cash transfer data sources used in the study. 
Methods, paragraph 7 describes how included household income data were identified by 
rigorous search of countries’ national statistical websites and the international household 
survey network website. Table S11 provides a summary of household income data sources 
used in the study. 
 11b  
Synthesis-based estimates: 
Describe fully the methods 
used for identification of 
included studies and 
synthesis of clinical 
effectiveness data. 
This study did not use synthesis based estimates for its input parameters. 
Measurement 
and valuation of 
preference based 
outcomes 
12 
If applicable, describe the 
population and methods 
used to elicit preferences 
for outcomes. 
This study did not attempt to elicit preferences for outcomes. 
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Estimating 
resources and 
costs  
13a 
Single study-based 
economic evaluation: 
Describe approaches used 
to estimate resource use 
associated with the 
alternative interventions. 
Describe primary or 
secondary research 
methods for valuing each 
resource item in terms of its 
unit cost. Describe any 
adjustments made to 
approximate to opportunity 
costs. 
This study was not a single study-based economic evaluation. 
 13b 
Model-based economic 
evaluation: Describe 
approaches and data 
sources used to estimate 
resource use associated 
with model health states. 
Describe primary or 
secondary research 
methods for valuing each 
resource item in terms of its 
unit cost. Describe any 
adjustments made to 
approximate to opportunity 
costs. 
Resource use, value and opportunity costs associated with model health states were not 
estimated in this study. 
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Currency, price 
date, and 
conversion 
14 
Report the dates of the 
estimated resource 
quantities and unit costs. 
Describe methods for 
adjusting estimated unit 
costs to the year of 
reported costs if necessary. 
Describe methods for 
converting costs into a 
common currency base and 
the exchange rate. 
Methods, paragraph 10 describes methods for adjusting included monetary data to a 
common year and converting it into a common currency: "To allow comparison of monetary 
data extracted in different currencies and measured in different years all extracted monetary 
values were inflated and converted to 2013 international dollars ($) using the purchasing 
power parity conversion factor that accounts for differences in the cost of living across 
countries." 
Choice of model 15 
Describe and give reasons 
for the specific type of 
decision analytical model 
used. Providing a figure to 
show model structure is 
strongly recommended. 
The analytical model used in this study is represented by the quantitative relationship 
between TB-related costs, household income and cash transfers depending on whether cash 
transfers are provided with a TB-specific or a TB-sensitive approach. Methods, paragraphs 13-
17, give reasons for the specific for the specific type of decision analytical model used. Box 2 
provides a summary of how the relationships between TB-related costs, household income 
and cash transfers is modelled depending on whether cash transfers are provided with a TB-
specific or a TB-sensitive approach 
Assumptions 16 
Describe all structural or 
other assumptions 
underpinning the decision-
analytical model. 
Assumptions were made about the size of countries’ TB-specific target population. Methods, 
paragraph 8 describes this: "Because estimates of the percentage of TB-affected households 
represented in the poorest population quintile were not available in any countries included in 
the study, we used the unweighted mean multiplier for TB prevalence in the poorest 
population quintile observed in India and South Africa to estimate the size of countries’ TB-
specific target population. Therefore, countries TB-specific target population was extracted as 
40% of countries’ estimated 2013 DS TB burden or 2015 DR TB burden. For country estimates 
of DR TB burden, we used 2015 estimates because 2013 estimates weren’t available. We 
assumed that each estimated case of active TB disease in the World Health Organisation’s TB 
data represented one household with a confirmed TB diagnosis." 
 
Assumptions were also made about the value of missing cost components of countries TB-
related costs. Methods, paragraph 11 describes this: "In countries that had missing values for 
direct or indirect costs, pre- or during-treatment we estimated their value. To do this, we 
assumed that average TB-related costs followed a make-up of cost components equivalent to 
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the one synthesised by Tanimura et al. in their systematic review of TB-related costs in low- 
and middle-income countries, which is that direct and indirect costs are equivalent to 40% 
and 60% of total costs respectively, and pre- and during-treatment costs are each equivalent 
to 50% of total costs respectively" 
 
An assumption was made about countries’ average household income value. Methods, 
paragraph 7 describes this: "For countries with an eligible TB-related cost survey and existing 
poverty-reduction cash transfer programme, we used countries’ mean household income or 
expenditure in the poorest population quintile to approximate household income of both TB-
specific and TB-sensitive target populations." 
 
Assumptions were made about the standard deviation of included estimates of countries 
average TB-related costs, cash transfers, and household income. Methods, paragraph 12 
describes this: "Random samples were generated for TB-related costs using a standard 
deviation with a ratio of 1.1 to mean estimates, which was the ratio estimated by Tanimura et 
al. for average total costs across all low- and middle-income countries, and a sample size 
equivalent to countries’ cost surveys (3). For annual household income, we used a standard 
deviation with a ratio of 0.8 to mean estimates, which was the average observed across two 
studies investigating the household-level income effect of poverty-reduction cash transfer 
programmes in Brazil and Colombia (4,5), and a sample size equivalent to countries’ 
household income surveys (6–12). For cash transfers, we used a standard deviation with a 
ratio to mean estimates equivalent to a quarter of maximum minus minimum cash transfers, 
and a sample size equivalent to the one reported in studies from which we extracted mean 
cash transfers. In Ecuador and Ghana, we did not simulate sampling distributions for cash 
transfers because respectively, all beneficiary households receive the same flat cash transfer, 
and the mean cash transfer we extracted was estimated from all beneficiary households." 
Analytical 
methods 
17 
Describe all analytical 
methods supporting the 
evaluation. This could 
include methods for dealing 
with skewed, missing, or 
censored data; 
extrapolation methods; 
In this study, missing data was interpolated. Methods, paragraph 11 describes how this was 
done: "In countries that had missing values for direct or indirect costs, pre- or during-
treatment we estimated their value. To do this, we assumed that TB-related costs followed a 
make-up of cost components equivalent to the one synthesised by Tanimura et al. in their 
systematic review of TB-related costs in low- and middle-income countries, which is that 
direct and indirect costs are equivalent to 40% and 60% of total costs respectively, and pre- 
and during-treatment costs are each equivalent to 50% of total costs respectively." 
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methods for pooling data; 
approaches to validate or 
make adjustments (such as 
half cycle corrections) to a 
model; and methods for 
handling population 
heterogeneity and 
uncertainty.  
 
In this study a multiway analysis was used to account for uncertainty in input parameters. 
Methods, paragraph 12 describes how this was done: "To account for uncertainty in the value 
of extracted TB-related costs, annual household income and cash transfers, we conducted a 
multiway analysis that allowed all three of these inputs to vary simultaneously according to 
their sampling distributions. Sampling distributions were simulated from 10,000 
computationally generated random samples, and were all assumed normal according to the 
central limit theorem." 
 
In this study, sensitivity analyses were run to test the sensitivity of results to imputation of 
missing data, and the use of a 20% threshold for defining catastrophic costs. Methods, 
paragraph 18 describes how this was done: "We tested the sensitivity of our results in Brazil, 
Colombia, Tanzania and Mexico to imputation of missing TB-related cost components by 
repeating our analysis omitting rather than imputing the value of missing TB-related cost 
components. We separately tested the sensitivity of our results across all countries included 
in the study to the use of 20% as the threshold for measuring countries’ TB-related cost 
burden as catastrophic. We did this by repeating our analyses instead using a 10% and 30% 
threshold." 
Results    
Study parameters 18 
Report the values, ranges, 
references, and, if used, 
probability distributions for 
all parameters. Report 
reasons or sources for 
distributions used to 
represent uncertainty 
where appropriate. 
Providing a table to show 
the input values is strongly 
recommended. 
Table 1, Table 2 and Table S12 report values, 95% confidence intervals or ranges, and 
probability distributions with reasoning for all TB-related cost, cash transfers and household 
income data used in the study. 
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Incremental costs 
and outcomes 
19 
For each intervention, 
report mean values for the 
main categories of 
estimated costs and 
outcomes of interest, as 
well as mean differences 
between the comparator 
groups. If applicable, report 
incremental cost-
effectiveness ratios.  
Figure 2 and Table S12 report included countries TB-related cost burden before cash 
transfers, and after TB-specific or TB-sensitive cash transfers. Table 3 reports included 
countries’ household-level additional and total cash transfer needed to prevent catastrophic 
costs. Figure 3 and Table S13 report included countries’ total TB-specific or TB-sensitive 
country-level cash transfer budget needed to prevent catastrophic costs. 
Characterising 
uncertainty 
20a 
Single study-based 
economic evaluation: 
Describe the effects of 
sampling uncertainty for 
the estimated incremental 
cost and incremental 
effectiveness parameters, 
together with the impact of 
methodological 
assumptions (such as 
discount rate, study 
perspective). 
This study was not a single study-based economic evaluation. 
 20b 
Model-based economic 
evaluation: Describe the 
effects on the results of 
uncertainty for all input 
parameters, and 
uncertainty related to the 
Results, paragraph 11 describes the effects of imputation of missing cost components on the 
results: "Before cash transfers, the TB-related cost burden remained catastrophic in the same 
countries as when missing TB-related cost components were imputed, and the only difference 
after cash transfers was that TB-specific cash transfers prevented catastrophic costs in 
Colombia, Table S12. Across countries, TB-specific cash transfers remained more affordable at 
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structure of the model and 
assumptions. 
preventing catastrophic costs compared to TB sensitive cash transfers both at the household 
and country level, Table S13." 
 
Results, paragraph 12 describes the effects of using a 10% threshold TB-related cost burden 
for measuring catastrophic costs instead of a 20% threshold: "Before cash transfers, in 
addition to Colombia, Ecuador, Ghana, Mexico, Tanzania and Yemen, the DS TB-related cost 
burden was also catastrophic in Brazil. In Ecuador, the DR TB-related cost burden before cash 
transfers remained catastrophic. Across countries, TB-specific cash transfers remained more 
affordable than TB-sensitive cash transfers at preventing DS and DR TB catastrophic costs 
both at the household and country level, Table S16. " 
 
Results, paragraph 13 describes the effects of using a 30% threshold TB-related cost burden 
for measuring catastrophic costs instead of a 20% threshold: "Before cash transfers, the DS 
TB-related cost burden remained catastrophic in Colombia, Ghana, Mexico, Tanzania and 
Yemen, but ceased to be catastrophic in Ecuador. In Ecuador, the DR TB-related cost burden 
before cash transfers remained catastrophic. Across countries, TB-specific cash transfers 
remained more affordable than TB-sensitive cash transfers at preventing DS and DR TB 
catastrophic costs both at the household and country level, Table S17: Summary of countries’ 
household-level additional and total cash transfer, and country-level cash transfer budget 
needed to prevent catastrophic costs using a 30% threshold TB-related cost burden for 
measuring catastrophic costs." 
Characterising 
heterogeneity 
21 
If applicable, report 
differences in costs, 
outcomes, or cost-
effectiveness that can be 
explained by variations 
between subgroups of 
patients with different 
baseline characteristics or 
other observed variability in 
effects that are not 
reducible by more 
information. 
This study considered differences in costs and outcomes between patients with drug-
susceptible and drug-resistant TB. Findings and their implications are consistently reported 
separately for these two subgroups.  
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Discussion    
Study findings, 
limitations, 
generalisability, 
and current 
knowledge 
22 
Summarise key study 
findings and describe how 
they support the 
conclusions reached. 
Discuss limitations and the 
generalisability of the 
findings and how the 
findings fit with current 
knowledge. 
Discussion, paragraphs 1 and 2 summarise key study findings. Discussion, paragraph 3 
describes how the study’s findings support the conclusions reached. Discussion, paragraph 5 
discusses the study’s limitations. Discussion, paragraph 6 discusses how the study’s findings fit 
with current knowledge. 
Other    
Source of funding 23 
Describe how the study was 
funded and the role of the 
funder in the identification, 
design, conduct, and 
reporting of the analysis. 
Describe other non-
monetary sources of 
support. 
The financial disclosure field describes how the study was funded: "This research and 
members of the research team were funded by the Medical Research Council (award 
MR/K006584/1); the charity Innovation For Health And Development (IFHAD); the Joint Global 
Health Trials consortium (MRC, DFID, & Wellcome Trust award MR/K007467/1); the Bill and 
Melinda Gates Foundation (award OPP1118545); TB REACH and the Wellcome Trust (award 
104473/Z/14/Z). The funders had no role in study design, data collection and analysis, 
decision to publish, or preparation of the manuscript." 
Conflicts of 
interest 
24 
Describe any potential for 
conflict of interest of study 
contributors in accordance 
with journal policy. In the 
absence of a journal policy, 
we recommend authors 
comply with International 
Committee of Medical 
Journal Editors 
recommendations. 
Conflicting interests are described in the competing interests field with the disclaimer: "All 
authors have declared that they have no competing interests. CAE notes that he is an 
academic editor for PLOS Medicine." 
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Table S11. Summary of cash transfer and household income data sources. 
Country 
Cash transfer data Household income data 
Poverty-reduction 
cash transfer 
programme 
Year of reported 
data 
Sample size, 
in 
households 
Household income or 
expenditure survey 
Year of 
reported 
data 
Sample size, 
in 
households 
Household 
income† 
2013 PPP$ 
Brazil 
Programa Bolsa 
Familia (4,13) 
2008 and 2013 9,149 
Pesquisa de Orçamentos 
Familiares (6) 
2008 55,970 5,331 
Ecuador 
Bono de Desarollo  
Humano (14) 
2013 N.A. 
Encuesta Nacional de 
Ingresos y Gastos de los 
Hogares Urbanos y Rurales 
(7) 
2011 40,932 8,692 
Yemen 
Social Welfare Fund 
(15) 
2013 3,886 
Household Budget Survey 
(8) 
2005 13,136 2,143 
Tanzania 
Productive Social 
Safety Net (16–18) 
2013, 2014 and 2015 892 
Household Budget Survey‡ 
(9) 
2007 10,466 2,812 
Ghana 
Livelihood 
Empowerment 
Against Poverty (19) 
2014 72,400 
Ghana Living Standards 
Survey-Round Five (10) 
2006 8,687 1,785 
Colombia 
Mas Familias en 
Accion (5,20) 
2005 and 2013 2,804 
Encuesta Nacional de 
Ingresos y Gastos de los 
Hogares (11) 
2006 42,733 2,214 
Mexico 
Oportunidades* 
(21,22) 
2004 and 2013 5,055 
Encuesta Nacional de 
Ingresos y Gastos de los 
Hogares (12) 
2010 30,169 4,755 
Abbreviations: PPP, purchasing power parity. *Formerly PROGRESA. †Refers to mean annual household income in countries’ poorest population quintile. 
‡Survey only reported mean household expenditure in country’s poorest population quintile. 
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Table S12. Summary of countries’ household-level TB-related cost burden before, and after cash transfers. 
  TB-related cost burden (% of annual household income) * 
Country 
Before cash transfers 
(95% CIs) †‡ 
After TB-specific cash transfers 
(95% CIs) †‡ 
After TB-sensitive cash 
transfers (95% CIs) †‡ 
DS TB    
Brazil 15 (12 to 18) 0.0 (0.0 to 2.0) 13 (10 to 15) 
Ecuador 27 (21 to 32) 14 (8.6 to 20) 24 (19 to 29) 
Yemen 41 (36 to 46) 0.0 (0.0 to 3.3) 28 (25 to 32) 
Tanzania 59 (46 to 73) 51 (38 to 63) 55 (43 to 67) 
Ghana 68 (55 to 80) 42 (30 to 55) 54 (44 to 64) 
Colombia 64 (53 to 75) 26 (15 to 38) 46 (38 to 55) 
Mexico 125 (105 to 145) 106 (86 to 126) 105 (88 to 121) 
DR TB    
Ecuador 192 (86 to 299) 179 (74 to 286) 170 (77 to 265) 
Abbreviations: CI, confidence interval; DS, drug-susceptible; DR, drug-resistant; TB, tuberculosis. The “Before cash transfers” column represents countries’ 
mean TB-related cost burden without cash transfer data. The “After TB-specific cash transfers” column represents countries’ mean TB-related cost burden 
after cash transfers have been subtracted from TB-related costs. The “After TB-sensitive cash transfers” column represents countries’ mean TB-related cost 
burden after cash transfers have been added to countries’ pre-illness household income. *Household income refers to average household income in the 
poorest population quintile. †For interpretability, negative estimates and confidence intervals were reported as 0. ‡To estimate 95% confidence intervals, 
all mean TB-related costs were assumed to have a standard deviation with a ratio of 1.1 to their value (3), all mean household incomes were assumed to 
have a standard deviation with a ratio of 0.8 to their value (4,5), and all mean cash transfers were assumed to have a standard deviation equal to a quarter 
of maximum minus minimum cash transfers. Probability distributions for all three input parameters were assumed to be normal. This was justified because 
our analysis was at the national level and we used mean values.  
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Table S13. Summary of countries’ country-level cash transfer budget needed to prevent catastrophic costs. 
 Cash transfer budget (2013 PPP$ in millions) 
Country 
0.5% of  
country GDP 
Poverty-reduction 
programme (Range) 
TB-specific approach 
(95% CIs) *† 
TB-sensitive approach 
(95% CIs) *† 
DS TB     
Brazil 16,061 11,593 (7,835-25,412) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 
Ecuador 857 485 3.8 (3.8-3.8) ‡ 1,337 (491-2,417) 
Yemen 483 1,391 (927-1,546) 4.4 (4.4-4.5) 3,424 (2,614-4,228) 
Tanzania 588 32 (22-44) 75 (50-100) 833 (556-1,106) 
Ghana 518 32 (24-46) 15 (11-19) 298 (219-378) 
Colombia 3,009 2,216 (506-4,705) 5.9 (5.0-7.3) 126,352 (93,595-159,037) 
Mexico 10,023 6,204 (1,624-13,616) 50 (41-60) 165,367 (134,085-196,425) 
DR TB     
Ecuador 857 485 4.5 (1.6-7.3) 33,469 (12,072-55,052) 
Abbreviations: CI, confidence interval; GDP, gross domestic product; DS, drug-susceptible; DR, drug-resistant; TB, tuberculosis. The “0.5% of country GDP” 
column represents the upper limit that governments in low- and middle-income countries spend on a poverty-reduction cash transfer programme (23). The 
“poverty-reduction programme” column represents countries’ actual poverty-reduction cash transfer programme budget. The “TB-specific approach” 
column represents the mean budget that countries would need to prevent their TB-specific target population from incurring catastrophic costs. The “TB-
sensitive approach” column represents the mean budget that countries’ would need to prevent their TB-sensitive target population from incurring 
catastrophic costs. *For interpretability, negative estimates and confidence intervals were reported as 0. †To estimate 95% confidence intervals, all mean 
TB-related costs were assumed to have a standard deviation with a ratio of 1.1 to their value (3), all mean household incomes were assumed to have a 
standard deviation with a ratio of 0.8 to their value (4,5), and all mean cash transfers were assumed to have a standard deviation equal to a quarter of 
maximum minus minimum cash transfers. Probability distributions for all three input parameters were assumed to be normal. This was justified because 
our analysis was at the national level and we used mean values. ‡Because data were highly skewed we reported median instead of mean.  
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Table S14. Summary of countries’ household-level TB-related cost burden before and after cash transfers without imputation of missing costs 
components. 
  
Cash transfers  
(% of) 
TB-related cost burden 
(% of annual household income) * 
Country  
TB-related costs 
(95% CIs) § 
Before cash transfers 
(95% CIs) § 
After TB-specific cash 
transfers (95% CIs) § 
After TB-sensitive cash 
transfers (95% CIs) § 
DS TB         
Brazil† 215 (177-266) 7.3 (5.8-8.7) 0.0 (0.0-0.0) 6.3 (5.0-7.6) 
Tanzania† 28 (23-36) 30 (23-36) 22 (15-28) 28 (20-33) 
Colombia† 119 (102-144) 32 (26-38) 0.0 (0.0-0.0) 23 (19-27) 
Mexico‡ 40 (34-47) 50 (42-58) 30 (22-38) 42 (35-49) 
Abbreviations: CI, confidence interval; DS, drug-susceptible; TB, tuberculosis. The “Before cash transfers” column represents countries’ mean TB-related 
cost burden without cash transfer data. The “After TB-specific cash transfers” column represents countries’ mean TB-related cost burden after cash 
transfers have been subtracted from TB-related costs. The “After TB-sensitive cash transfers” column represents countries’ mean TB-related cost burden 
after cash transfers have been added to countries’ pre-illness household income. *Household income refers to average household income in the poorest 
population quintile. †TB-related costs only refer to mean total costs incurred during TB treatment. ‡TB-related costs only refer to mean direct costs. §To 
estimate 95% confidence intervals, all mean TB-related costs were assumed to have a standard deviation with a ratio of 1.1 to their value (3), all mean 
household incomes were assumed to have a standard deviation with a ratio of 0.8 to their value (4,5), and all mean cash transfers were assumed to have a 
standard deviation equal to a quarter of maximum minus minimum cash transfers.  
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Table S15. Summary of countries’ household-level additional and total cash transfer, and country-level cash transfer budget needed to prevent 
catastrophic costs without imputation of missing costs components. 
 
Additional cash transfer 
2013 PPP$ (95% CIs) ‡ 
Total cash transfer,  
2013 PPP$ (95% CIs) ‡ 
Cash transfer budget, 
2013 PPP$ in millions (95% CIs) ‡ 
Country  
TB-specific 
approach 
TB-sensitive 
approach 
TB-specific 
approach 
TB-sensitive 
approach 
TB-specific  
approach 
TB-sensitive 
approach 
DS TB       
Brazil* 
0.0  
(0.0-0.0) 
0.0  
(0.0-0.0) 
0.0  
(0.0-0.0) 
0.0  
(0.0-0.0) 
0.0  
(0.0-0.0) 
0.0  
(0.0-0.0) 
Tanzania* 
63  
(0.0-225) 
1,136  
(209-2,063) 
294  
(229-459) 
1,367  
(441-2,294) 
20  
(16-31) 
205  
(66-344) 
Colombia* 
0.0  
(0.0-0.0) 
495  
(0.0-1,097) 
837  
(823-851) 
1,332  
(835-1,934) 
5.0  
(4.9-5.1) 
34,637  
(21,713-50,288) 
Mexico† 
490  
(109-870) 
6,208  
(4,314-8,110) 
1,430  
(1,050-1,810) 
7,148  
(5,252-9,048) 
14  
(11-18) 
47,176  
(34,660-59,717) 
Abbreviations: PPP, purchasing power parity; CI, confidence interval; DS, drug-susceptible; TB, tuberculosis. The “additional cash transfer” column 
represents the additional value of cash transfer that countries’ average TB-affected household would need to prevent catastrophic costs using a TB-specific 
versus a TB-sensitive approach. The “total cash transfer” column represents the total value that countries’ average TB-affected household would need to 
prevent catastrophic costs using a TB-specific versus a TB-sensitive approach. The “cash transfer budget, in millions” column represents the mean budget 
that countries would need to prevent catastrophic costs for its TB-specific versus TB-sensitive target populations. *TB-related costs only refer to mean total 
costs incurred during TB treatment. †TB-related costs only refer to mean direct costs. ‡To estimate 95% confidence intervals, all mean TB-related costs 
were assumed to have a standard deviation with a ratio of 1.1 to their value (3), all mean household incomes were assumed to have a standard deviation 
with a ratio of 0.8 to their value (4,5), and all mean cash transfers were assumed to have a standard deviation equal to a quarter of maximum minus 
minimum cash transfers.  
254 
Table S16. Summary of countries’ household-level additional and total cash transfer, and country-level cash transfer budget needed to prevent 
catastrophic costs using a 10% threshold TB-related cost burden for measuring catastrophic costs. 
  
Additional cash transfer, 
2013 PPP$ (95% CIs) * 
Total cash transfer, 
2013 PPP$ (95% CIs) * 
Cash transfer budget, 
2013 PPP$ in millions (95% CIs) * 
Country 
TB-specific 
approach 
TB-sensitive 
approach 
TB-specific 
approach 
TB-sensitive 
approach 
TB-specific 
approach 
TB-sensitive 
approach 
DS TB             
Brazil 0.0 (0.0-0.0) 1,595 (32-3,156) 823 (815-831) 2,424 (855-3,976) 29 (28-29) 33,939 (11,976-55,659) 
Ecuador 365 (0.0-854) 13,467 (8,593-18,360) 1,464 (1,091-1,945) 14,558 (9,684-19,451) 5.2 (3.8-6.8) 6,551 (4,358-8,753) 
Yemen 0.0 (0.0-0.0) 5,786 (4,711-6,856) 923 (920-926) 6,709 (5,632-7,779) 4.4 (4.4-4.5) 10,064 (8,448-11,669) 
Tanzania 1,175 (805-1,540) 13,701 (10,006-17,346) 1,392 (1,022-1,756) 13,918 (10,223-17,562) 94 (69-119) 2,088 (1,533-2,634) 
Ghana 578 (355-806) 9,835 (7,609-12,118) 1,029 (806-1,257) 10,286 (8,060-12,569) 18 (14-22) 720 (564-880) 
Colombia 356 (106-608) 11,096 (8,579-13,618) 1,193 (942-1,445) 11,933 (9,417-14,448) 7.2 (5.7-8.7) 310,268 (244,845-375,659) 
Mexico 4,547 (3,597-5,490) 53,926 (44,445-63,345) 5,487 (4,539-6,428) 54,866 (45,387-64,281) 55 (45-64) 362,118 (299,555-424,258) 
DR TB       
Ecuador 
14,652 (5,142-
24,241) 
156,334 (61,239-
252,232) 
15,744 (6,233-
25,332) 
157,435 (62,330-
253,323) 
4.7 (1.9-7.6) 70,846 (28,049-113,995) 
Abbreviations: PPP, purchasing power parity; CI, confidence interval; DS, drug-susceptible; DR, drug-resistant; TB, tuberculosis. The “additional cash 
transfer” column represents the additional value of cash transfer that countries’ average TB-affected household would need to prevent catastrophic costs 
using a TB-specific versus a TB-sensitive approach. The “total cash transfer” column represents the total value that countries’ average TB-affected 
household would need to prevent catastrophic costs using a TB-specific versus a TB-sensitive approach. The “cash transfer budget, in millions” column 
represents the mean budget that countries would need to prevent catastrophic costs for their TB-specific versus TB-sensitive target populations. *To 
estimate 95% confidence intervals, all mean TB-related costs were assumed to have a standard deviation with a ratio of 1.1 to their value (3), all mean 
household incomes were assumed to have a standard deviation with a ratio of 0.8 to their value (4,5), and all mean cash transfers were assumed to have a 
standard deviation equal to a quarter of maximum minus minimum cash transfers.  
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Table S17. Summary of countries’ household-level additional and total cash transfer, and country-level cash transfer budget needed to prevent 
catastrophic costs using a 30% threshold TB-related cost burden for measuring catastrophic costs. 
  
Additional cash transfer 
2013 PPP$ (95% CIs) * 
Total cash transfer 
2013 PPP$ (95% CIs) * 
Cash transfer budget 
2013 PPP$ in millions (95% CIs) * 
Country  
TB-specific  
approach 
TB-sensitive 
approach 
TB-specific 
approach 
TB-sensitive 
approach 
TB-specific 
approach 
TB-sensitive 
approach 
DS TB             
Brazil 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 
Ecuador 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 
Yemen 0.0 (0.0-0.0) 0.0 (0.0-244) 923 (920-926) 952 (920-1,167) 4.4 (4.4-4.5) 1,428 (1,380-1,751) 
Tanzania 612 (242-977) 2,548 (1,314-3,760) 829 (460-1,193) 2,765 (1,533-3,978) 56 (31-81) 415 (230-597) 
Ghana 221 (0-449) 1,788 (1,045-2,551) 673 (451-900) 2,239 (1,496-3,002) 12 (7.9-16) 157 (105-210) 
Colombia 0.0 (0.0-167) 1,665 (826-2,504) 856 (823-1,002) 2,502 (1,661-3,339) 5.1 (4.9-6.0) 65,046 (43,188-86,807) 
Mexico 3,596 (2,646-4,538) 14,179 (11,015-17,317) 4,536 (3,587-5,477) 15,119 (11,958-18,258) 45 (36-55) 99,784 (78,920-120,501) 
DR TB       
Ecuador 
12,913 (3,410-
22,512) 
45,589 (13,911-77,584) 
14,010 (4,501-
23,603) 
46,692 (15,002-78,675) 4.2 (1.4-7.1) 21,011 (6,751-35,404) 
Abbreviations: PPP, purchasing power parity; CI, confidence interval; DS, drug-susceptible; DR, drug-resistant; TB, tuberculosis. The “additional cash 
transfer” column represents the additional value of cash transfer that countries’ average TB-affected household would need to prevent catastrophic costs 
using a TB-specific versus a TB-sensitive approach. The “total cash transfer” column represents the total value that countries’ average TB-affected 
household would need to prevent catastrophic costs using a TB-specific versus a TB-sensitive approach. The “cash transfer budget, in millions” column 
represents the mean budget that countries’ would need to prevent catastrophic costs for their TB-specific versus TB-sensitive target populations. *To 
estimate 95% confidence intervals, all mean TB-related costs were assumed to have a standard deviation with a ratio of 1.1 to their value (3), all mean 
household incomes were assumed to have a standard deviation with a ratio of 0.8 to their value (4,5), and all mean cash transfers were assumed to have a 
standard deviation equal to a quarter of maximum minus minimum cash transfers.
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